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The mammalian forebrain, which consists of the telencephalon and the diencephalon, 
is responsible for many higher cognitive functions such as thinking, learning and 
memory. The cerebral cortex, which is important for language and processing 
information, is located in the dorsal portion of the telencephalon. The basal ganglia, 
which are important for movement, are located in the ventral telencephalon. Many 
genes are involved in patterning and the development of the forebrain. One gene that 
appears to be crucial for forebrain development is Gli3. Gli3 has been shown to work 
as both a transcriptional activator and a repressor of the Sonic Hedgehog (Shh) 
signalling pathway in the developing spinal cord and limb buds. In the telencephalon, 
Shh has been shown to be important for induction of ventral cell fate, but the exact 
function of Gli3 in the forebrain and the interactions between Gli3 and Shh are still 
obscure.  
 
Previous studies have shown that Gli3 is required for the formation of the cortical 
hem area of the telencephalon, which does not form in Gli3Xt/Xt mutant mice lacking 
functional Gli3. The residual dorsal telencephalon of the Gli3Xt/Xt mutants is partially 
‘ventralized’. 
 
The main aim of this study was to re-examine the developing forebrain of Gli3Xt/Xt 
mouse mutants to gain insight into the function of Gli3 during forebrain 
development. 
 
In this thesis, the expression of Gli3 mRNA and protein was examined in the E12.5 
and E14.5 wild type telencephalon. The highdorsal-to-lowventral expression pattern of 
Gli3 corresponds to severedorsal-to-mildventral defects observed in the Gli3Xt/Xt mutants. 
The ratios between the levels of the cleaved and full length isoforms of Gli3 in dorsal 
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and ventral telencephalon resemble those described in dorsal and ventral spinal cord 
and in the anterior and posterior limb bud, respectively, suggesting Gli3 in the dorsal 
telencephalon may act as a repressor of the Shh signalling pathway. The total amount 
and the ratios of the two isoforms of Gli3 protein were examined in Shh and Foxg1 
null mice, which lack ventral telencephalon. The results obtained agree with a role of 
Gli3 as a repressor of the Shh pathway in the dorsal telencephalon.  
 
The forebrains of Gli3Xt/Xt mutants were analysed systematically both anatomically 
and by molecular markers in this thesis. The border between the telencephalon and 
the diencephalon was delineated in the Gli3Xt/Xt mutants by using a combination of 
markers expressed in different areas within the forebrain. This lead to the observation 
that the previously reported ‘ventralization’ only occurred in the very rostral 
telencephalic sections of the Gli3Xt/Xt mutant embryos, suggesting a possible shape 
change of the Gli3Xt/Xt telencephalon. To examine the possible causes of the 
significant size reduction of Gli3Xt/Xt mutant telencephalon compared to wild type 
telencephalon from E10.5, cell proliferation and cell death properties studies were 
undertaken. The changes observed were not sufficient to explain the phenotypic 
differences between the Gli3Xt/Xt mutant and the wild type embryos indicating that 
they might be the result of an early patterning defect.  
 
The dorsal telencephalon is severely reduced in volume at both E12.5 and E10.5, 
containing cells from adjacent eminentia thalami, probably due to the loss of the 
dorso-medial telencephalon. Large clusters of eminentia thalami cells were observed 
at later developmental stages, when the neocortex becomes highly disorganized, 
forming rosettes comprising mainly neural progenitors. These results suggest Gli3 is 
important for the formation of an intact telencephalic-diencephalic boundary and for 
preventing the abnormal location of diencephalic cells in the dorsal telencephalon.  
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The volume of Gli3Xt/Xt ventral telencephalon was increased compared to that of the 
wild types at E10.5, but became smaller than that of the wild type littermates at 
E12.5. This might have been the result of a combination of more cells exiting the cell 
cycle and increased cell death observed in the Gli3Xt/Xt ventral telencephalon at E10.5, 
suggesting Gli3 regulates cell differentiation and cell death properties at this age and 
brain region. The significant expansion of rostro-ventral telencephalon observed in 
the Gli3Xt/Xt mutant might correlate with the expansion of Fgf8 expression and this 























Chapter 1: Introduction 
 
1.1 THE PATTERNING OF THE MAMMALIAN FOREBRAIN 
 
The forebrain, which consists of the telencephalon and the diencephalon, is important 
for learning, memory and movement. The mammalian telencephalon, which contains 
the cerebral cortex (including the hippocampus and the neocortex), basal ganglia and 
olfactory bulbs, is the largest, most complex part of the central nervous system 
(CNS). Telencephalic function is dependent on its connections with other neural 
structures including the thalamus, hypothalamus, olfactory epithelium, etc. Together, 
these structures are essential for transmission of sensory information, integration of 
new sensory information with established memories, and then formulating and 
effecting behavioural responses (Bear et al., 2001). The telencephalon is derived 
from the anterior margin of the neural plate, which is known as the anterior neural 
ridge (ANR) (Rubenstein et al., 1998; Varga et al., 1999; Tomioka et al., 2000; 
Whitlock and Westerfield, 2000). During development, different parts of the 
telencephalon express different sets of genes that instruct the development of each 
area in a region-specific manner, and control processes including cell proliferation, 
cell fate determination and migration. The mechanisms that drive regional patterning 
become more and more complex as the telencephalon develops, but their origins can 
be traced back to interactions between the embryonic germ layers and between the 
embryo and the extra-embryonic tissue before the closure of the neural tube (Sasai 
and De Robertis, 1997).  
 
1.1.1 Mouse early embryogenesis 
 
During the period of early embryogenesis, cells proliferate rapidly from the one cell 
stage, and form the blastocyst (Fig. 1.1A-D). The blastocyst consists of the inner cell 
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mass, which gives rise to the extraembryonic structures and the embryo, and the 
trophectoderm, which becomes the placenta and the extraembryonic membrane. The 
blastocyst continues to form the three primary germ layers of the embryo, the 
endoderm, mesoderm and ectoderm (Fig. 1.1G-I). The endoderm gives rise to the 
inner organs. The mesoderm forms the mesenchyme, the notochord and muscles. The 
ectoderm forms the spinal cord and the outer epithelium of the body and the neural 
tube, which later forms the forebrain (telencephalon and diencephalon), midbrain 
(mesencephalon) and hindbrain (rhombencephalon). The telencephalon arises from 
the most rostral part of the neural tube, and gives rise to the adult neocortex, 

































Figure 1.1 During mouse early embryogenesis, the fertilized egg (A) keeps dividing 
(B) to form first the morula (C) and then the blastocyst (D). The blastocyst implants 
(E) forms the egg cylinder (F). Gastrulation begins at late egg cylinder stage (G). At 
about embryonic day 7 (H), the embryonic mesoderm first emerges. During the 
primitive streak stage (I), the neural plate is defined anteriorly and the head process 
is developing. 1. inner cell mass; 2. trophectoderm; 3. anterior visceral endoderm; 4. 
embryonic ectoderm; 5. embryonic mesoderm; 6. amnion; 7. primitive streak; 8. node. 




































Figure 1.2 Schematic represantation of an E12.5 mouse brain. The forebrain 
consists of the telencephalon (Te) and the diencephalon (Di), which are located in 
the anterior part of the brain. The telencephalon is comprised dorsally, the cerebral 
cortex (ctx), and ventrally, the lateral (LGE) and medial (MGE) ganglionic eminences. 
The mesencephalon (Me) and the rhombencephalon (Rh) are located in the posterior 







1.1.2 Induction of the telencephalon 
 
The forebrain is patterned by many transcription factors and signalling molecules, 
which both regulate antero-posterior (AP) and dorso-ventral (DV) patterning of the 
neural tissue. Signalling molecules, both surrounding and within the telencephalon, 
send signals to regulate expression of transcription factors, which bind to DNA and 
control the transcription of their downstream genes.  
 
Previous studies in fish and frogs support a model in which the induced neural tissue 
will develop anterior character, unless it is exposed to posteriorizing signals (Fekany 
et al., 1999; Koos and Ho, 1999; Fekany-Lee et al., 2000; Hashimoto et al., 2000). 
The primary role for signals that promote forebrain development may be to 
antagonize or negatively regulate factors that would posteriorize the anterior neural 
plate. In mammals, there appears to be two signalling centres, one in the node and 
one in the anterior visceral endoderm (AVE) (Fig. 1.1I), which are responsible for 
forming the anterior region of the embryo (Bachiller et al., 2000). When genes 
required for development of the AVE and the node are mutated or lost, embryos lose 
anterior structures including the telencephalon (Knoetgen et al., 1999; Bachiller et al., 
2000). Although it is still unclear how exactly they regulate brain development, they 
may produce signals including antagonists of Wingless-type MMTV integration site 
(Wnt), bone morphogenetic proteins (Bmp) (including Noggin and Chordin) and 
Nodal signalling (Glinka et al., 1998; Niehrs, 1999; Piccolo et al., 1999; Bachiller et 
al., 2000; Foley et al., 2000), which are required for the induction and/or 
maintenance of the adjacent neural plate.  
 
Houart and colleagues (Houart et al., 2002) showed that the local antagonism of Wnt 
signalling within the anterior neural plate can result in ectopic induction of 
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telencephalon in wild type embryos. Furthermore, they provided evidence that the 
posterior diencephalon is a likely source of Wnt ligands, including Wnt8b, which 
antagonize telencephalic specification. Thus, telencephalic identity is established 
through local suppression of Wnt signalling in the anterior neural plate during 
gastrulation.  
 
The inhibition of BMP activity through the action of Bmp antagonists from the node 
has also been shown to be crucial in establishing all anterior neural plate fates, 
including the telencephalon, the diencephalon, and the eye (Wilson and Edlund, 
2001). Mice lacking activity of extracellular Bmp antagonists Chordin and Noggin 
lack forebrain (Bachiller et al., 2000).  
 
1.1.3 Antero-posterior (AP) patterning of the telencephalon 
 
Subsequent to the initial subdivision of the neural plate, each territory undergoes 
further regional patterning. The earliest step in telencephalic induction is mediated 
by an organizer at the rostral-most end of the neural plate known as the anterior 
neural ridge (ANR), which is a specialised tissue found at the junction between the 
anterior neural plate and the non-neural ectoderm (Fig. 1.3) (Shimamura and 
Rubenstein, 1997; Houart et al., 1998). Removal of the ANR from explants results in 
a failure to express the winged-helix transcription factor Foxg1 (previous known as 
Bf1) (Xuan et al., 1995), which marks the future telencephalon (Shimamura and 
Rubenstein, 1997) and is required for neural telencephalic and cortical 
morphogenesis (Xuan et al., 1995; Dou et al., 1999; Hanashima et al., 2004; 
Martynoga et al., 2005).  
 
Fibroblast growth factors (Fgfs) have been suggested to be crucial in patterning the 
AP axis of the telencephalon. Several members, including Fgf8, Fgf17 and Fgf18 are 
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expressed in the anterior end of the telencephalon, the commissural plate (also 
known as ANR) (Fig. 1.3) (Maruoka et al., 1998). Among them, Fgf8 has been 
demonstrated to be particularly important (Lee et al., 1997; Shimamura and 
Rubenstein, 1997; Meyers et al., 1998; Martinez et al., 1999; Crossley et al., 2001; 
Fukuchi-Shimogori and Grove, 2001). Fgf8 expression in the commissural plate 
instructs cells along the AP axis to express different levels of regulatory genes that in 
turn result in the adoption of different fates. Fgf8 has been suggested to regulate 
Foxg1 expression (Shimamura and Rubenstein, 1997; Ye et al., 1998; Erter et al., 
2001), and Fgf8 expression is reduced in the Foxg1-/- mutants (Martynoga et al., 
2005). Fgf8 expression is probably initiated too late (around E6) in embryonic 
development (Crossley and Martin, 1995) to be the primary inducer of the 
telencephalon, and indeed much of the telencephalon is still present in mice mutant 
for Foxg1 (Meyers et al., 1998; Martynoga et al., 2005), suggesting there must be 
other signalling pathways that help induce the telencephalon.  
 
Another signalling pathway that might influence early AP patterning is the Wnt 
pathway, which is suggested to be critical for the establishment of the earliest 
subdivision of the neural plate (Yamaguchi, 2001; Houart et al., 2002). For instance, 
Wnt8 and the extracellular Wnt antagonists Dikkopf-1 (Dkk-1) are important for the 
establishment of the vertebrate head. Forebrain is absent in mice lacking the function 
of Dkk-1 (Mukhopadhyay et al., 2001), and the loss of Wnt8 expression in zebrafish 
results in an enlarged forebrain, while more caudal neural tissue is reduced in size or 

















Figure 1.3 Mid-sagittal view of an E12.5 wild type embryo showing the signalling 
centres within the forebrain. Several Fgf family members, including Fgf8, Fgf17 and 
Fgf18, are expressed in the anterior neural ridge (ANR, red). A cocktail of Wnt and 
Bmp genes are expressed in the cortical hem and the surrounding dorso-medial 
telencephalon (green). Shh is expressed in the ventral telencephalon (vTel), the 









1.1.4 Dorso-ventral (DV) patterning of the telencephalon 
 
Dorso-ventral patterning mainly occurs later than antero-posterior patterning (Zaki et 
al., 2003), and the telencephalon becomes specified into dorsal (pallial) and ventral 
(subpallial) regions. The pallium gives rise to the cerebral cortex, while the 
subpallium consists of the medial (MGE) and lateral (LGE) ganglionic eminences, 
which later form the globus pallidus and the striatum of the basal ganglia.  
 
1.1.4.1 Regional subdivisions along the DV axis of the telencephalon 
 
The boundary between the dorsal and ventral telencephalon does not lie at the 
morphological angle of the pallium and LGE, but is slightly more ventral in the 
dorsal-most portion of the LGE (Puelles et al., 2000; Campbell, 2003). The 
expression of many transcription factors abuts the pallial-subpallial boundary (PSB); 
for example, Pax6 is expressed on the dorsal side and Gsh2 is expressed on the 
ventral side (Toresson et al., 2000; Yun et al., 2001).  
 
The dorsal telencephalon (pallium) can be subdivided into ventral, lateral, dorsal and 
medial components, which give rise to neurons of the claustroamygdaloid complex, 
lateral cortex, neocortex and hippocampus, respectively (Puelles et al., 1999; Puelles 
et al., 2000; Stoykova et al., 2000; Yun et al., 2001). The ventral pallium is defined 
both by its expression of Pax6 in the ventricular zone and Tbr1 in the mantle region, 
and lacks Emx1 expression (Puelles et al., 1999; Puelles et al., 2000). The boundaries 
of the other dorsal domains are not as easily marked by distinct gene expression as 
the ventral pallium. These regions show gradients of gene expression. For example, 
Emx1, Emx2 (Simeone et al., 1992; Gulisano et al., 1996) and Lhx2 (Monuki et al., 
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2001) show their highest expression in the medial pallium, and progressive reduction 
of expression in more ventral regions. In contrast, Pax6 and Tbr2 show the opposite 
pattern with their highest expression in the ventricular zone of the ventral and lateral 
pallium (Stoykova et al., 2000; Toresson et al., 2000; Yun et al., 2001).  
 
In the ventral telencephalon, many genes are expressed in both the LGE and MGE, 
including Gsh2 in the ventricular zone (Hsieh-Li et al., 1995), and members of the 
Dlx gene family in both the ventricular zone and the subventricular zone (Eisenstat et 
al., 1999). The LGE has been divided into a small dorsal domain (dorsal LGE) and a 
lateral ventral domain (ventral LGE) (Yun et al., 2001). The dorsal LGE expresses 
the Ets gene Er81, which has been suggested to give rise to interneurons that migrate 
in the rostral migratory stream to populate the olfactory bulb (Stenman et al., 2003). 
The mantle zone of the ventral LGE uniquely expresses the LIM homeobox protein 
Islet1 and generates striatal projection neurons (Toresson et al., 2000; Stenman et al., 
2003).  
 
1.1.4.2 Patterning of the dorsal telencephalon 
 
Dorsal structures such as the roof plate and cortical hem are important for the 
dorso-ventral identities of early neurectodermal cells (Lee and Jessell, 1999; Monuki 
et al., 2001). The roof plate has been suggested to be an organizing centre of the 
telencephalon, and to have an essential role in patterning the dorsal telencephalon 
(Monuki et al., 2001; Chizhikov and Millen, 2004). Many members of the Bmp 
family are expressed in the roof plate (Fig. 1.3) (Monuki and Walsh, 2001; Ragsdale 
and Grove, 2001). In vitro studies showed that Bmp2 and Bmp4 from the roof plate 
regulate the dorsal telencephalic development, and, in particular, the expression of 
the homeobox transcription factor Lhx2 (Monuki et al., 2001). In vivo studies also 
showed that when the Bmp receptor in the telencephalon is removed, the choroid 
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plexus is missing, while the dorso-lateral and the ventral telencephalon are normal 
(Hebert et al., 2002), which suggests Bmp signalling has an essential role in 
patterning the dorsal midline (Campbell, 2003). Members of the Wnt protein family 
are also expressed in the dorsal midline region. When Wnt2b is lost from the dorsal 
midline, the roof plate of the telencephalon disappears (Monuki et al., 2001). These 
results suggest that the telencephalic roof plate is a crucial organizing centre of the 
dorsal telencephalon.  
 
Another important dorsal signalling centre within the telencephalon is the cortical 
hem, which is the medial margin of the embryonic cerebral cortex. The cortical hem 
provides patterning signals and gives rise dorsally to the hippocampus and ventrally 
to the choroid plexus, and expresses several Bmp and Wnt genes (Fig. 1.3) (Furuta et 
al., 1997; Grove et al., 1998; Ragsdale and Grove, 2001). Mice mutant for Wnt3a 
show a deletion of the hippocampus, which is represented by tiny populations of 
residual cells or is missing completely, whereas the rest of the neocortical areas 
appear relatively normal (Lee et al., 2000). Mice mutant for Lef1 show a similar 
defect in the hippocampus. Lef1 interferes with the function of several members of 
the TCF/LEF family (Galceran et al., 2000). The TCF/LEF transcription factors 
mediate Wnt signalling via β-catenin (Patapoutian and Reichardt, 2000). Both Wnt3a 
and Lef1 mutants have a reduction in cell proliferation in the hippocampal anlage 
(Galceran et al., 2000; Lee et al., 2000), suggesting that Wnt signalling is required 
for expansion of this structure. Furthermore, certain Wnts are also expressed 
throughout the ventricular zone of the cortex at early stages of telencephalic 
development (Parr et al., 1993; Grove et al., 1998). They may have a broader role in 
patterning the dorsal telencephalon.  
 
It is still poorly understood how signalling molecules influence morphogenesis. One 
of the possibilities is that transcription factors respond to the signalling molecules 
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regionally and activate downstream targets (Monuki and Walsh, 2001; Ragsdale and 
Grove, 2001; Rallu et al., 2002a; Schuurmans and Guillemot, 2002). For instance, 
the downstream genes of Bmp and/or Wnt signalling in the dorsal telencephalon 
interrupt the functions of transcription factors, such as Emx1, Emx2 (Simeone et al., 
1992; Gulisano et al., 1996) and Lhx2 (Monuki et al., 2001). Lhx2 is selectively 
expressed in the cortical ventricular zone, but not in the dorsal midline area (Fig. 1.4). 
Lhx2-/- mutant mice lose almost all cortical progenitor cells and cortical plate neurons, 
while they have a massive excess of cortical hem tissue and choroid plexus in the 
lateral ventricle (Monuki et al., 2001). The expression of Foxg1 and Ngn2 can still be 
found in the remaining cells of the Lhx2-/- mutants, indicating that the specification of 
the cortex is still happening at some level in these mutants. This suggests that Lhx2 is 
not essential for the specification of telencephalic or dorsal identity, but acts instead 
to select a specific cortical fate. In addition, the telencephalic enhancer of the Emx2 
gene has been shown to be expressed at its highest levels in the medial and dorsal 
pallium (Theil et al., 2002a). This enhancer contains binding sites for both Smad and 
Tcf proteins, which are transcriptional mediators of Bmp and Wnt signalling, 
respectively. In addition, Bmps and Wnts can activate this DNA enhancer in 
midbrain explants (Theil et al., 2002a). This leads to the possibility that Bmp 
signalling from the dorsal midline is functionally redundant with Wnt signalling in 
specifying certain aspects of dorsal telencephalic fate (Campbell, 2003).  
 
The transcription factors Emx2 and Pax6 are expressed in the cortical ventricular 
zone in the dorsal telencephalon (Fig. 1.4), and they are suggested to be necessary 
both for the development of dorsal structures such as cortex, and for repressing 
ventral structures such as striatum (Bishop et al., 2000; Stoykova et al., 2000; Tole et 
al., 2000b; Toresson et al., 2000; Yun et al., 2001). Emx2 and Pax6 are expressed in 
graded and opposing fashions within the cortical ventricular zone. The Emx2 
gradient is highposterior-to-lowanterior, highmedial-to-lowlateral, whereas the Pax6 
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expression has a highanterior-to-lowposterior, highlateral-to-lowmedial profile (Bishop et 
al., 2000). Loss of Emx2 function in mice results in size reductions in posterior 
cortical areas (including hippocampus and visual neocortical areas), whereas anterior 
neocortical regions (including motor areas) are either shifted or expanded (Bishop et 
al., 2000). Correspondingly, loss of Pax6 function (Small eye mutations) results in a 
decreased anterior neocortical size (Bishop et al., 2000). Importantly, these defects 
correspond well to the normal expression gradient of Emx2 and Pax6, suggesting 
Emx2 and Pax6 countergradients within the cortical ventricular zone provide an 
intrinsic code that directly regulates the size of the cortical area (Monuki et al., 
2001).  
 
1.1.4.3 Patterning of the ventral telencephalon 
 
The Fgf signalling pathway also appears to regulate patterning along the DV axis, in 
addition to the AP axis. Previous work in fish (Shanmugalingam et al., 2000) showed 
Nkx2.1 expression is reduced and ventral telencephalic midline tissue is disrupted in 
ace mutant embryos that lack Fgf8 function. Indeed, more severe reduction of ventral 
telencephalic markers confirms a role of Fgf signalling in promoting ventral 
telencephalic identity or growth (Wilson and Rubenstein, 2000). Fgf8 hypomorphic 
and conditional null mutants show a loss of rostro-ventral structures, including the 
septum, LGE and MGE (Storm et al., 2006). A recent study has shown that mice 
carrying mutations in Fgf receptors fail to develop ventral telencephalon from very 
early stages, and cells along the DV axis adopt a dorsal fate (Gutin et al., 2006). 
More importantly, an in vitro study provides evidence that ectopic Fgf8 can induce 
ventral markers expression in dorsal telencephalic explants (Kuschel et al., 2003).  
 
Sonic hedgehog (Shh) is a member of the hedgehog (Hh) family of secreted 
signalling proteins implicated in a wide variety of developmental processes (Fig. 1.3). 
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The role of Shh signalling in neural development has been extensively studied in the 
developing mammalian spinal cord (Ericson et al., 1995a; Roelink et al., 1995), and 
it is now clear that Shh and the downstream zinc finger transcription factor Gli3 are 
essential for the patterning of the DV axis, including the telencephalon (Chapter 1.2 
and 1.3).  
 
Retinoic acid (RA) signalling has been suggested to be important for neuronal 
progenitors and neuronal differentiation (Maden et al., 1998; LaMantia, 1999; 
Pierani et al., 1999; Schneider et al., 2001; Diez del Corral et al., 2003). In the spinal 
cord, evidence has led to a model that RA signalling establishes the intermediate 
region of the caudal neural tube, partially by antagonizing Fgf signalling (Diez del 
Corral et al., 2003; Novitch et al., 2003). In the telencephalon, evidence has 
suggested that RA influences anterior forebrain development (Toresson et al., 1999; 
Schneider et al., 2001; Smith et al., 2001; Marklund et al., 2004). Studies in chick 
embryos showed that RA signalling is crucial in specifying telencephalic cells to an 
intermediate fate (including the striatum, the olfactory bulb and parts of the 
amygdala), opposing Fgf functions (Marklund et al., 2004). At later stages of 
telencephalic development, radial glial cells in the LGE serve as a source of RA, and 
retinoid signalling appears to enhance neuronal differentiation (Toresson et al., 
1999).  
 
Several transcription factors such as Pax6, Gsh2 and Nkx2.1 are involved in the DV 
patterning of the telencephalon. Pax6sey/sey mutants show a progressive dorsal spread 
of ventrally-expressed genes, such as Dlx1 and Vax1 (Stoykova et al., 1996). 
Conversely, Gsh2-/- mutants show a reduction in size of LGE and expression of Dlx2 
(Szucsik et al., 1997). Mice carrying both Pax6 and Gsh2 deletions show milder 
phenotypes than single mutants (Toresson et al., 2000; Yun et al., 2001), indicating 
that the interactions between Pax6 and Gsh2 regulate DV patterning on either side of 
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the PSB (Toresson et al., 2000; Yun et al., 2001). In addition, the expression of Pax6 
and Gsh2 is not expanded in the Nkx2.1-/- mutants, and Nkx2.1 expression is not 
expanded in either Pax6Sey/Sey or Gsh2-/- mutants, suggesting neither Pax6 nor Gsh2 
are cross repressive with Nkx2.1 (Corbin et al., 2003). Furthermore, Gsh2;Nkx2.1 
double mutants show combined phenotypes of both Nkx2.1 and Gsh2 single mutants, 
suggesting that Gsh2 and Nkx2.1 cooperate in patterning the LGE and MGE (Corbin 
et al., 2003). Together, these results suggest that homeobox genes function to 
mediate DV patterning of the telencephalon and establish boundaries between 
regional subdivisions.  
 
Pax6 and Gsh2 are also suggested to control telencephalic patterning by regulating 
Mash1, Neurogenin1 (Ngn1) and Neurogenin2 (Ngn2) expression (Yun et al., 2001). 
Ngn1, Ngn2 and Mash1 encode basic helix-loop-helix (bHLH) transcription factors 
that are implicated in regulating telencephalic DV fates (Fode et al., 2000). Ngn1 and 
Ngn2 are expressed in the ventricular zone of the dorsal pallium, lateral pallium, and 
ventral pallium while Mash1 is expressed in the ventricular zone of the LGE and 
MGE as well as the medial pallium (Gradwohl et al., 1996; Sommer et al., 1996; Ma 
et al., 1997). Studies on Ngn1 and Ngn2 mutants show that they function to specify, 
or at least maintain, the dorsal and repress ventral properties including Mash1 
expression (Fode et al., 2000). In contrast, Mash1 is necessary for the development 
of some early-born subpallial neurons (Casarosa et al., 1999; Horton et al., 1999; 
Marin et al., 2000), but it is not necessary for the repression of dorsal properties 
including the expression of Ngn1 and Ngn2 (Casarosa et al., 1999; Yun et al., 2001). 
 
Pax6 mutants show ectopic expression of Mash1 and reduction of Ngn1 and Ngn2 
expression at E10.5. Subpallial markers are present in the pallium of Pax6 mutants 
(Stoykova et al., 1996), which is similar to what happens in the Ngn1 and Ngn2 
mutants (Fode et al., 2000). Toresson et al. (2000) suggested that Pax6 represses 
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ventral genes via Ngn1 and Ngn2. In contrast, Gsh2 mutants show ectopic expression 
of Ngn1 and Ngn2, and the reduction of Mash1 expression in the dLGE at E10.5 
(Yun et al., 2001). However, evidences have shown that Gsh2 is not required for the 
expression of Mash1 and the repression of Ngn1 and Ngn2 directly. The role of Gsh2 
in the telencephalic development is to repress Pax6 and its dorsalizing function and 



























Figure 1.4 Coronal section of E12.5 mouse telencephalon, and the expression 
patterns of transcription factors that are involved in the development of 
telencephalon. Dorsally expressed transcription factors include Emx1, Emx2, Ngn1, 
Ngn2 and Pax6. Gli3, Foxg1 and Lhx2 are expressed in both dorsal and ventral 






The development of functional and morphological subdivisions of the telencephalon 
is incredibly complex. More and more evidence shows that the interaction between 
secreted signalling molecules and transcription factors controls the process of 
telencephalic development. However, there are still critical questions that need to be 
answered. Which signalling centres are involved in the early cortical patterning? 
What is the link between these early signals and the differential expression of the 
transcription factors which appear to be involved in the patterning of the 
telencephalon? How do these and other transcription factors function in patterning 
the telencephalon? To fully understand these processes, we need to identify the 
genetic targets of the signalling molecules and transcription factors that regulate 
regional and neuronal specification, differentiation and migration.  
 




Sonic hedgehog (Shh) along with Desert hedgehog (Dhh) and Indian hedgehog (Ihh) 
are the mammalian homologues of the Drosophila Hedgehog (Hh) family of 
signalling molecules (Riddle et al., 1993; Fietz et al., 1994). Among the three, Shh is 
the only one which has been shown to be expressed in the forebrain (Echelard et al., 
1993; Riddle et al., 1993). The Hh gene was first identified in Drosophila because of 
its role in embryonic segment polarity (Nusslein-Volhard and Wieschaus, 1980) and 
the patterning of the imaginal discs (Mohler, 1988; Tabata et al., 1992; Basler and 
Struhl, 1994). Shh was identified in chick and mouse afterwards, and it was shown to 
be important in patterning the limb and the neural tube (Echelard et al., 1993; Riddle 
et al., 1993; Roelink et al., 1994).  
 33 
 
1.2.1.1 Hh signalling pathway in Drosophila and vertebrates 
 
Hh signalling has been studied in greatest depth in Drosophila (Hooper and Scott, 
2005). The Shh signalling pathway in vertebrates is very similar to the Hh pathway 
(Fig. 1.5). At the cell surface, Shh binds to its receptor Patched 1 (Ptc1), a 
twelve-transmembrane protein (Fig. 1.5a) (Goodrich et al., 1997). Unlike other 
receptors, in the absence of Shh, Ptc1 blocks the downstream signalling pathway, and 
the binding of Shh relieves this repression. A seven-transmembrane protein 
Smoothened (Smo) acts downstream of Ptc1. Smo is an essential positive mediator of 
the Hh signalling pathway (Zhang et al., 2001), by regulating the Gli family of 
transcription factors, Gli1, Gli2 and Gli3 (Murone et al., 1999). Gli responds to Shh 
and functions as a transcriptional activator. In the absence of Shh, Gli3 protein binds 
to Fused (Fu), Supressor of Fused (Sufu), microtubules and is phosphorylated by 
Protein Kinase A (PKA) to form a short cleaved form of Gli3, which acts as a 
transcriptional repressor (Fig. 1.5b) (Ruiz i Altaba, 1999; Sasaki et al., 1999; Shin et 
al., 1999). Several studies in the vertebrate spinal cord and limb development have 
shown that expression of Gli1 and Gli2 results in activation of Shh target genes (Ruiz 
i Altaba, 1999; Sasaki et al., 1999), while expression of Gli3 results in repression of 
Shh target genes (Ruiz i Altaba, 1999; Persson et al., 2002). These suggested that 
Gli1 and Gli2 act primarily as activators, while Gli3 acts both as an activator and 
repressor of the Shh pathway (Ruiz i Altaba, 1998, 1999; von Mering and Basler, 
1999; Aza-Blanc et al., 2000). In the developing forebrain, Gli1 is expressed in the 
ventral forebrain near Shh expression, and Gli1 has been suggested to be a direct 
readout of the Shh signalling pathway (Goodrich et al., 1996; Lee et al., 1997). Gli1 
has been suggested to be redundant with other Gli proteins, because Gli1 knock out 
mice seem to be normal (Park et al., 2000). Studies on Gli2-/- mutants have suggested 
that Gli2 is important for the induction of floor plate cells (Ding et al., 1998), 
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however the role of Gli2 in the developing forebrain is still unknown. Gli2 and Gli3 
might have partially overlapping functions in skeleton formation, but the loss of Gli3 
affects dorsal brain development can not be compensated for by Gli2 (Theil et al., 
1999; Tole et al., 2000). Thus it appears that Gli3 is the major factor in the Shh 




























Figure 1.5 Shh signalling pathway in vertebrates. A. When Shh is present, it binds to 
Patch1 (Ptch1), which relieves Smoothened (Smo). The activation of Smo leads to 
the formation of a macromolecular complex with Su(fu) (Supressor of fused) , PKA, 
and the Gli proteins. These are imported into the nucleus and activate target genes. 
The processing of Gli3 is inhibited. B. In the absence of Sonic hedgehog, Patched 
(Ptch1) inhibits (Smo), blocking the downstream transduction cascade. Gli3 is 
phosphorylated by protein kinase A (PKA), cleaved to form the repressor Gli3 
(Huangfu and Anderson, 2005). 
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1.2.1.2 The phenotype of Shh-/- mutant mice 
 
When humans lose one copy of the Shh gene, they suffer from holoprosencephaly 
(HPE), which made people propose that Shh might be one of the important 
molecules in the development of the CNS. The holoprosencephalic patient has a 
single unpaired telencephalic vesicle and a single eye (Ericson et al., 1996; Roessler 
et al., 1996; Roessler et al., 1997). Ventral structures, such as striatum, are lost in 
some extreme cases (Roessler et al., 1997).  
 
There are many studies about Shh in mammals up to date. Shh-/- mouse mutants die 
at or just before birth. They have fused optic vesicles; they have neither optic stalk 
nor olfactory bulbs (Chiang et al., 1996). Ventral structures are absent from very 
early stages along the neural tube (Ishibashi and McMahon, 2002; Ishibashi et al., 
2005). The telencephalon is severely hypoplastic and ventral structures are not 
identifiable. The expression of ventral telencephalic markers, such as Nkx2.1, Gsh1, 
Olig2 and Lhx6, is absent due to the loss of the ventral telencephalon (Corbin et al., 
2000; Lu et al., 2000; Corbin et al., 2003). In contrast, dorsal telencephalic markers, 
including Emx1 and Pax6, are expressed throughout most of the remaining 
telencephalic tissue in the Shh-/- mutants (Chiang et al., 1996; Ohkubo et al., 2002). 
Recent studies have shown a small expression of the ventral markers Gsh2, Dlx2 and 
ER81, indicating that not all the ventral structures are lost. At least the most dorsal 
part of the lateral ganglionic eminence (dLGE) is still present (Corbin et al., 2003; 
Fuccillo et al., 2006).  
 
1.2.2 The function of Shh 
 
Shh acts on many different aspects of CNS development, including induction of 
different classes of neurons in the ventral brain (Echelard et al., 1993; Roelink et al., 
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1994; Ericson et al., 1996), early regionalization (Shimamura et al., 1997), 
generation of oligodendrocyte precursors in both spinal cord and brain (Orentas et al., 
1999; Tekki-Kessaris et al., 2001), proliferation of specific neuron progenitor 
populations (Rowitch et al., 1999; Tekki-Kessaris et al., 2001; Ishibashi and 
McMahon, 2002), eye patterning (Ekker et al., 1995; Chiang et al., 1996; Huh et al., 
1999) and modulation of growth cone movements (Trousse et al., 2001).  
 
1.2.2.1 Shh functions as a morphogen 
 
Shh protein is cleaved to yield two secreted proteins (Bumcrot et al., 1995), a 25 kDa 
C-terminal protein (C-Shh), which has protease activity (Porter et al., 1995), and a 19 
kDa N-terminal protein (N-Shh), which mediates all signalling activities, including 
the control of left-right asymmetry, and dorso-ventral patterning of the CNS and 
antero-posterior patterning of the limbs (Hammerschmidt et al., 1997).   
 
Shh signalling has been studied in detail in the mouse neural tube, where different 
concentrations of Shh appear to specify a series of cell fates (Jacob and Briscoe, 
2003). Shh can regulate the fate of immediately adjacent cells. Alternatively, Shh can 
function as a short-range morphogen (over 10-15 cell diameters) that controls three 
alternative fates depending on its concentration. Shh can also work as a long range 
morphogen that controls several cell fates, for example in the neural tube, a field that 
spans many cell diameters (Briscoe and Ericson, 1999). There is evidence in 
zebrafish showing that Shh could act directly over a distance of up to 200 µm (Lewis 
et al., 2001). Shh is produced by two ventral midline signalling centres: the 
notochord, an important part of the mesoderm, which lies beneath the ventral neural 
plate and the floor plate, at the ventral midline of the central nervous system (Marti 
et al., 1995a). Mutants that lack all Shh signalling fail to specify correctly different 
cell types in the ventral half of the neural tube (Wijgerde et al., 2002). Gli3 repressor 
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is essential for the fates of cells that are exposed to low concentrations of Shh (lateral 
neural cell types) (Persson et al., 2002) and Gli2 activator is essential for the ventral 
neural cells that respond to highest levels of Shh in the floor plate (Ding et al., 1998; 
Matise et al., 1998). The intervening neural cell types can be specified by different 
levels of Gli activator (Stamataki et al., 2005), suggesting that different levels of Shh 
are directly translated into different ratios of Gli activator/Gli repressor, which 
control cell fate.  
 
1.2.2.2 Shh and the patterning of forebrain 
 
The phenotype of Shh-/- mutants provides good evidence that Shh is important for the 
formation of ventral telencephalic structures. Several studies have suggested that Shh 
is required for the induction of ventral telencephalic cell fate during a specific time 
frame. Machold et al. (2003) removed Smo gene function by using Cre recombinase 
under the control of Nestin promoter in the CNS. Nestin is expressed by all neural 
progenitors (Dahlstrand et al., 1995), and this recombination starts ventrally around 
E9.5 and removes Hh signalling completely by E12.5. In these mutants 
(Smoc/-;NestinCre), both medial and lateral ganglionic eminences are morphologically 
present, and the expression of ventral markers is largely restored (Machold et al., 
2003). Fuccillo et al. (2004) used another floxed allele of Smo to ablate Shh 
signalling using Cre recombinase under the control of the Foxg1 promoter. Foxg1 
expression starts in the prospective ventral telencephalon as early as E8.5 (Xuan et 
al., 1995), and the ablation of Smo is completed at around E9.5. Surprisingly, the 
expression of ventral markers is totally absent in these mutants (Smoc/-;Foxg1Cre), 
whereas dorsal markers are expanded (Fuccillo et al., 2004). These findings suggest 
that the period between E9 and E12 is crucial for the induction of ventral cell fate by 
Hh signalling. Gunhaga et al. (2000) showed that exposure of prospective forebrain 
cells to Shh signalling at grastrula stage is sufficient to generate both progenitor cells 
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and post mitotic neurons with ventral telencephalic character in chick, suggesting 
that it is also possible that the induction of ventral telencephalon by Shh signalling 
happens as early as gastrulation (Gunhaga et al., 2000). It is interesting that not all 
ventral gene expression is lost in the Shh-/- mutants. It is possible that other Hh 
homologues can pattern the telencephalon or can partially compensate for the 
absence of Shh. In fact, mice mutant for both Shh and Ihh appear to lack all ventral 
characters throughout the CNS (Zhang et al., 2001). This phenotype is very similar to 
that of the Smo-/- mutants, which are unable to transduce any Hh signal and die 
around E9.5 (Zhang et al., 2001). In addition, although Shh has been shown to be 
crucial in ventral telencephalic patterning, ventral telencephalon is largely restored 
when Gli3 is removed from the Shh-/- mutants (Rallu et al., 2002b). This suggests 
that there might be other factors besides Shh that may induce ventral telencephalic 
fate. 
 
The role of Shh in patterning the dorso-medial telencephalon is still obscure. The 
dorsal midline is lost in both Shh-/- and Gli3-/- mutants and also in Shh-/-;Gli3-/- double 
mutants (Chiang et al., 1996; Grove et al., 1998; Theil et al., 1999; Rallu et al., 
2002b), suggesting that Shh and Gli3 might co-operate in patterning this region. 
Fuccillo et al. (2004) showed that the dorso-cortical midline seems to be unaffected 
in the Smoc/-;Foxg1Cre mutants, which suggests that Shh signalling is required to 
pattern this region earlier than E9 (Fuccillo et al., 2004). Another interesting result 
has been shown very recently by the same group (Fuccillo et al., 2006). When they 
removed Pax6 from the Shh-/- mutant, the expression of Wnt8b and Bmp4 was 
partially rescued in the Shh-/-;Pax6-/- compound mutant, which suggests that 
increased levels of Pax6 might be partially responsible for the defective dorsal 
midline of Shh-/- mutants (Fuccillo et al., 2006).  
 
The Shh source outside the telencephalon might also affect its patterning. For 
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example, Shh from the anterior part of the primitive streak and Henson’s node at 
gastrula stages might be crucial for the specification of the MGE (Gunhaga et al., 
2000). Shh from the prechordal plate also plays an important role in specification of 
the ventral telencephalon. The prechordal plate is part of the mesoderm which lies 
under the rostral diencephalon (Dale et al., 1997; Dale et al., 1999). Also, Shh from 
the adjacent zona limitans intrathalamica (ZLI) of the diencephalon might influence 
the specification of the ventral telencephalon. The ZLI is a neuroepithelial domain in 
the alar plate of the diencephalon which separates the ventral thalamus from the 
dorsal thalamus (Rubenstein et al., 1998; Vieira et al., 2005). The ZLI functions as a 
diencephalic signalling centre, and Shh derived from the ZLI has been shown to 
affect the induction of the ZLI itself, and give morphogenetic information to the 
thalamus (Kiecker and Lumsden, 2004; Zeltser, 2005).  
 
1.2.2.3 Shh and the specification of Oligodendrocytes  
 
Another important role of Shh is the specification of oligodendrocytes in ventral 
CNS development (Tekki-Kessaris et al., 2001). Oligodendrocyte precursors (OLPs) 
in the spinal cord and caudal forebrain arise from specific regions of the ventral 
neuroepithelium at either side of the floor plate and then disperse throughout the 
developing gray matter and populate white matter tracts (Miller, 1996; Miller et al., 
1999; Richardson et al., 2000; Spassky et al., 2000). In the anterior forebrain, OLPs 
emerge from the anterior entopeduncular area and probably from the ZLI (Olivier et 
al., 2001). OLPs in the spinal cord express a number of markers including the basic 
helix-loop-helix transcription factors Olig1 and Olig2 (Lu et al., 2000; Zhou et al., 
2000). Neuroepithelial cells in the ventral spinal cord of the Olig2-/- mouse mutants 
fail to differentiate into oligodendrocytes (Takebayashi et al., 2002). The generation 
of OLPs appears to require Shh signalling, since all OLPs originate in areas of the 
CNS that either express Shh themselves or are in close proximity to Shh expressing 
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cells (Davies and Miller, 2001), which at least partially explains their ventral origin 
within the spinal cord. There is evidence that oligodendrocyte lineage genes (Olig1, 
Olig2) are lost in the Shh-/- mutants (Lu et al., 2000), which also suggests that Shh is 
required for the induction of OLPs. Several studies showed that Shh can initially 
induce oligodendrocyte differentiation (Poncet et al., 1996; Pringle et al., 1996; 
Orentas et al., 1999), and many gain- and loss-of-function experiments in mouse 
embryos have shown that Shh is both necessary and sufficient for the specification of 
OLPs in the spinal cord (Orentas et al., 1999) and the forebrain (Nery et al., 2001; 
Tekki-Kessaris et al., 2001).   
 
1.2.2.4 Shh and cell growth and survival 
 
Shh is also suggested to regulate cell growth and survival in the CNS. First of all, the 
reduction in the overall brain size of the Shh-/- mutant suggested that cell cycle or cell 
death parameters might be altered in these mutants. It has been shown that ectopic 
expression of Shh or ectopic activation of the Shh signalling pathway through the 
removal of Ptc1 activity results in massive proliferation in brain and spinal cord 
(Goodrich et al., 1997; Rowitch et al., 1999; Dahmane et al., 2001). Several studies 
in diencephalon and mesencephalon (Ishibashi and McMahon, 2002) and cerebellum 
(Kenney and Rowitch, 2000) have suggested that G1-phase cyclins, including Cyclin 
D1 (Sherr and Roberts, 1999), are transcriptional targets of Shh signalling. Ptc1 is 
suggested to regulate directly the G2-phase Cyclin B (Barnes et al., 2001). These all 
suggest that Shh possibly plays a direct role in regulating cell proliferation.  
 
Shh is also suggested to be involved in cell death. Ectopic cell death was detected in 
the developing spinal cord (Chiang et al., 1996; Litingtung and Chiang, 2000), the 
diencephalon and the anterior midbrain (Ishibashi and McMahon, 2002) of Shh-/- 
mutants. Also Shh-/- mutants exhibit an increased Bmp and Msx expression (Ohkubo 
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et al., 2002). These suggested that Shh might regulate cell death in many places of 
the developing embryo, including the brain and the spinal cord.  
 




The zinc finger transcription factor Gli3 is a mammalian homologue of Drosophila 
cubitus interruptus (ci), which is an important mediator of the Hh signalling pathway 
(Ruppert et al., 1990; Ingham and McMahon, 2001). Gli3 is important in 
development because it has been observed that strains of mice mutant for Gli3 have 
many malformations. They are called ‘extra-toes’ (Xt) mice because the 
heterozygous mutants (Gli3Xt/+) have extra digits on both forelimbs and hindlimbs 
(Johnson, 1967). The heterozygous mutant mice have one or two extra digits on the 
limbs, while the homozygous mutant mice (Gli3Xt/Xt) can have as many as ten digits 
on one limb. These mutants do not survive beyond birth and are severely abnormal.  
 
1.3.1.1 Gli3 expression 
 
The expression of the Gli3 gene is first detected at around E7.0-E7.5 and is found 
throughout embryogenesis in derivatives of both the ectoderm and the mesoderm 
(Hui et al., 1994). The Gli3 gene is normally expressed in the telencephalon, the roof 
of the diencephalon, midbrain and the hindbrain during gestation of wild type 
embryos (Schimmang et al., 1992). The onset of expression in the neural ectoderm 
begins at the primitive streak stage. Gli3 is first expressed in rather broad domains; in 
general, the expression domains become more restricted at later stages of 
development (Schimmang et al., 1992; Hui and Joyner, 1993; Hui et al., 1994). 
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1.3.1.2 The general brain phenotype of extra-toes mutant mice 
 
Johnson (1967) first described extra-toes mutant mice from Harwell and several 
other Xt alleles have been reported since. Among them, the allele from Jackson 
Laboratory, XtJ, is one of the most widely studied allelic variants (Hui and Joyner, 
1993). The XtJ mutant contains a 51.5 Kb intragenic deletion of Gli3, which removes 
all Gli3 sequence 3’ of the second zinc finger (Maynard et al., 2002). The Gli3 gene 
transcript is absent in the XtJ homozygotes. Thus, the XtJ mice have a deficiency of 
Gli3 expression (Hui and Joyner, 1993). The heterozygous XtJ mouse has been 
shown to be the mouse model for Greig Cephalopolysyndactyly Syndrome (GCPS), 
a human genetic condition that results in skeletal defects, including the formation of 
a duplicated, fused fifth digit and craniofacial anomalies (Hui and Joyner, 1993). 
Mutations in human GLI3 can also cause Pallister-Hall syndrome (Kang et al., 1997), 
Postaxial Polydactyly type A/B (Radhakrishna et al., 1997; Zhao et al., 2002) or 
Acrocallosal syndrome (Elson et al., 2002) 
 
XtJ homozygous embryos are classified into two groups based on overall brain 
morphology. Some embryos show severe exencephaly, probably as a result of a 
delay in neural tube closure (Hui and Joyner, 1993). They have an overgrowth of 
neural tissue in the mesencephalon, as Johnson (1967) described in the Harwell mice. 
Recent research focuses mostly on the non-exencephalic XtJ homozygous mutant 
mice (Gli3Xt/Xt). The telencephalic vesicles of the non-exencephalic Gli3Xt/Xt embryos 
are smaller than those of the wild type embryos, but their cerebral cortex is relatively 
thicker (Tole et al., 2000a). The dorsal medial wall of the telencephalic vesicles fails 
to invaginate, and these mutants do not have medial structures, such as the 
hippocampus and choroid plexus (Grove et al., 1998; Theil et al., 1999). The 
conjunction between the telencephalon and the diencephalon does not form normally, 
and the olfactory structures are absent (Johnson, 1967; Hui and Joyner, 1993; Franz, 
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1994; Theil et al., 1999; Fotaki et al., 2006). There are variable defects of the eyes. 
The eye of mice homozygous for the Harwell mutation may be just half of the 
normal diameter. In some extreme cases, the eye may be represented by a pigmented 
hollow ball with a lens rudiment, by a pigment mass, or may have disappeared 
without trace (Johnson, 1967; Franz, 1994). The eyes of Gli3Xt/Xt mice are poorly 
developed as well (Hui and Joyner, 1993). The optic stalk is thicker than in the wild 
types (Aoto et al., 2002). 
 
1.3.2 Analysis of the forebrain of Gli3Xt/Xt mutant embryos 
 
Previous studies have shown that the expression of many transcription factors and 
signalling molecules that are involved in forebrain patterning have changed in the 
Gli3Xt/Xt mutant mice (Table 1.1).  
 
1.3.2.1 The dorso-medial telencephalon of the Gli3Xt/Xt mutant embryos 
 
The cortical hem is lost in Gli3Xt/Xt mutant embryos, and as a consequence the 
choroid plexus in the lateral ventricle and the hippocampus are missing (Franz, 1994). 
The cortical hem is derived from the dorsal midline of the telencephalic vesicle and 
is marked by the expression of multiple Wnt and Bmp genes, including Wnt2b, 3a, 5a, 
and 7a (Grove et al., 1998). Among them, Wnt2b, 3a and 5a show a strikingly similar 
pattern of expression in the telencephalon. In the Gli3Xt/Xt embryos at E12.5, no 
expression of Wnt2b, 3a or 5a is detected in adjacent tissue that might correspond to 
the cortical hem. Expression of these three Wnt genes elsewhere in the telencephalon 
is either undetectable or weak and diffuse. Nonetheless, Wnt2b, 3a and 5a are 
strongly expressed at other appropriate sites (Grove et al., 1998). Wnt8b, which is 
expressed in a broader region in the dorso-medial telencephalon, is reported to be 
unaltered in the Gli3Xt/Xt mutants at E12.5 (Tole et al., 2000a; Theil, 2005).  
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The choroid plexus and cortical hem are linked by shared expression of the members 
of the Bmp and Msx families (Furuta et al., 1997; Grove et al., 1998). Tole et al. 
(2000a) showed that at E12.5, Bmp2, 4, 6 and 7 are strongly expressed in the cortical 
hem and the developing choroid plexus in the wild types. Gli3Xt/Xt mutants are 
deficient in the dorsal telencephalic expression of all four Bmp genes (Theil et al., 
1999; Tole et al., 2000a). By contrast, a small region of Bmp7 expression in the 
ventral telencephalon appears unaltered in the mutants (Tole et al., 2000a). The 
homeobox gene Msx1, which can be induced by Bmp2 and Bmp4 (Furuta et al., 
1997), starts to be expressed in the dorsal midline and the surface ectoderm at E9.5 
and reaches a higher level at E11.5. Msx1 expression is lost specifically from the 
dorsal midline, consistent with the loss of Bmp4 expression in the Gli3Xt/Xt embryos. 
In the dorsal midline of the more posterior neural tube and in the surface ectoderm of 
the mutants, Msx1 expression is unaffected (Theil et al., 1999). Noggin, a negative 
regulator of the Bmp signalling pathway, is normally expressed in the dorsal midline 
along the entire neuraxis (Shimamura et al., 1995). The expression is reported 
unaltered in Gli3Xt/Xt embryos (Theil et al., 1999).  
 
The telencephalic hippocampus also appears to be missing from the Gli3Xt/Xt mutants, 
as assessed by both morphology (Franz, 1994) and molecular markers (Tole et al., 
2000a). In wild type mice at E12.5, a marker of the embryonic hippocampus Ephb1 
is expressed along the medial face of the telencephalic hemisphere (Donoghue and 
Rakic, 1999). In the dorsal telencephalon of Gli3Xt/Xt mutants, no Ephb1 expression is 
detected (Tole et al., 2000a). At E15.5, expression of the glutamate receptor subunit, 
KA1, marks the major hippocampal field CA3 in wild type mice (Tole et al., 1997). 
In Gli3Xt/Xt mutants at the same age, KA1 expression appears normally in the 
thalamus, but no KA1 expression is detected in the medial telencephalon (Tole et al., 
2000a), confirming loss of the hippocampal structures.  
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1.3.2.2 Analysis of dorsal telencephalic markers in the Gli3Xt/Xt mutant 
telencephalon 
 
Members of the Emx gene family, which are involved in the development of dorsal 
structures, are reduced or lost in some sites of the Gli3Xt/Xt telencephalon (Theil et al., 
1999; Tole et al., 2000a). Emx1 expression is normally restricted in the dorsal 
telencephalon, and Emx2 is expressed in a broader domain than Emx1 in wild type 
embryos (Simeone et al., 1992; Theil et al., 1999; Tole et al., 2000a). Emx1 
expression is shown to be completely lost at E10.5 (Theil et al., 1999) and E12.5 
(Tole et al., 2000a). Emx2 expression is shown to be absent from the rostral forebrain 
at E8.5, E9.5 and E11 (Theil et al., 1999). However, at E12.5, Emx2 expression is 
detected in the Gli3Xt/Xt mutant dorsal telencephalon by another group (Tole et al., 
2000a), although at a lower level compared to the wild types. The differences 
between these studies might be due to the differences among ages they studied.  
 
The expression of the transcription factor Pax6, which also might be involved in the 
development of the dorsal structures, is reported to be reduced greatly in the Gli3Xt/Xt 
mutant telencephalon (Aoto et al., 2002). Based on Pax6 and Engrailed2 (En2) 
expression, Aoto et al. (2002) proposed that the ventral thalamus, the posterior 
midbrain and the anterior hindbrain are significantly expanded, while the dorsal 
telencephalon and the anterior midbrain are reduced in size in the Gli3Xt/Xt mutants. 
 
The expression of Otx1 and Otx2, which are both involved in the AP patterning of 
the rostral telencephalon, are expressed normally in E8.5 to E10.5 Gli3Xt/X mutant 




1.3.2.3 Analysis of ventral telencephalic markers in the Gli3Xt/Xt mutant 
telencephalon  
 
The dorsal telencephalon is partially ventralized in Gli3Xt/Xt mutants (Tole et al., 
2000a; Kuschel et al., 2003). In E12.5 wild types, the mantle zone of the MGE and 
LGE are marked by the expression of the homeobox gene Islet1, with no expression 
detected in the dorsal telencephalon. Strong expression of another homeobox gene 
Dlx2 and the proneural gene Mash1 also distinguish the ventral from the dorsal 
telencephalon at this age. By contrast, in Gli3Xt/Xt mutants, Islet1, Dlx2 and Mash1 
expression are reported to be extended in a dramatic manner into the dorsal 
telencephalon along the rostro-caudal axis (Tole et al., 2000a; Aoto et al., 2002; 
Kuschel et al., 2003). This ectopic expression is most striking in the rostral 
telencephalon. Another ventral specific marker, Dlx5, is found to be upregulated in 
Gli3Xt/Xt dorsal telencephalon, with a similar but slightly delayed expression profile 
as compared to the ventral progenitor markers Dlx2 and Mash1 (Kuschel et al., 
2003).  
 
Gli3 has been reported to repress expression of Shh in the anterior limb regions and 
in the dorsal spinal cord. The expression of Shh has been analyzed in the Gli3Xt/Xt 
mutant telencephalon by whole mount in situ hybridization. Shh expression can 
normally be found throughout the ventral neuroaxis in wild types (Echelard et al., 
1993). Theil and colleagues (1999) showed that Shh transcripts are confined 
exclusively to the ventral neural tube at all axis levels of Gli3Xt/Xt mutants at E8.5 and 
E10.5. This was confirmed by Aoto et al. (2002) at E11.5 and Tole et al. (2000a) at 
E12.5. In both wild type and Gli3Xt/Xt E9.5 embryos, expression of the Shh target 
genes Patched1 (Ptc1) and Gli1 is confined to the ventral region of the neural tube 
and excluded from the dorsal brain (Theil et al., 1999; Tole et al., 2000a). The 
expression of Nkx2.1 was reported to be confined to the ventral telencephalon at 
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E10.5 by Theil et al. (1999) and at E12.5 by Tole et al. (2000a), but was shown to be 
expanded by Aoto et al. (2002) in E11.5 Gli3Xt/Xt mutant embryos. 
 
Aoto et al. (2002) indicated that not only the DV patterning but also the AP 
patterning of the forebrain is affected in Gli3Xt/Xt mutants. Starting at E8.5, Fgf8 and 
its downstream target, Sprouty2, are expressed in a restricted region of the rostral end 
of the telencephalon, corresponding to the ANR (Aoto et al., 2002). In contrast, 
Gli3Xt/Xt mutant embryos show a huge expansion of Fgf8 and Sprouty2 expression 
into more caudal regions. In extreme cases, this domain covers the entire 





















Table 1.1 The expression of maker genes analyzed in the wild type and Gli3Xt/Xt 
mutant embryos. 
 
Markers Age Expression in wild type 
embryos 





E12.5 Along the medial 
telencephalic wall 
Undetectable or weak 
and diffuse  in the 
telencephalon 
Grove et al. 
1998 









Persists in the dorsal 
part of the 
telencephalon, but 
marks a smaller domain 
Tole et al. 
2000a 
Wnt8b E12.5 In the hippocampus, 
cortical hem, the choroid 
plexus epithelium (CPe), 
eminentia thalami 






In the junction of the 
telencephalon and the 
diencephalon, and in the 
anterior most dorsal roof 
of the telencephalon 
Undetectable in the 
di-telencephalic 
boundary 
Theil et al. 
1999 
Bmp6 E12.5 In the cortical hem and 
the developing CPe 
Lost in the dorsal 
telencephalon 
Tole et al. 
2000a 
Bmp7 E12.5 In the cortical hem, in the 
ventral part of the 
telencephalon, and in the 
CPe 
Lost in the dorsal part of 
the telencephalon, but 
unaltered in the ventral 
telencephalon 
Tole et al. 
2000a 
Noggin E9.5 In the dorsal midline 
throughout the entire 
neuraxis, with highest 
expression levels in the 
telencephalon 
Unaltered Theil et al. 
1999 
Msx1 E12.5 In the cortical hem, the 
CPe, the telencephalic 
roof, the head 
mesenchyme, the 
surface ectoderm  
Lost  specifically from 
the telencephalic roof 






Table 1.1 The expression of maker genes analyzed in the wild type and Gli3Xt/Xt 




In the dorsal 
telencephalon 
Reduced in the 
telencephalon at E11.5 
Theil et al. 
1999 
Emx1 E10.5 Confined to the dorsal 
telencephalon 
Not detectable Theil et al. 
1999; Tole 
et al. 2000a; 




Lost from the 
telencephalic vesicles 




In the dorsal 
telencephalon, 
expanding into the 
ventral telencephalon 
Readily detectable in 
the dorsal 
telencephalon 




Unaltered Theil et al. 
1999 
 Greatly reduced in the 
telencephalon; but 
expanded in the ventral 
thalamus 





amygdala in the ventral 
telencephalon, dorsal 
and ventral 
diencephalon, and optic 
cup 
Pattern of protrusions of 
the ventricular zone 
Theil 2005 
Ngn2 E12.5 Throughout the dorsal 
telencephalon 
Detectable in the dorsal 
telencephalon 




Exclusively confined to 
the ventral neural tube 
Unaltered Theil et al. 
1999; Tole 
et al. 2000a; 




Confined to the ventral 
region of the neural tube 
Unaltered Theil et al. 
1999; Tole 
et al. 2000a 
Ptc1 E9.5, 
E12.5 
Ventral part of the neural 
tube 
Unaltered Theil et al. 
1999; Tole 
et al. 2000a 
E9.5, 
E12.5 
Unaltered Theil et al. 
1999; Tole 











Table 1.1 The expression of maker genes analyzed in the wild type and Gli3Xt/Xt 
mutant embryos (continue). 
 
Gsh2 E12.5 The PSB and the lateral 
ganglionic eminence 
Expands into cortical 
areas 
Rallu et al. 
2002b 
Islet1 E12.5 Postmitotic neurons of 
the ventral telencephalon 
Expanded in the dorsal 
telencephalon 
Tole et al. 
2000a 
Mash1 E12.5 Ventral telencephalon Expanded into cortical 
area 
Rallu et al. 
2002b; Theil 
2005 
Unaltered Theil et al. 
1999 
Dlx2 E12.5 Ventral telencephalon 
Extended into dorsal 
telencephalon, most 
striking in the rostral 
part 
Tole et al. 
2000a; Aoto 








Shows an extension 
into more caudal 
regions 






In the anterior neural 
ridge (ANR) and the roof 
of telencephalon and 
diencephalon 
Partially maintained in 
the dorsal midline of the 
telencephalon 
Grove et al. 
1998 
Sprouty2 E12.5 Confined to the ANR Expanded throughout 















1.3.2.4 The cortical lamination of the Gli3Xt/Xt mutant embryos 
 
Histological analyses of Gli3Xt/Xt mutants have shown that cortical lamination is lost 
(Franz, 1994; Theil et al., 1999). A recent study has shown that the mantle zone, the 
cortical plate and the subplate fail to form, and the cortical progenitors lose their 
apical-basal cell polarity (Theil, 2005). The loss of early cortical layers in the 
mutants was suggested to be caused by several defects, including a reduction of 
reelin and p73 positive Cajal-Retzius cells (Yang et al., 2000; Meyer et al., 2002), 
whereas another marker for early born Cajal-Retzius cells, Calretinin (del Rio et al., 
1995), is increased in the mutant neocortex. These results suggest the Cajal-Retzius 
cells are misspecified in the mutant embryos (Theil, 2005).  
 
1.3.3 Loss of Gli3 partially rescues Shh-/- telencephalic phenotype 
 
Work on spinal cord has demonstrated that many of the ventral spinal cord defects 
observed in the Shh-/- mutants are partially rescued by removing one copy of Gli3 
(Shh-/-;Gli3Xt/+), and further rescued in Shh-/-;Gli3Xt/Xt double mutants (Litingtung and 
Chiang, 2000; Persson et al., 2002). In addition, studies on limb showed a similar 
result (Litingtung et al., 2002). These findings suggest that Shh is required to specify 
the ventral fate in the spinal cord and Gli3 normally suppresses this. In the 
telencephalon, Gli3 has been shown to partially rescue the telencephalic phenotype 
of Shh-/- mutants (Rallu et al., 2002b). However, this has not been fully studied due 
to a high incidence of exencephaly in the double mutants. Nonetheless, these results 
suggest that there might be other pathways working in parallel to the Shh-Gli3 one to 
induce DV patterning in the telencephalon.  
 
1.3.4 Gli3 and cell growth and survival 
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Not much is know about Gli3 function in the cell cycle. The only information 
available comes from the analysis of BrdU labelling index in the E12.5 Gli3Xt/Xt 
mutant telencephalon (Theil et al., 1999), which showed no changes compared to 
wild types. Gli3 is suggested to regulate cell survival via a negative control of Fgf8 
(Aoto et al., 2002). In vitro studies have shown that Gli3Xt/Xt mutant cells survive 
better in cultures and release more survival promoting factors than the control 
telencephalic cells (Zaki et al., 2005), suggesting a role for Gli3 in regulating cell 
death. 
 
1.4 AIM OF THE STUDY 
 
The main aim of this thesis is to analyse further the Gli3Xt/Xt mutant forebrain to gain 
insight into the function of Gli3, and specifically: 
 
1. To investigate whether Gli3 may act as a transcriptional repressor of the Shh 
signalling pathway in the telencephalon, 
 
2. To study the Gli3Xt/Xt mutant dorsal telencephalon, and examine to what extent 
the dorsal telencephalon is affected by the loss of Gli3, 
 
3. To study the Gli3Xt/Xt mutant ventral telencephalon, 
 
4. To investigate whether Gli3 may regulate cell proliferation, cell differentiation 










Mice were housed and bred according to Home Office regulations in a dedicated 
facility. Gli3Xt/+ mice were maintained on a CBA background. Foxg1+/- mice were 
maintained on a mixed CBA X C57/B16 background. Pax6Sey/+ mice were 
maintained on a mixed Swiss/CD1 background. Shh-/- mutant embryos were kindly 
provided by Dr. Laura Lettice (MRC, Human Genetics Unit, Western General 
Hospital, Edinburgh). Embryonic day (E) 0.5 was defined as the morning of the 
vaginal plug discovery.  
 
2.2 GENOTYPING OF MICE 
 
DNA samples from embryonic tissues of embryos from the Gli3Xt/+ heterozygous 
matings (yolk sac for E11.5 or younger embryos, tail tip or limb bud for E12.5 or 
older embryos) were used for genotyping mice and embryos by polymerase chain 
reaction (PCR). Gli3Xt/+ were identified by the presence of at least one extra digit on 
the hindlimbs. Shh-/- mutants embryos were identified by the characteristic fused 
telencephalic vesicles. Pax6Sey/Sey embryos were identified by the lack of eyes. 
Foxg1-/- embryos were identified by a smaller telencephalon compared to the wild 
type littermates and confirmed by PCR genotyping by Ben Martynoga.  
 
2.2.1 DNA extraction 
 
DNA was extracted from embryonic tissue samples for Hot SHOT PCR genotyping 
(Truett et al., 2000). Samples were incubated with an alkaline lysis buffer (25 mM 
NaOH, 0.2 mM disodium EDTA, pH 12) to 96 ْC for 1 hour. After heating, samples 
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were cooled at 4 ْC, and 75 µl neutralizing reagent (4mM Tris-HCl, pH 5) were 
added to each sample. 5 µl of the final preparation were used per each PCR reaction 
for E11.5 or younger embryos, and 5 µl of 1:10 dilution of the final preparation were 
used for E12.5 or older embryos.  
 
2.2.2 PCR reaction and visualization of product 
 
The PRC reaction mix contained: 50-100 ng genomic DNA, 2 µl 10X reaction buffer 
(1X: 20 mM Tris-HCl (pH 8.4), 50 mM KCl), 30 µM Magnesium Chloride, 5 pM of 
each forward and reverse primer (Table 2.1), 4 µM dNTP, 1U Taq Polymerase and 
ddH2O. The PCR conditions were as follows: initial denaturation at 95 ْC for 2 
minutes, followed by 35 cycles of denaturation at 94 ْC for 1 minutes, annealing at 
63 ْC for 20 seconds and extension at 72 ْC for 50 seconds (Maynard et al., 2002). 
The C3 Forward /C3 Reverse primers amplified a wild type band of 193 bp and the 
580 Forward/580 Reverse primers amplified a mutant band of 580 bp.  
 
PCR products were run on 1% agarose gels (LE Seakem) in 1X Tris-boric 
acid-EDTA (TBE, 89 mM Tris-Base, 89 mM boric acid, 2 mM EDTA) buffer with 
0.1 µg/µl Ethidium bromide (10 µg/ml stock, SIGMA) at 60 mA for about 45 
minutes. The bands were visualized in a transilluminator under UV. The expected 
sizes were 193 bp wild type and 580 bp mutant band.  
 
Primer Sequence 
C3 Forward (Gli3+/+) 5’-GGCCCAAACATCTACCAACACATAG-3’ 
C3 Reverse (Gli3+/+) 5’-GTTGGCTGCTGCATGAAGACTGAC-3’ 
580 Forward (Gli3Xt/Xt) 5’-TACCCCAGCAGGAGACTCAGATTAG-3’ 
580 Reverse (Gli3Xt/Xt) 5’-AAACCCGTGGCTCAGGACAAG-3’ 
 
Table 2.1 Primers used in Gli3Xt PCR genotyping.  
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2.3 EMBRYONIC FIXATION AND HISTOLOGY 
 
2.3.1 Semithin sections 
 
For semithin sections, embryos were dissected in cold phosphate-buffered saline 
(PBS, pH 7.4), and fixed in 4% paraformaldehyde (PFA) and 2% glutaraldehyde in 
PBS overnight at 4 ْC. After being dehydrated through a series of ascending ethanols 
(50%, 70%, 90% and 100%), embryos were infiltrated and embedded in plastic 
(Technovit 7100, Kulzer Histo-Technik, Heraeus Kulzer, Germany), according to the 
manufacturer’s recommendations. Blocks were cut in a frontal plane using a 
microtome with disposal Kulzer knives at 4 µm thickness. Sections were placed on a 
hot water bath (40 ْC) and collected on poly-L-lysine (Sigma) coated slides before 
drying in a 37 ْC oven for at least 2 hours. After drying, sections were stained with 
cresyl violet for detection of pyknotic nuclei.  
 
2.3.2 Paraffin sections for immunohistochemistry and immunofluorescence 
 
For most of the immunohistochemistry and immunofluorescence reactions, embryos 
were dissected in cold PBS, and fixed in cold 4% PFA in PBS overnight at 4 ْC. 
Embryos were washed in cold PBS for three times, and dehydrated through a series 
of ascending ethanols (70%, 90%, 95% and 100%) prior to xylene washes and 
embedding in paraffin in an automated tissue processor (Tissue-Tek VIP, Sakura, see 
Table 2.2 for program used). Embryos younger than E11.5 were pre-embedded in 2% 
agarose (Sigma) in PBS before being processed. Paraffin blocks were cut at 10 µm 
(E12.5 and older embryos) or 7 µm (E11.5 and younger embryos), and sections were 
collected serially on poly-L-lysine (Sigma) coated slides. For cresyl violet staining, 
sections were dewaxed in xylene and rehydrated through a descending ethanol series 
(100%, 95%, 90% and 70%) to ddH2O. Sections were incubated in cresyl violet 
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(0.5% with 1.2% acetic acid) for 1 minute before washing in ddH2O, and being 
passed through 70% ethanol, 95% ethanol with acetic acid to 100% ethanol, prior to 
being washed in xylene and mounted with DPX (BDP). 
 
For immunofluorescence against Sonic hedgehog (Shh), embryos were dissected in 
cold PBS and fixed in cold 4% PFA in PBS for 2 hours at 4 ْC. Embryos were 
washed in cold PBS, and cryoprotected through 5%, 10% and 15% sucrose in PBS 
until they submerged at 4 ْC. Embryos were embedded in a mixture of 15% sucrose 
and 7.5% gelatine (Sigma) in PBS overnight at 4 ْC. They were then frozen on dry 
ice, and kept at -70 ْC until sectioning. Blocks were cut on a Leica cryostat at 10 µm, 
and sections were collected on superfrosted slides (Fisher).  
 
Step Solution Time (h) Temperature P/V Agitation 
1 50% Ethanol 1:00 R/T On Yes 
2 80% Ethanol 1:00 R/T On Yes 
3 95% Ethanol 1:00 R/T On Yes 
4 99% Ethanol 1:00 R/T On Yes 
5 99% Ethanol 1:00 R/T On Yes 
6 Absolute Ethanol 1:30 R/T On Yes 
7 Absolute Ethanol 2:00 R/T On Yes 
8 Xylene 1:00 R/T On Yes 
9 Xylene 2:00 R/T On Yes 
10 Xylene 2:00 R/T On Yes 
11 Wax 1:00 60 ْC On Yes 
12 Wax 1:00 60 ْC On Yes 
13 Wax 1:00 60 ْC On Yes 
14 Wax 1:00 60 ْC On Yes 
 
Table 2.2 Steps of the Tissue-Tek tissue processor. 
R/T: room temperature. P/V cycle: 30 seconds ambient, 90 seconds pressure, 30 
seconds ambient, 90 seconds vacuum. 
 
2.3.3 Preparations for in situ hybridization 
 
E10.5 embryos for whole mount in situ hybridization were dissected in RNase free 
 58 
PBS and fixed in 4% PFA in PBS overnight at 4 ْC. After being washed in PBS with 
0.1% Triton X-100 (Fisher) (PBT1), embryos were dehydrated through a series of 
descending methanols in PBT1 (25%, 50% and 75%) to 100% methanol for 10 
minutes each, at room temperature. Embryos were kept at -20 ْC prior to use.  
 
Embryos for in situ hybridization on paraffin sections were collected and embedded 
as for immunohistochemistry in paraffin wax, except all the solutions used were 
made in RNase free conditions. Blocks were cut at 10 µm and sections were 




Sections were dewaxed in xylene and rehydrated through a series of descending 
ethanols to PBS. Endogenous peroxidases were blocked with 3% H2O2 (stock 30%, 
Sigma) and 10% methanol in PBS for 15 minutes in the dark. After washing in PBS 
with 0.2% Triton X-100 (PBT2), antigen retrieval was carried out by microwaving 
sections at full power in 10 mM sodium citrate buffer (pH 6.0) for four times of 5 
minutes each. After cooling for 20 minutes, sections were blocked in 10% normal 
goat serum (NGS) and 0.2% gelatine in PBT2 for an hour at room temperature and 
incubated with the primary antibodies at 4 ْC overnight. All primary antibodies were 
diluted in PBT2 with 5% NGS, 0.2% gelatine at optimal conditions (Table 2.3).  
 
Slides were washed for three times, 10 minutes each, in PBT2 and then incubated 
with appropriate biotinylated secondary antibodies (goat anti-mouse IgG and goat 
anti-rabbit IgG, 1:200, Dako) in 5% NGS, 0.2% gelatine in PBT2 for 1 hour at room 
temperature. After washing in PBT2 for three times, 10 minutes each, slides were 
incubated for 1 hour with avidin-biotin-peroxidase reagent (1:200 of the A and B 
reagents in PBT2, Vectorlabs). They were then washed in PBT2, three times, 10 
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minutes each, and visualized with 0.03% diaminobenzidine (stock 30% in Tris-HCl, 
Sigma)/ 0.0003% hydrogen peroxide (stock 30%, Sigma). Some reactions were 
counterstained with cresyl violet (as above), and after staining, slides were 
dehydrated through a series of ascending ethanols and cleared in xylene before 




Immunofluorescence was carried out following a similar protocol as for the 
immunohistochemistry, except that the washes and the blocking reagent were made 
with 0.1% Triton-X in PBS (PBT1) instead of PTB2. Fluorescence double 
immunohistochemistry was carried out by selecting two primary antibodies (Table 
2.3) from two different species. Slides were incubated with the appropriate secondary 
antibodies (Table 2.4) for 1 hour in the dark at room temperature. TO-PRO-3 iodide 
(Molecular Probes, Invitrogen) was used to counterstain the cell nuclei. Fluorescence 
immunoreacted slides were mounted with Mowiol (Calbiochem).  
 
Cryostat sections for Shh fluorescent immunohistochemistry were post-fixed for 10 
minutes in 4% PFA at 4 ْC, prior to three washes in cold PBS of 5 minutes each. 
Sections were blocked in PBS containing 4% NGS and 0.3% albumin from bovine 
serum (BSA, Sigma) (blocking buffer) for 2 hours at room temperature before adding 
mouse anti-Shh antibody (1:25) in blocking buffer, and were incubated overnight at 4 
ْC. Sections were washed in PBS for three times, 5 minutes each, and were incubated 
with secondary antibody (1:200, Alexa488 conjugated goat anti-mouse IgG1, 
Molecular Probes, Invitrogen, A21121) for 45 minutes at room temperature in the 
dark. Excessive antibodies were removed by washing with PBS for 10 minutes 






































Table 2.3 Primary antibodies used in this thesis.  
Several monoclonal antibodies were obtained from the Developmental Studies 
Hybridoma Bank (DSHB) developed under auspices of the NICHD and maintained 
by the University of Iowa, Development of Biological Sciences, Iowa City, IA 52242. 
 
 








BU1/75 1:100 Abcam 
BrdU/IddU Mouse B44 1:100 
BD 
Bioscience 
β-III-tubulin Mouse Tuj1 1:800 Sigma 
β-actin Rabbit  1:500 Sigma 
Calbindin Rabbit  1:2000 Swant 
Calretinin Rabbit  1:2000 Swant 
Cyclin D1 Rabbit  1:400 Abcam 
Pan-Dlx Rabbit  1:100 J. Kohtz 
Dlx2 Rabbit  1:500 Abcam 
Foxg1 Rabbit  1:500 Abcam 
Gli3 Rabbit  1:100 Santa Cruz 
Gsh2 Rabbit  1:1500 K. Campbell 
Islet1 Mouse 39.4D5 1:50 DSHB 
Lhx2/9 Rabbit  1:1000 T. Jessell 
Lim1/2 Mouse 4F2 1:100 DSHB 
Mash1 Mouse 24B7.2D11 1:100 
BD 
Pharmingen 
Nestin Mouse RAT401 1:50 DSHB 
Nkx2.1 Mouse 8G7G3/1 1:100 Abcam 
Olig2 Rabbit  1:10000 D. Rowitch 
Pax2 Rabbit  1:100 Covance 
Pax6 Mouse PAX6 1:400 DSHB 





Tbr2 Rabbit  1:500 R. Hevner 
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IgG (H+L) highly 
absorbed 
A11029 1:200 Invitrogen 
Goat 
anti-mouse 
Biotinylated IgG E 0433 1:200 Dako 
Goat 
anti-mouse 





IgG (H+L) A11011 1:200 Invitrogen 
Goat 
anti-rabbit 
Biotinylated IgG E 0432 1:200 Dako 
Goat 
anti-rabbit 





IgG (H+L) A11077 1:200 Invitrogen 
 
Table 2.4 Secondary antibodies used in this thesis. 
Goat anti-mouse Alexa Fluor 488 IgG1 was used with anti Shh antibody.  
Goat anti-mouse Alexa Fluor 488 IgG (H+L) highly absorbed was used with 
anti-BrdU/IddU antibody. 













2.5 MORPHOMETRIC MEASUREMENTS 
 
Areal and volumetric measurements were carried out on E10.5 and E12.5 wild type 
and Gli3Xt/Xt mutant embryos. Tissue was processed, sectioned and mounted serially 
at a frontal (E10.5, 7 µm thickness-4 series; every 3 consecutive sections) or a 
coronal plane (E12.5, 10 µm thickness-4 series; every 4 consecutive sections) 
throughout the telencephalon. Each series of sections was immunoreacted with either 
Foxg1 or double immunofluorescence with Pax6 and Olig2 at E10.5, and with Foxg1, 
Pax6, Mash1 or Olig2 at E12.5. Four embryos per genotype were analysed in all 
cases, except for E12.5 embryos immunoreacted with Olig2, where 2 embryos of 
each genotype were included in the analysis. Photos of immunoreacted sections were 
taken serially throughout the telencephalon, and the expression domain of each 
protein was traced by Image Tool (UTHSCSA) to get the area of expression. The 
total volume was calculated by summing up all the areas and multiplying the sum by 
the section thickness. The area of expression of each protein was also compared on 
defined rostral, middle and caudal sections of the telencephalon at both ages. The 
rostral and caudal sections were chosen at about 30 µm from where the most rostral 
and caudal tips of the telencephalic lobes appear, and the middle sections were 
selected as the sections in the centre of the rostro-caudal axis. For each marker, two 
sections at each level were measured and averaged for each embryo. Examples of 
E10.5 and E12.5 wild type and Gli3Xt/Xt mutant embryos and defined sections are 
shown in Figure 5.1 and Figure 2.1, respectively. These embryos were scanned and 
reconstructed with optical projection tomography (OPT) microscope at the MRC 





Figure 2.1 OPT images of E12.5 wild type (Gli3+/+) and Gli3 mutant (Gli3Xt/Xt) heads 
(A and A’) and their defined caudal (cTel), middle (mTel) and rostral (rTel) 
telencephalic sections (B-D and B’-D’).  
 
 
Figure 2.2 IddU/BrdU double labelling experiment allows the estimation of the 
duration of S-phase and cell cycle. Pregnant dams were injected with IddU at T=0 hr 
to label cells in S-phase at the beginning of the experiment. At T=1.5 hr, BrdU was 
given and the animals were sacrificed after 30 minutes, to label the cells in S-phase 
(Scells) at the end of the experiment. During the interval (Ti=1.5 hr), some cells leave 




2.6 CELL CYCLE STUDIES 
 
2.6.1 Iododeoxyuridine (IddU) and bromodeoxyuridine (BrdU) injections  
 
For double labelling experiments, pregnant females were intraperitonally injected 
with 200 µl (10 mg/ml) iododeoxyuridine (IddU, diluted in 0.9% NaCl) (50-70 mg 
per kilogram of body weight) (Sigma) and 1.5 hours later with the same amount of 
bromodeoxyuridine (BrdU) (Sigma). These animals were sacrificed after 30 minutes 
of the BrdU injection, and E10.5 and E12.5 embryos were collected. For BrdU 
labelling index experiments, a 30 minutes pulse of BrdU (as above) was given to 
pregnant dams, and E12.5 and E13.5 embryos were collected.  
 
2.6.2 Measurements of cell cycle and S-phase duration 
 
For IddU/BrdU double labelling, embryos were collected at E10.5 and processed as 
above (Chapter 2.4.2). This method allows the estimation of duration of S-phase (TS) 
and cell cycle (TC) (Fig. 2.2) (Shibui et al., 1989; Martynoga et al., 2005). IddU and 
BrdU are thymidine analogues that are incorporated into DNA synthesised during 
S-phase. Cells that are in S-phase at the beginning of this experiment are labelled 
with IddU and those in S-phase at the end of the experiment are labelled with both 
BrdU and IddU (Scells). The interval during which cells are labelled with IddU but not 
BrdU is 1.5 hours. Thus, cells that leave the cell cycle (Lcells) will be labelled with 
IddU but not BrdU, and cells entering the cell cycle during the last 30 minutes will 
be labelled with only BrdU. By antibody staining, it is possible to distinguish BrdU 
positive cells from those that are positive for both IddU and BrdU, which allows the 
counting of the Lcells and Scells. Counts of BrdU positive cells and BrdU and IddU 
positive cells were done in 60 µm wide sampling bins distributed in the dorsal and 
ventral telencephalon along the rostro-caudal axis of wild type and Gli3Xt/Xt mutant 
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embryos (2-4 bins in each area (dorsal and ventral telencephalon) per embryo, five 
embryos per genotype).  
 




Pcells is the total number of cells that are proliferating in the ventricular zone. 
Immunoreactivity to β-III-tubulin (Tuj1) was used to label the postmitotic neurons. 
Thus, Pcells is calculated as the number of cells that are negative for Tuj1 throughout 
the thickness of the dorsal and ventral telencephalon. 
 
2.6.3 Calculation of labelling index 
 
The labelling indices (LI) of BrdU and IddU in two hours at E10.5 were calculated as 
double labelled cells in proportion to total number of cells in the ventricular zone 
(counterstained by TO-PRO-3) in the wild type and mutant telencephalon (n=5 per 
genotype). Counts were done in bins as described above (Chapter 2.6.2). 
 
A short pulse of BrdU was given to pregnant females, and E12.5 and E13.5 embryos 
were collected and processed as above (Chapter 2.4.2). BrdU-labelled and total 
number of cells (counterstained by TO-PRO-3) in the ventricular (proliferative) zone 
were counted in 125 µm wide strips through the thickness of the neocortex to give 
the labelling index (LI). In the wild type neocortex, samples were taken from the 
dorsal, dorso-lateral and lateral neocortex (box a, b and c in Fig 4.11A, respectively). 
Samples were taken throughout the neocortex in the mutant. The percentage of cells 
that were outside the ventricular zone in relation to the total number of cells 
throughout the thickness of the cortex was also calculated to estimate the size of the 
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postmitotic layer (PL). Four to twelve fields of view from control (n=4) and Gli3Xt/Xt 
(n=6) embryos were counted at each age.  
 
2.7 IN SITU HYBRIDIZATION 
 




The Shh plasmid for riboprobe synthesis was a gift from J. Rubenstein’s lab, 
University of California, CA. The Wnt8b plasmid for riboprobe synthesis was 
a gift from J. O. Mason (University of Edinburgh, UK). A 669 bp fragment 
(nucleotides 560-1170) of Gli3 mouse cDNA was a gift from T. Theil, 
(University of Edinburgh, UK), and was PCR-amplified and subcloned into a 





About 1 ng of plasmid was added to 50 µl of chemically competent cells 
(One Shot TOP10, Invitrogen) and incubated for 10 minutes on ice before 
heating at 42 ْC for 45 seconds. After cooling on ice for 20 minutes, bacteria 
were recovered in 500 µl SOC medium (Invitrogen) for 1 hour at 37 ْC with 
shaking. 20 to 200 µl from each transformation were spread on separate LB 
(Luria broth) agar (Sigma l-2897) plates containing ampicillin (100 µg/ml, 
Roche 835242), and incubated at 37 ْC overnight.  
 
3) Bacterial cultures and extraction of plasmid DNA 
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Bacteria picked from a single colony were cultured in LB medium (Sigma) 
overnight at 37 ْC with agitation. Plasmid DNA was extracted by using 
Qiagen midi or maxi-prep kits. DNA was incubated with a digestion mix, 
containing: 1-3 µg DNA, 1-3 units of appropriate restricted enzyme (Table 
2.5), 10X reaction buffer, 0.1 mg/ml Bovine Serum Albumin (BSA) in 
ddH2O, at 37 ْC for 2 hours. A small amount was run on an agarose gel with 
DNA ladder of known concentration (1 kb DNA ladder, Roche) to quantify 
the yield and confirm plasmid linearization. 
 
4) Labelling of probes 
 
1 µg of linearized plasmid was transcribed by T3 or T7 RNA polymerase 
(Table 2.5) with a digoxigenin (DIG) labelled nucleotide mix (Roche Applied 
Science) at 37 ْC for 2 hours. Labelled RNA probes were precipitated with 
4M LiCl and cold ethanol and resuspended in 50 µl of sterile, RNase free 
ddH2O, and stored at -80 ْC. Probes were quantified by Boehringer DIG 
Quantification test strips (Roche Applied Science 1714755) and Boehringer 







Polymerase Enzyme Source 
Gli3 T. Theil SpeI T7 
New England 
BioLabs 
Shh J. Rubenstein HindIII T3 
New England 
BioLabs 




Table 2.5 RNA probes used in this thesis. 
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2.7.2 Whole mount in situ hybridization 
 
Whole mount in situ hybridization was carried out following a published protocol 
(Theil et al., 2002b). Embryos were prepared as described in Chapter 2.3.3, and 
rehydrated through a series of descending methanols to PBT1 before treatment with 
proteinase K (10 mg/ml, Sigma) for 5-10 minutes. Small holes were made using fine 
needles (30G 1/2, Microlance) at the back of the heads of embryos for better probe 
penetration. Embryos were then post-fixed in 4% PFA, 0.1% glutaraldehyde in PBT1. 
After a few washes in PBT1, embryos were pre-hybridized in pre-hybridization mix 
(50% de-ionized formamide, 5X SSC (1X SSC: 0.15 M NaCl, 15 mM Trisodium 
citrate, pH 7.5), 0.1% Triton X-100, 50 µg/ml heparin, 0.1 mg/ml yeast tRNA and 5 
mM EDTA) at hybridization temperature (65 ْC in this study) for 1-2 hours. The 
pre-hybridization mix was replaced by pre-warmed pre-hybridization mix with 
150-300 mg/ml of labelled probe, and embryos were hybridized at the same 
temperature overnight with rotation.  
 
Embryos were washed twice for 30 minutes each in pre-hybridization mix and 
solution 1 (50% formamide in 1X SSC with 0.1% Triton X-100), 20 minutes in 1:1 
solution 1 : MABT (100 mM Maleic acid (Sigma) pH 7.5, 150 mM NaCl, 0.1% 
Triton X-100) at 65 ْC, and then with MABT twice for 10 minutes at room 
temperature. Embryos were then blocked with blocking solution (2% Boehringer 
blocking reagent (Roche Applied Science), 20% sheep serum (Sigma) in MABT) for 
2-4 hours at room temperature before replacing with sheep anti-DIG antibody 
(1:2000, Roche Applied Science) diluted in blocking solution and incubating for 16 
hours at 4 ْC with agitation. After five one hour washes in MABT at room 
temperature, embryos were washed twice with freshly prepared NTMT (100 mM 
NaCl, 100 mM Tris-HCl, pH 9.5, 50 mM MgCl2, 0.5% Tween-20, 0.2 mg/ml 
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Levamisole (Sigma)) prior to staining with NTMT containing 2% stock 
p-nitrotetrazolium blue chloride / 5-bromo-4-chloro-3-indolyl-phosphate (NBT/BCIP, 
Roche Applied Science) in the dark. After the colour had developed to a desired 
extent (approximately 2 hours), embryos were washed with PBS, fixed in 4% PFA, 
and kept in 60 % glycerol.  
 
2.7.3 In situ hybridization on paraffin sections 
 
In situ hybridization on paraffin sections was carried out following a published 
protocol with slight modification (Nieto et al., 1996). Sections were dewaxed in 
Histoclear (Fisher) and rehydrated through a descending series of ethanol to 2X SSC. 
After incubating in proteinase K for 7.5 minutes and washing in 2X SSC for 30 
minutes at room temperature, slides were post-fixed in 4% PFA for 15 minutes. 
Samples were treated with 0.2 M HCl for 15 minutes, and 0.1 M Triethanolamine 
(TEA, Sigma) for 30 seconds and then with 3.125 µl/ml acetic anhydride in 0.1 M 
TEA for 10 minutes before being pre-hybridized in pre-hybridization mix (50% 
formamide (deionised, Sigma), 2X SSC, 5X Denhardt’s (Sigma), 10% Dextran 
(Sigma), 0.2 mg/ml yeast tRNA, 0.5% SDS, DEPC (Diethyl pyrocarbonate, Sigma) 
treated ddH2O) for 1-2 hours at 60 ْC. Hybridization was carried out using 
approximately 150 mg/ml probe in pre-hybridization mix for each slide, overnight in 
a humidified chamber at 60 ْC.  
 
After hybridization, slides were washed in 2X SSC for 10 minutes at 50 ْC, 50% 
formamide in 2X SSC for 45 minutes at 60 ْC, 4X SSC for 5 minutes at 50 ْC, 4X 
SSC plus 20 µg/ml RNase A for 30 minutes at 37 ْC, 2X SSC for 30 minutes at 50 ْC, 
PBST1 for 10 minutes and PBST1 with 1% BSA at room temperature prior to 
incubation with anti-DIG antibody diluted in 1% BSA, PBT1 at 4 ْC overnight. 
Slides were then washed in PBT1 three times, 20 minutes each, and incubated in 
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buffer 3 (0.1 M Tris-HCl, 0.1 M NaCl, 0.05 M MgCl2) for 5 minutes before the 
colour reaction in staining solution (1% NBT/BCIP stock in buffer 3) to obtain the 
desired colour. Slides were mounted with Aquamount (BD Bioscience) after brief 
washes with PBS.  
 
2.8 TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TDT) 
-MEDIATED DUTP-BIOTIN NICK END LABELLING (TUNEL) 
 
2.8.1 Whole mount TUNEL 
 
E10.5 embryos were dissected in cold PBS, fixed in cold 4% PFA in PBS overnight 
and washed in PBS the day before dehydration through an ascending ethanol series 
and kept at -20 ْC in 100% ethanol until use. Whole mount TUNEL was performed 
following a published protocol (Smith and Cartwright, 1997) using ApopTag in situ 
apoptosis detection kit (Chemicon International). Briefly, embryos were rehydrated 
through a descending ethanol series to PBS, and incubated in equilibration buffer 
(supplied by the manufacturer) for 5 minutes at room temperature prior to adding 
working strength terminal deoxynucleotidyl transferase (TdT) enzyme solution (70% 
reaction buffer: 30% enzyme, supplied by the manufacturer) for 2 hours at 37 ْC in a 
humidified chamber. The reaction was terminated by adding stop buffer (supplied by 
the manufacturer) at 37 ْC for 20 minutes. After the reaction, embryos were washed 
in freshly prepared TBST (0.14 M NaCl, 10 mM KCl, 25 mM Tris-HCl pH 7.0, 0.1% 
Tween-20, 1 mM Levamisole) and NTMT (0.1 M NaCl, 0.1 M Tris-HCl pH 9.5, 50 
mM MgCl2, 0.1% Tween-20, 2mM Levamisole), for 15 minutes in each solution, 
before being blocked in TBST with 10% sheep serum for 30 minutes at room 
temperature. After incubating with anti-DIG antibody (1:3000, Roche Applied 
Science) in NTMT for 40 minutes at room temperature, samples were washed in 
TBST and NTMT respectively for three times, 10 minutes each. Staining was 
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visualized by incubating embryos with 2% NBT/BCIP (Roche Applied Science) in 
NTMT for about 10 minutes in the dark. The staining was stopped by adding PBS 
with 10 mM EDTA, and embryos were post-fixed in 4% PFA. After a few washes in 
PBS, embryos were cleared in a graded series of glycerols and stored in 60% 
glycerol at 4 ْC.  
 
2.8.2 TUNEL on paraffin sections 
 
Embryos were collected and processed as for immunohistochemistry (Chapter 2.3.2). 
TUNEL on paraffin sections was performed by using the In Situ Cell Death 
Detection Kit Fluorescein (Roche Applied Science). Sections were dewaxed in 
xylene and dehydrated through a descending ethanol series to PBS before treating 
with proteinase K for 15 minutes at 37 ْC. After washing in PBS for 10 minutes, 
antigen retrieval was carried out by microwaving sections in 10 mM sodium citrate 
buffer (pH 6.0) for 2 minutes in low power. Slides were incubated with reaction mix 
(10% enzyme solution: 90% label solution, supplied by the manufacturer) at 37 ْC 
for an hour. After a few washes in PBS in the dark, samples were counterstained with 
TO-PRO-3 for 10 minutes, and slides were mounted with Mowiol (Calbiochem).  
 
2.9 CULTURES OF EMBRYONIC TELENCEPHALON  
 
Heads of E9.5 embryos were dissected and cut into two half hemispheres manually 
in cold EBSS medium, and cultured on poly-L-lysine (Fisher) coated 6 wells plates 
containing 2 ml of defined culture medium (see below) plus 10% foetal bovine serum 
(Sigma). After 1 hour incubation at 37 ْC in a 5% CO2 humidified chamber, 2 µg/ml 
of anti-Fgf8b antibody (R&D system) was added to one half of the heads. The other 
half was used as control. Both pieces of tissue were cultured for 16 hours. Explants 
were fixed in 4% PFA and washed in PBS with 0.25% Tween-20 (PBSTw) for 10 
 72 
minutes prior to dehydration through an ascending series of methanols in PBSTw up 
to 100% methanol. Explants were stored at -20 ْC in 100% methanol until whole 
mount immunofluorescence was performed.  
 
EBSS medium was prepared by mixing the following reagents together under sterile 
conditions and stored at 4 ْC until use. 
100 ml Earle’s balanced salt solution 10X (EBSS) (Sigma E7510) 
0.22 g Na2HCO3 (Sigma S5761, final concentration 22 mg/ml) 
0.065 g Glucose (Sigma G7021, final concentration 6.5 mg/ml) 
900 ml double deionised H2O 
EBSS was oxygenated by bubbling with 95% O2 and chilled on ice before use. 
 
Serum free culture medium was prepared by mixing the following reagents 
together under sterile conditions and stored at 4 ْC until use.  
100 ml F12 (Sigma N4888) 
100 ml Dulbecco’s modified Eagles’ medium (DMEM) (Sigma D5671) 
1 mg Insulin (Sigma I6634, final concentration 5 µg/ml) 
2 mg apo-transferrin (Sigma T1147, final concentration 10 µg/ml) 
3 ml HEPES buffer (Sigma H0887) 
0.24 g Na2HCO3 (Sigma S5761, final concentration 0.12 mg/ml) 
3 ml antibiotics (100 mg Gentamycin (Sigma G1264) and 100 mg Kanamycin 
(Sigma K1377) diluted in 20 ml sterile double deionised water) 
2 ml Putrescene (161.1 mg Putrescene (Sigma P5780) diluted in 100 ml ddH2O) 
20 µl Progesterone (6.29 mg Progesterone (Sigma P8783) diluted in 100 ml 
ethanol) 
20 µl Na2SeO3 (5.2 mg Na2SeO3 (Sigma S5261) diluted in 100 ml sterile ddH2O) 
2 ml L-glutamine (6.344 g L-glutamine (Sigma G2128) diluted in 100 ml ddH2O) 
Medium was warmed and equilibrated in a 37 ْC humidified incubator containing 5% 
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CO2 for at least one hour before use. 
 
2.10 IMMUNOFLUORESCENCE ON CULTURED EXPLANTS  
 
Explants were bleached in methanol: 30% Hydrogen peroxide (5:1) for 1-2 hours at 4 
ْC with agitation prior to rehydration through descending methanol series to PBST1. 
Antigen retrieval was carried out by microwaving the explants for 2 minutes in 
sodium citrate (10 mM). They were then blocked in PBST1 with 5% goat serum 
(Sigma) (blocking solution) for 1 hour at 4 ْC with rocking. Rabbit anti-Olig2 
antibody (1:200 in blocking solution) was added to the explants and incubated 
overnight at 4 ْC with agitation. Explants were washed in PBST1 for 30 minutes at 
room temperature prior to overnight washes at 4 ْC with several changes of PBST1. 
A fluorescently conjugated goat anti-rabbit secondary antibody (goat anti-rabbit 
Alexa568, 1:200, Molecular Probes) was added to the explants at 4 ْC overnight 
before washing in PBST1 for 30 minutes at room temperature and 4 ْC overnight 
with rocking. Explants were post-fixed in 4% PFA for 1 hour at room temperature 
and cleared and kept in 60% glycerol.  
 
2.11 PHOTO IMAGING 
 
Slides for immunohistochemistry, in situ hybridization and TUNEL were examined 
and photographed with a Leica DMLB upright compound microscope with a 
DSC480 digital camera. Double immunofluorescence reacted slides and whole 
mount immunofluorescent explants were imaged with a Leica TCS NT confocal 
microscope. Whole mount in situ hybridization and TUNEL reacted embryos were 
either photographed on a Wild M5A dissecting microscope with a Nikon Coolpix 
995 digital camera or scanned and reconstructed by optical projection tomography 




2.12 PROTEIN EXTRACTION FROM MOUSE EMBRYOS 
 
E12.5 mouse whole heads or telencephalic tissue was dissected in cold PBS and 
frozen on dry ice immediately. The telencephalon was dissected into dorsal and 
ventral, or rostral, middle and caudal part, respectively. Tissues were washed and 
homogenized in freshly made buffer H (20 mM Tris-HCl with the following protease 
inhibitors: 1 µg/ml Leupeptin, 1 µg/ml Aprotinin, 17 µg/ml PMSF) and then mixed 
with Laemmli SDS sample buffer (25 mM Tris-HCl, 2% SDS) prior to sonicating for 
three times, 30 seconds each. β-Mercaptoethanol was added to the mix at a final 
concentration of 5%, and then samples were boiled for 10 minutes, aliquoted and 
stored at -70 ْC. Proteins were quantified with BSA (bicinchoninic acid) Protein 
Assay Reagent (PIERCE) according to the manufacturer’s instructions. Each protein 
sample has been tested at least in two individual western blots, and at least two 
embryos from each genotype were analysed. 
 
2.13 WESTERN BLOTTING 
 
10 µg of protein sample was loaded to a precast gel (Invitrogen) and run for 1-1.5 
hours at 150V with appropriate running buffer (Table 2.6). After transferring samples 
to a nitrocellulose membrane (Bio-Rad) for 2 hours at 150V at 4 ْC, the membrane 
was blocked in PBS with 0.25% Tween-20 and 10% goat serum (blocking buffer), 
and then incubated with primary antibody (Table 2.6) for an hour at room 
temperature or overnight at 4 ْC. After incubating with HRP-conjugated anti-mouse 
or anti-rabbit IgG secondary antibody (1:200, Dako cytomation) for 45-60 minutes at 
room temperature, signal was detected using ECL Plus detection (GE Healthcare) on 
an X-ray film (Kodak, BioMax, XAR film, Sigma) according to the instructions of 
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the manufacturer. Following the detection of primary antibody, the membrane was 
incubated for an hour with rabbit anti-β-actin antibody (1:500, Abcam) to confirm 
loading and allow normalization. Band intensity was scanned and measured using a 
densitometer and the Quantity One-4.0.3 software (Bio-Rad).  
 
 
Table 2.6 Antibodies and corresponding gels and buffers used for western blotting in 
this thesis. Gels and buffers were obtained from Invitrogen.  
RT, room temperature; O/N, overnight.  
 
2.14 DATA ANALYSIS AND GRAPH PLOTTING 
 
Statistical analyses were done and graphs were generated by EXCEL (Microsoft) and 
Sigmastat (Systat Software Inc.). Statistical tests used in this thesis were Student’s 
t-test (most cases) and One Way ANOVA (for comparison of Gli3 protein expression 
in rostral, middle and caudal parts). Each sample corresponded to average 
measurements from each embryo. When P<0.05, difference between samples was 
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As mentioned in the Introduction, Gli3 acts as an important regulator of the Shh 
signalling pathway. When Shh is present, full length Gli3 responds to Shh and 
functions as a transcriptional activator (Gli3-F). In the absence of Shh, Gli3 protein is 
cleaved to form a short cleaved form of Gli3 (Gli3-C), which acts as a transcriptional 
repressor (Ruiz i Altaba, 1999; Sasaki et al., 1999; Shin et al., 1999). Gli3 activity 
has been shown to be negatively regulated by Shh in spinal cord and limbs (Masuya 
et al., 1995; Marigo et al., 1996; Ruiz i Altaba, 1998; Wang et al., 2000). Clues to 
gene function can often be obtained by examining when and where a gene is 
expressed, thus Gli3 expression is studied here.  
 
The expression of Gli3 mRNA is first detected around E7, and is found throughout 
embryogenesis in derivatives of both the ectoderm and the mesoderm (Hui et al., 
1994). The onset of the expression in the neural ectoderm begins at the primitive 
streak stage. Gli3 is first expressed in rather broad domains; in general, the 
expression domain becomes more restricted at later stages of development. Gli3 is 
normally expressed in the telencephalon, the diencephalon, the midbrain and the 
hindbrain during gestation and in the cerebellum during postnatal development of the 
wild type embryos (Schimmang et al., 1992; Hui and Joyner, 1993; Hui et al., 1994).  
 
However, there is no detailed description of Gli3 mRNA or protein expression in the 
developing telencephalon, or whether there is any Gli3 protein made in the Gli3Xt/Xt 
mice. Here, by using in situ hybridization, the expression pattern of Gli3 mRNA is 
studied on coronal sections in E12.5 and E14.5 wild type embryos, and the 
distribution of the two isoforms of Gli3 protein in the dorso-ventral and rostro-caudal 
 77 
axes of the developing telencephalon is examined by western blot.  
 
The Gli3 mRNA in situ hybridization experiment described in this chapter was 
completed in collaboration with Vassiliki Fotaki. Some of the results in this chapter 
have been published (Zaki et al., 2005; Fotaki et al., 2006) and these papers are 




3.2.1 Gli3 mRNA expression 
 
The expression of Gli3 mRNA in mouse forebrain was examined at E12.5 and E14.5. 
In situ hybridization showed that in the telencephalon of E12.5 wild type embryos, 
Gli3 expression was found in the ventricular zone of the developing neocortex and 
cortical midline at both ages (Fig. 3.1A and B). No expression was detected in the 
choroid plexus (Fig. 3.1B), in agreement with previous studies (Grove et al., 1998). 
In the ventral telencephalon, there was a highlateral-to-lowmedial gradient of 
expression of Gli3 through the ventricular zone of the lateral (LGE) and medial 
ganglionic eminence (MGE) (Fig. 3.1B). Gli3 expression was also found in the 
ventricular zone of diencephalon, in a high to low gradient from the epithalamus 
through dorsal to ventral thalamus (Fig. 3.1A), and in the hypothalamus at the level 
of the optic chiasm (Fig. 3.1B). At E14.5, Gli3 is found in the ventricular zone of the 
neocortex and the ganglionic eminences (GE) (Fig. 3.1C), and the expression at 
E14.5 seems to be reduced compared to E12.5. 
 
3.2.2 Gli3 protein expression 
 
The structure of the two isoforms of Gli3 protein and the cleavage site are shown in 
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Figure 3.1D. To detect expression of Gli3 in wild type embryos and whether there is 
any Gli3 protein made in the Gli3Xt/Xt mutants, western blot and 
immunohistochemistry were performed on wild type and Gli3Xt/Xt mutants. At present, 
there are several commercial antibodies directed against Gli3 available (Table 3.1), 
and their epitopes are shown in Figure 3.1E. All of them were evaluated by western 
blot, but only the rabbit anti-Gli3 antibody (Santa Cruz, H-280) gave reliable results.  
 





GLI-3 (H-280) Rabbit amino acids 1-280 
Santa Cruz 
Biotechnology 
GLI-3 (N-19) Goat N-terminus Santa Cruz Biotechnology 
GLI-3 (C-20) Goat C-terminus Santa Cruz Biotechnology 
 



















Figure 3.1 In situ hybridization on E12.5 (A and B) and E14.5 (C) wild type coronal 
sections show Gli3 mRNA expression. At E12.5, Gli3 is expressed in the epithalamus 
(ET), dorsal (DT) and ventral (VT) thalamus (A) and hypothalamus at the level of 
optic chiasm (op) (B) of the diencephalon. In the telencephalon, Gli3 is highly 
expressed in the neocortex (nctx) and dorso-medial telencephalon (dmT), but not in 
the adjacent choroid plexus (ChP) (A and B). In the ventral telencephalon, Gli3 
expression has a highlateral-to-lowmedial gradient (B). At E14.5, Gli3 expression is 
observed in the ventricular zone of the neocortex (nctx) and the ganglionic 
eminences (GE) (C). Scale bars, 250 µm. D shows schematically the protease 
cleavage site of the Gli3 protein and the two isoforms. The zinc finger domain (ZnF) 
is the DNA binding site. (E) Schematic diagram of the Gli3 protein. The purple boxes 
represent the five zinc fingers. The commercial anti-Gli3 antibodies used in this 
thesis with their corresponding epitopes (boxed area) are shown above and below 




Western blots showed bands at approximately 170 kDa and 80 kDa in E12.5 and 
E14.5 wild type extracts from dorsal and ventral telencephalon that were absent from 
Gli3Xt/Xt tissue (Fig. 3.2A) and corresponded to the previously described full-length 
(Gli3-F) and cleaved forms (Gli3-C) of Gli3 (Dai et al., 1999; Ruiz i Altaba, 1999). 
The antibody also detected non-specific bands of intermediate size and unknown 
identity (Fig. 3.2A). At E12.5 levels of Gli3 protein were approximately two-fold 
higher in the dorsal than in the ventral telencephalon (Fig. 3.2B), reflecting the 
pattern of Gli3 mRNA expression (Fig. 3.1A and B). Overall, the highest 
concentration of Gli3 was of the cleaved form in the dorsal telencephalon (mean 
density is 5.62 ± 0.30 in the dorsal telencephalon, and 2.66 ± 0.85 in the ventral 
telencephalon, Student’s t test, p<0.05, n=4, Fig. 3.2C). The ratio between the 
cleaved and full length isoforms was quantified in these tissues at E12.5. Dorsally, 
the cleaved form was present at 2.75 times (± 0.45, n=7) the concentration of the full 
length form, whereas ventrally the ratio was lower, at 1.33 (± 0.50, n=8) (Fig. 3.2D). 
These differences are statistically significant (Student’s t test, p<0.05, n=7/8).  
 
As Gli3Xt/Xt mutant embryos show morphological defects along the antero-posterior 
axis (see Chapter 5), the distribution of Gli3 proteins was also measured in rostral 
(rTel), middle (mTel) and caudal (cTel) wild type telencephalon (Fig. 3.2B) at E12.5. 
Although tissue from 8 different embryos was analyzed, it was not possible to detect 
any significant difference between the ratio of the two Gli3 isoforms and the total 
amount of Gli3 protein in rostral, middle and caudal telencephalon. Two individual 
western examples (Fig. 3.2B) are shown here. β-actin expression was used to 
confirm equal loading. Overall, sample 1 seems to have more full length Gli3 protein 
(Gli3-F) than sample 2 (Fig. 3.2B). In sample 1, rostral telencephalon (R1) seems to 
have less Gli3-F than the other two parts (M1 and C1) of the telencephalon, while in 
sample 2 the caudal telencephalon (C2) has the lowest amount of Gli3-F protein (Fig. 
3.2B). The quantification results showed that overall there is slightly more Gli3 
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(Gli3-C+Gli3-F) in the middle telencephalon than in the rostral or caudal parts (n=4) 
(Fig. 3.2E), and the ratio between cleaved Gli3 isoform and the full length in rostral, 
middle and caudal telencephalon is 3.4 (± 1.3, n=5), 4.4 (± 1, n=6) and 5.6 (± 1.6, 
n=5) respectively (Fig. 3.2F). None of these differences is significant (One Way 
ANOVA, SigmaStat), which might be due to variations between embryonic 
dissections.  
 
Once the rabbit anti-Gli3 antibody (Santa Cruz, H-280) had been validated by 
western blot, it was used for immunohistochemistry on wild type (Fig. 3.3A and B) 
and Gli3Xt/Xt mutants (Fig. 3.3A’ and B’) on coronal paraffin sections. At both E12.5 
and E14.5, Gli3 seems to be expressed not only in the cerebral cortex and thalamus 
of the wild type embryos (Fig. 3.3A and B), but also in these regions of Gli3Xt/Xt 
mutants (Fig. 3.3A’ and B’). The Gli3 immunostaining in the mutants might reflect 
the bands that appeared in the western blot with the mutant tissues (Fig. 3.2A). 
Because this antibody gave strong signal in the mutant tissue, it was not used further 
for protein expression studies. Although the protein expression in the wild type 
embryos resembles the highdorsal-to-lowventral mRNA expression pattern (Fig. 3.1A 











Figure 3.2 (A) Western blot of Gli3Xt/Xt mutant head and wild type dorsal (dTel) and 
ventral (vTel) telencephalic tissue with rabbit anti-Gli3 antibody (Santa Cruz, H-280) 
at E12.5 and E14.5. At both ages, bands at 170k Da and 80 kDa are observed in the 
wild type dorsal and ventral telencephalon, corresponding to the full length (Gli3-F) 
and cleaved (Gli3-C) isoform of Gli3 protein, respectively. These bands are absent in 
the Gli3Xt/Xt mutant tissue. At E12.5, the total amount (mean density) of Gli3 
(Gli3-F+Gli3-C) (C) in the dorsal telencephalon is significantly increased than that of 
the ventral telencephalon. (D) The measure relative ratio  between cleaved and full 
length Gli3 (Gli3-C/Gli3-F) shows there is about three times more cleaved Gli3 in the 
dorsal telencephalon than in the ventral telencephalon. Two individual western blots 
with different rostral (R), middle (M) and caudal (C) telencephalic (Tel) samples show 
Gli3 expression along the rostro-caudal axis. β-actin was used as loading control (B). 
The measurements of mean density of total amount of Gli3 protein (E) and the 















Figure 3.3 Gli3 immunohistochemistry with rabbit anti-Gli3 antibody (Santa Cruz, 
H280) on wild type (A and B) and Gli3Xt/Xt mutant (A’ and B’) coronal sections at 
E12.5 and E14.5. Gli3 protein is observed in the diencephalon (Di), the neocortex 
(nctx) and ganglionic eminences (GE) of both wild type (A and B) and the mutant (A’ 
and B’) embryos at both ages. Gli3 is also expressed in the wild type dorso-medial 










The morphogen sonic hedgehog (Shh), a member of the Hedgehog (Hh) family of 
secreted proteins, is expressed in the ventral neural tube including the ventral 
forebrain (Echelard et al., 1993; Riddle et al., 1993), and is involved in ventral cell 
fate specification in all regions of the neural tube (Ericson et al., 1995a; Ingham and 
McMahon, 2001). In the ventral neural tube and the posterior part of the limbs, 
production of full length Gli3 (transcriptional activator) responds to Shh. In the 
dorsal part of the neural tube or the anterior part of the limb bud where Shh is not 
present, Gli3 is cleaved to a transcriptional repressor (Ruiz i Altaba, 1998; Murone et 
al., 1999; Ruiz i Altaba, 1999; von Mering and Basler, 1999; Aza-Blanc et al., 2000), 
and the expression of Gli3 results in the repression of Shh target genes (Ruiz i Altaba, 
1999; Persson et al., 2002).  
 
Gli3 is highly expressed in the developing telencephalon, and this strong expression 
indicates a function of Gli3 in patterning the developing telencephalon. In addition, 
Gli3 is highly expressed in the ventricular zone, indicating a role in proliferation. The 
protein expression in the telencephalon, shown by western blot, reflects the mRNA 
expression of Gli3, which has a highdorsal-to-lowventral pattern. Furthermore, the 
cleaved isoform of Gli3 is about three times more concentrated than the full length 
isoform in the dorsal telencephalon, while in the ventral telencephalon, the amounts 
of full length and cleaved isoforms of Gli3 are about the same. The ratios of the 
cleaved to the full length isoforms of Gli3 in the dorsal and ventral telencephalon are 
analogous to those described in the anterior and posterior limb bud respectively 
(Wang et al., 2000; Litingtung et al., 2002; Chen et al., 2004), and this ratio was 
suggested to be crucial for digit number and identity (Persson et al., 2002; Wang et 
al., 2007). The difference in the ratio of the two isoform of Gli3 in the dorsal and 
ventral telencephalon might also be important for dorso-ventral patterning of the 
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forebrain. The absence of Shh in the dorsal telencephalon may account for the high 
levels of the cleaved Gli3 isoform. As described in the Drosophila anterior wing bud 
(Methot and Basler, 1999) and vertebrate anterior limb bud (Wang et al., 2000), Gli3 
in the dorsal telencephalon might act as a repressor of the Shh signalling pathway.  
 
The anti-Gli3 antibody used also detected positive signals in the Gli3Xt/Xt mutant 
embryos by immunohistochemistry, which might correspond to one (or several) of 
the bands with unknown identity detected by western blot. This (these) band(s) could 
correspond either to some other antigens that crossreact with this rabbit anti-Gli3 
antibody (e.g. Gli2). It is also possible that some Gli3 protein is made by the 
non-functional fusion transcripts in the Gli3Xt/Xt mutant embryos (Buscher et al., 
1998), although there did not seem to appear any shifts in the size of the protein 

















Chapter 4: Analyses of Gli3Xt/Xt mutant forebrain after 





Gli3Xt/Xt mouse mutants exhibit many forebrain malformations. Previous studies have 
shown that the mutant mice have a smaller dorsal telencephalon compared to the 
wild type embryos, and they do not have olfactory bulbs (Franz, 1994; Theil et al., 
1999; Aoto et al., 2002). The expression of dorsal telencephalic markers, like Emx1 
and Emx2, are either lost or reduced from the dorsal telencephalon of the Gli3Xt/Xt 
mutants (Theil et al., 1999; Tole et al., 2000a). The dorso-medial telencephalic wall 
of the Gli3Xt/Xt mutant fails to invaginate, and the hippocampus and the choroid 
plexus of the lateral ventricles do not form (Hui and Joyner, 1993; Grove et al., 1998; 
Theil et al., 1999; Tole et al., 2000a). The expression of a number of Wnt and Bmp 
genes are specifically lost from the Gli3Xt/Xt dorso-medial telencephalon, including 
Bmp2, 4, 6 and 7 and Wnt 2b, 3a and 5a, but their expression in the adjacent 
diencephalon remains (Grove et al., 1998; Theil et al., 1999; Tole et al., 2000a). 
Histological analyses have suggested lack of lamination of the Gli3Xt/Xt mutant 
neocortex (Franz, 1994; Theil et al., 1999). Recently, Theil (2005) showed that the 
organization of the ventricular zone, the apical/basal cell polarity of cortical 
progenitors and the differentiation of early born cortical neurons are affected in the 
Gli3Xt/Xt mutants from E11.5 (Theil, 2005). 
 
Several studies have reported ectopic expression of ventral markers, such as Mash1, 
Dlx2, Gsh2 and Islet1, in the Gli3Xt/Xt mutant dorsal telencephalon along the 
rostro-caudal axis at E12.5 (Tole et al., 2000a; Rallu et al., 2002b; Kuschel et al., 
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2003). However, most of these analyses were carried out by whole mount in situ 
hybridization, and they did not clearly define the limits of each forebrain structure.  
 
The size reduction of Gli3Xt/Xt telencephalon suggested that Gli3 might affect one of 
the following factors that ensure the telencephalon grows at the right rate to produce 
the correct numbers of cells at the right time and place: 
 
1. Commitment of cells to their particular fates (specification) 
2. Rate of cell proliferation 
3. Rate of cell exiting the cell cycle to differentiate 
4. Rate of cell migration in and out of the tissue 
5. Rate of cell death 
 
In this chapter, markers which are normally expressed in different regions within the 
forebrain were analysed in detail in E12.5 wild type and Gli3Xt/Xt mutant embryos. 
The expression of ventral markers such as Mash1, Dlx2, Gsh2 and Islet1 were found 
confined to ventral telencephalon and ventral thalamus in more caudal sections of the 
Gli3Xt/Xt mutant embryos, in contrast to previous publications. Their expression in the 
most rostral forebrain sections was found expanded in the mutants, in agreement with 
previous results. Similar results were observed at later stages of development, 
although the neocortex of the Gli3Xt/Xt mutants became highly disorganized. 
Rosette-like structures are found in the neocortical area of the Gli3Xt/Xt mutants from 
E13.5, and these rosettes comprised well organized neocortical progenitors. 
 
The boundary between the telencephalon and the diencephalon was found to be 
compromised in the Gli3Xt/Xt mutants, and clusters of cells that have eminentia 
thalami identity were found at E12.5 in the neocortical area of the Gli3Xt/Xt mutants. 
These two types of cells were well segregated from each other at later developmental 
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stages examined (E13.5 to E16.5). Diencephalic cells were also observed in the most 
rostral sections of the Gli3Xt/Xt mutant telencephalon at E12.5. The mutant 
diencephalon was found join with the septum of the ventral telencephalon in more 
rostral areas than in the wild types.  
 
Finally, a 73% reduction of the dorsal telencephalon, and about 20% reduction of the 
ventral telencephalon of the Gli3Xt/Xt mutant embryos was found at E12.5. However, 
no cell proliferation or cell death defects were detected in E12.5 Gli3Xt/Xt mutant 
telencephalon, suggesting that the telencephalic size reduction must have been 
initiated at earlier developmental stages.  
 
Some of the immunohistochemical experiments and cell proliferation measurements 
described in this chapter were done in collaboration with Vassiliki Fotaki and 
Paulette Zaki, and many of the results in this chapter have already been published 
(Fotaki et al., 2006). This paper is bound into this thesis and will not be cited again in 




4.2.1 Identification of the limits of the dorsal telencephalon in Gli3Xt/Xt mutants 
 
To study the dorso-ventral patterning of the Gli3Xt/Xt mutant forebrains, E12.5 wild 
type and mutant forebrain sections were immunoreacted with Pax6, which is highly 
expressed in the dorsal telencephalon and diencephalon (Walther and Gruss, 1991; 
Stoykova and Gruss, 1994; Mastick et al., 1997), and Mash1, which is expressed in 
the ventral telencephalon and diencephalon (Lo et al., 1991; Guillemot and Joyner, 
1993; Porteus et al., 1994). Figure 4.1 shows wild type and mutant forebrain sections 
in caudal to rostral order. The expression of Pax6 and Mash1 is relatively normal in 
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caudal sections of Gli3Xt/Xt mutant embryos (Fig. 4.1A’ and D’) compared to wild 
types (Fig. 4.1A and D). In these caudal sections of wild type embryos, the 
telencephalic vesicles are clearly visible. However, only the most caudal tips of the 
telencephalic lobes are observed in the corresponding Gli3Xt/Xt mutant sections. This 
may be due to the diminished size of the Gli3Xt/Xt telencephalon compared to wild 
types and/or the alteration of the relative three dimensional positions of the 
telencephalon and the diencephalon. In middle sections along the rostro-caudal axis 
of the telencephalon, Pax6 is strongly expressed in the diencephalon, including the 
ventral thalamus and the eminentia thalami (Fig. 4.1B). In the telencephalon, Pax6 
expression has a highlateral-to-lowmedial gradient. This gradient of expression is lost in 
Gli3Xt/Xt mutants, probably because the dorso-medial telencephalon is lost in the 
mutants, and the highly Pax6 expressing diencephalon and neocortex are joined 
directly (Fig. 4.1B’). At this level, Mash1 expression is normally observed in the 
ventral thalamus and hypothalamus of the diencephalon and the ganglionic 
eminences (GE), but not in the neocortex (Fig. 4.1E). In comparable Gli3Xt/Xt sections, 
Mash1 immunoreactivity is also present in the GE (Fig. 4.1E’) and absent from the 
Pax6 positive area dorsally to the GE (compare Fig. 4.1B’ with E’). This suggests 
that the Mash1 negative region (area between the lines in Fig. 4.1E’) is neocortical 
tissue, and the Mash1 staining in the adjacent region most likely corresponds to 
diencephalic tissue (ventral thalamus (VT) and/or eminentia thalami (EmT) in Fig. 
4.1E’). The expression of Pax6 at most rostral sections of the wild type and mutant 
embryos is confined to the dorsal telencephalon (Fig. 4.1C and C’). The rostral 
expression of Mash1 is confined to the ventral area of wild type embryos (Fig. 4.1F), 
whereas in Gli3Xt/Xt mutants, Mash1 expression is found throughout the telencephalic 
vesicle (Fig. 4.1F’). Note that at very rostral level of the mutants, Mash1 and Pax6 














Figure 4.1 Pax6, Mash1, Foxg1 and Olig2 immunoreactivity on E12.5 wild type 
(Gli3+/+) (A-L) and Gli3Xt/Xt mutants (A’-L’) forebrain coronal sections. In the 
diencephalon, Pax6 is expressed in the epithalamus (ET), dorsal (DT) and ventral 
(VT) thalamus in both wild types (A) and mutants (A’) in more caudal sections. 
Moving to middle sections, Pax6 expression is observed in the eminentia thalami 
(EmT) in the wild type diencephalon (B). In the telencephalon (Tel), Pax6 is 
expressed highly in the neocortex (nctx) and lightly in the dorso-medial 
telencephalon (dmT) and is absent in the ventral telencephalon (ganglionic 
eminences, GE) (B). In the mutants, Pax6 is continuously highly expressed in the 
diencephalon and dorsal telencephalon (B’). Rostrally, Pax6 expression is restricted 
to the dorsal telencephalon (dTel) of both the wild types (C) and mutants (C’). Mash1 
expression is observed in ventral thalamus, hypothalamus (HT) and GE in both wild 
types (D) and mutants (D’). The neocortex in mid-telencephalic sections is negative 
for Mash1 in both wild types (E) and mutants (area between lines in E’). Rostrally, 
Mash1 expression is restricted in the ventral telencephalon of the wild types (F), but 
is found throughout the telencephalic vesicles of the Gli3Xt/Xt mutants (F’). Foxg1 
delineates the telencephalon of wild type (G-I) and Gli3Xt/Xt mutant (G’-I’) embryos. 
The area between the lines in H’ corresponds to the mutant neocortex. Olig2 is 
expressed in the ventral thalamus and the GE in more caudal sections of both the 
wild type (J and K) and mutant (J’ and K’) embryos. Rostrally, Olig2 expression is 
observed throughout the telencephalic lobes of the mutant embryos (L’) in contrast to 













To confirm that the Mash1 positive tissue dorsally to the neocortex is diencephalic, 
but not telencephalic, in middle telencephalic sections of Gli3Xt/Xt embryos (Fig. 
4.1E’), immunohistochemistry was performed using an antibody against Foxg1. 
Foxg1 is expressed in the dorsal and ventral telencephalon and is absent from the 
dorsal and ventral diencephalon (Tao and Lai, 1992; Hanashima et al., 2002). Foxg1 
expression delineates the telencephalon and is observed in both wild type and 
Gli3Xt/Xt embryos throughout the rostro-caudal axis (Fig. 4.1G-I and G’-I’). In the 
middle part of the telencephalon (Fig. 4.1G’), Foxg1 is absent from the Mash1 
positive tissue dorsally to the neocortex of the Gli3Xt/Xt mutants (VT & EmT in Fig. 
4.1E’), confirming that this tissue is not telencephalic. These results clearly delineate 
the neocortical region and confirm that in middle sections along the rostro-caudal 
axis, Mash1 positive tissue dorsally to the Foxg1 positive neocortical region is 
diencephalic. In rostral wild type (Fig. 4.1I) and Gli3Xt/Xt mutant sections (Fig. 4.1I’), 
Foxg1 expression is observed throughout the telencephalic vesicles, suggesting that 
the Mash1 positive region in the Gli3Xt/Xt mutants is telencephalic tissue (compare 
Fig. 4.1F’ with Fig. 4.1I’).  
 
To provide additional evidence for this, the expression of several ventral forebrain 
markers was examined in wild type and Gli3Xt/Xt mutant embryos. Olig2 is expressed 
in the precursors of both the lateral (LGE) and medial (MGE) ganglionic eminences 
of the wild types (Fig. 4.1J-L) (Lu et al., 2000; Zhou et al., 2000). The expression of 
Olig2 is generally broader than that of Mash1 in the wild type embryos (compare Fig. 
4.1D, E and F with Fig. 4.1J, K and L) (Gokhan et al., 2005; Parras et al., 2007). In 
the Gli3Xt/Xt mutants, Olig2 positive area seems to be also broader than Mash1 
expression (compare Fig. 4.1D’, E’ and F’ with Fig. 4.1J’, K’ and L’). The 
expression of Olig2 is confined to the mutant ventral telencephalon and ventral 
thalamus in more caudal sections (Fig. 4.1J’ and K’), but expanded to the dorsal area 




A number of ventral telencephalic markers that were previous described to be 
ectopically expressed were re-examined in Gli3Xt/Xt mutants. The expression pattern 
of Islet1 is normally observed in the postmitotic neurons of the GE and ventral 
thalamus of the wild type (Fig. 4.2A and B) (Wang and Liu, 2001). Its expression is 
not found in the neocortical area of the Gli3Xt/Xt mutants in middle telencephalic 
sections along the rostro-caudal axis (Fig. 4.2A’). In rostral sections of the mutant 
embryos (Fig. 4.2B’), dispersed Islet1 positive cells are detected in a more dorsal 
area, besides its normal expression in GE. This ectopic expression is never detected 
in the wild type dorsal telencephalon (Fig. 4.2B). The expansion of Islet1 in the 
mutant rostral sections is less prominent than those of the progenitor markers, such 
as Mash1 and Olig2 (compare Fig. 4.1F’, L’ with Fig. 4.2B’). Islet1 expression in the 
mutant in a ventral region that probably corresponds to the telencephalic septum 
seems to be expanded (arrowheads in Fig. 4.2B’). The expression of two other 
ventral markers, Dlx and Gsh2 was confined to the ventral telencephalon and the 
ventral thalamus and/or eminentia thalami region in Gli3Xt/Xt embryos (VT & EmT in 
Fig. 4.2C’ and D’) as in the wild types (Fig. 4.2C and D) in middle sections, in 
contrast to previous reports (Theil et al., 1999; Tole et al., 2000a; Rallu et al., 2002b). 
In addition, the expression pattern of Shh transcript in the zona limitans 
intrathalamica (ZLI) (Echelard et al., 1993; Marti et al., 1995a) defines the border 
between the dorsal and ventral thalamus (Figdor and Stern, 1993; Porteus et al., 1994; 
Kiecker and Lumsden, 2004). Shh mRNA expression is present in both wild type and 
Gli3Xt/Xt sections (Fig. 4.2E and E’), showing clearly that the Mash1, Olig2, Islet1, 
Dlx and Gsh2 expressing area below the ZLI corresponds to ventral thalamus in both 
wild types and mutants. Furthermore, the region that corresponds to the mutant 
neocortex (area of tissue between the lines in Fig. 4.1E’, K’, Fig. 4.2A’, C’ and D’) 
does not express any of these markers. Altogether these results show that the 
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previously described ectopic expression of Mash1, Islet1, Dlx and Gsh2 at middle 
parts of the Gli3Xt/Xt dorsal telencephalon (Tole et al., 2000a; Rallu et al., 2002b; 
Kuschel et al., 2003) actually reflects expression in the diencephalon (ventral 
thalamus and/or eminentia thalami). However, in the rostral telencephalon of Gli3Xt/Xt 
mutant embryos, these ventral markers are expanded to a more dorsal area, in 
agreement with previous published results (Theil et al., 1999; Tole et al., 2000a; 
Rallu et al., 2002b). 
 
To further examine the properties of the rostral expansion of the Gli3Xt/Xt ventral 
telencephalon, Nkx2.1 immunoreactivity was performed on E12.5 wild type and 
Gli3Xt/Xt mutant sections. Nkx2.1 is expressed in the precursor cells of the MGE 
(Shimamura et al., 1995; Sussel et al., 1999), but not the LGE, of the wild type 
embryos, and the expression can only be seen in more caudal sections (Fig. 4.2F and 
G). Nkx2.1 expression seems to be confined to the medial part of the ganglionic 
eminences of the mutant embryos in more caudal sections, although the distinct 
bulging shape of the MGE and LGE is lost (Fig. 4.2F’). Rostrally, no Nkx2.1 
expression is observed in the mutant embryos (Fig. 4.2G’), similar to the wild types. 
This result suggests that the precursor cells from the MGE of the Gli3Xt/Xt mutant 
















Figure 4.2 Forebrain marker analyses in wild types (Gli3+/+) (A-G) and Gli3Xt/Xt 
mutants (A’-G’) E12.5 coronal sections. Islet1 is expressed in the ventral thalamus 
(labelled VT in the wild types and VT & EmT in the mutants) and ventral 
telencephalon (GE) of both wild types (A) and mutants (A’). Rostrally, Islet1 
expression is restricted to the postmitotic cells in the wild type ventral telencephalon 
(B), but in the mutants, it is found in a more dorsal area (arrows in B’). The 
expression of Islet1 in the mutant septum seems to be expanded (arrowheads in B’) 
compared to that of the wild types (arrowhead in B). Gsh2 and Dlx expression are 
found in the ventral thalamus (VT or VT & EmT) and ventral telencephalon (GE) of 
both the wild type (C and D) and mutants (C’ and D’). Note that no ectopic 
expression of any of these markers is observed in the neocortical area of the mutants 
(area between lines in C’ and D’). Shh mRNA expression is observed in the zona 
limitans intrathalamica (ZLI) which defines the border between the dorsal (DT) and 
ventral (VT) thalamus, and hypothalamus (HT) of the wild type (E) and mutant 
embryos (E’). Nkx2.1 expression is confined to the medial ganglionic eminence 
(MGE) of both wild type (F) and Gli3Xt/Xt mutant (F’) embryos in middle sections, and 













4.2.2 The Gli3Xt/Xt neocortex contains clusters of cells with characteristics of the 
eminentia thalami 
 
In the Foxg1 expressing neocortical area of the Gli3Xt/Xt mutant embryos, some 
negative patches of expression were observed (Fig. 4.1H’ and Fig. 4.3A’), which 
were not detected in any sections of the wild type telencephalon (Fig. 4.1H and Fig. 
4.3A). A similar patchy staining was observed with Lhx2 expression (Fig. 4.3B’ and 
C’), which is normally found throughout the neocortex with a highmedial-to-lowlateral 
gradient (Fig. 4.3B and C) (Monuki et al., 2001). This gradient of expression is lost 
in the Gli3Xt/Xt mutant dorsal telencephalon (Fig. 4.3C’), although Lhx2 expression in 
the dorsal thalamus seems to be intact (compare thalamic expression in Fig. 4.3C 
with C’). The Foxg1 and Lhx2 negative area is positive for Pax6 (Fig. 4.1B’) in the 
Gli3Xt/Xt mutants. In wild types, Pax6 is expressed not only in the dorsal 
telencephalon and ventral thalamus, but also in the ventricular zone of the eminentia 
thalami (Fig. 4.1B) (Puelles et al., 2000), which forms part of the rostral boundary 
between the diencephalon and the telencephalon (Porteus et al., 1994; Puelles and 
Rubenstein, 2003). It is possible that these Foxg1 and Lhx2 negative patches of cells 
are comprised cells from the eminentia thalami, since they do not express markers of 
ventral thalamus, such as Mash1, Olig2, Islet1, Dlx and Gsh2 (Fig. 4.1E’, K’, 4.2A’, 
C’ and D’). To test whether these patches have an eminentia thalami identity, 
immunohistochemistry of several eminentia thalami markers was performed. 
Calretinin is expressed in the postmitotic somata and fibers of the eminentia thalami 
in wild type embryos (Fig. 4.3D and E) (Abbott and Jacobowitz, 1999). In Gli3Xt/Xt 
mutants, the eminentia thalami is intensely stained with calretinin (Fig. 4.3E’), and 
the mutant eminentia thalami is observed in a region dorsal to the neocortex (Fig. 
4.3D’ and E’). In addition, small calretinin positive cell clusters are observed in the 
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mutant neocortex (Fig. 4.3D’ and E’).  
 
To provide additional evidence about the eminentia thalami nature of these clusters, 
the expression pattern of Lim2 (also known as Lhx5) was examined, which 
specifically labels the eminentia thalami and ventral thalamus in E12.5 wild types, 
with more intense expression in the postmitotic cells (Fig. 4.3F and G) (Sheng et al., 
1997). The antibody used recognized both Lim1 (Lhx1) and Lim2 (Lhx5) proteins, 
but Lim1 mRNA expression is very weak in these tissues at this age (Sheng et al., 
1997). In the Gli3Xt/Xt mutant neocortex, Lim2 immunostaining showed a strong and 
patchy expression (Fig. 4.3F’ and G’), similar to that observed with calretinin, and 
complementary to the Foxg1 negative patches (compare Fig. 4.3A’, D’ and F’). Note 
that the Lim2 positive clusters appearing in the Gli3Xt/Xt mutant neocortex were 
intensely stained, suggesting they might share some properties with the postmitotic 
cells of the eminentia thalami (Fig. 4.3G’). To further confirm the eminentia thalami 
identity of these clusters, double immunofluorescence for Foxg1 and Lim2 was 
performed on E12.5 wild type and Gli3Xt/Xt sagittal sections. In wild types, Lim2 
immunostaining was confined in the eminentia thalami, whereas Foxg1 specifically 
labelled the dorsal and ventral telencephalon (Fig. 4.3H). In Gli3Xt/Xt mutants, 
clusters of Lim2 positive cells were found in the Foxg1 positive area, and Foxg1 and 
Lim2 expression did not co-localize (Fig. 4.3H’).  
 
Finally, Pax2, a well described marker of the hindbrain, optic chiasm and optic stalk 
(Nornes et al., 1990; Puschel et al., 1992), labels a distinct population of eminentia 
thalami cells, found in a region close to the choroid plexus in wild type sections (Fig. 
4.3I). In the Gli3Xt/Xt mutants, dispersed Pax2 positive cells were detected (Fig. 4.3I’), 








Figure 4.3 Marker analyses of E12.5 wild type (Gli3+/+) (A-I) and Gli3Xt/Xt mutant (A’-I’) 
dorsal telencephalon and eminentia thalami on coronal (A-G, I and A’-G’, I’) and 
sagittal sections (H and H’). Foxg1 shows a patchy expression in the Gli3Xt/Xt mutant 
neocortex (A’) which is never observed in the wild type dorsal telencephalon (A). 
Lhx2 is expressed in the wild type dorsal telencephalon with a highmedial-to-lowlateral 
gradient (B and C). This gradient is lost in the mutant neocortex, revealing the 
presence of immunonegative patches (B’ and C’). B and B’ are high magnification 
images of boxed area in C and C’, respectively. Calretinin expression is detected in 
both wild type (D and E) and mutant (D’ and arrowhead in E’) eminentia thalami 
(EmT). In the mutants, calretinin positive clusters are found within the neocortical 
area (Foxg1 positive) but they do not express Foxg1 (compare A’ with D’). D and D’ 
are high magnification images of boxed areas in E and E’, respectively, and they are 
counterstained with cresyl violet. Lim2 is expressed in both the wild type (F and G) 
and mutant (F’ and G’) eminentia thalami, with more intensity in the postmitotic cells 
(G and G’). Lim2 positive clusters were also found in the neocortical area of the 
mutants (F’ and G’). F and F’ are high magnification images of boxed area in G and 
G’. Double immunofluorescence with Foxg1 (red) and Lim2 (green) labels 
telencephalon (nctx + dmT + GE) and eminentia thalami (EmT) respectively on 
sagittal sections of wild type embryos (H). In the mutants, the Foxg1 negative 
patches within the neocortical area are immunopositive for Lim2 (H’). Pax2 is found 
to be expressed in a small population of cells of the eminentia thalami near the 
choroid plexus (ChP) in the wild type embryos (I). In the mutants, Pax2 positive 
clusters are found not only in the area that is positive for Lim2 but negative for Foxg1 
(arrow in I’), but also among the Foxg1 negative patches (arrowheads in I’). A’, B’, D’ 
and F’ are serial sections from the same specimen. Scale bars, A, A’, B’ and D’, 50 
µm; B, F, F’, H’, I, and I’, 100 µm; D and H, 150 µm; C, C’, G and G’, 250 µm; E and 










The above results strongly suggest that the cell clusters observed in the neocortical 
area of the Gli3Xt/Xt mutants are diencephalic. However, because calretinin and Lim2 
also label the earliest born neurons in the marginal zone, the Cajal-Retzius cells, 
which are negative for Foxg1 (del Rio et al., 1995; Super et al., 1998; Hevner et al., 
2001; Hevner et al., 2003; Yamazaki et al., 2004), it was possible that the calretinin 
and Lim2 positive clusters in the Gli3Xt/Xt neocortex comprised this cell type. To 
examine this possibility, the expression of reelin, which is also found in 
Cajal-Retzius cells (Alcantara et al., 1998), and calbindin, which is not normally 
observed in this cell population (Hevner et al., 2003; Jimenez et al., 2003) was 
performed on wild type and Gli3Xt/Xt mutant embryos. In the wild types, Reelin 
positive cells are found in the eminentia thalami and the Cajal-Retzius cells in the 
marginal zone (Fig. 4.4A and B). No reelin positive cell clusters were observed in the 
Gli3Xt/Xt mutants (Fig. 4.4A’ and B’), and in fact, there were less reelin positive cells 
in the mutants compared to wild types (compare Fig. 4.4B with B’), in accordance 
with recently published data (Theil, 2005). Calbindin expression was detected 
intensely in the ventral telencephalon (Fig. 4.4C and C’) (Davila et al., 2005) and 
lightly in the eminentia thalami neurites of the wild types and mutants (Fig. 4.4D and 
D’). In the mutants, it was also detected near the calretinin positive clusters in the 
neocortex (Fig. 4.4C’ and D’). These results indicate that Cajal-Retzius cells are not 
the major component of the calretinin and Lim2 positive clusters.  
 
In the calretinin and calbindin positive regions in the mutant neocortex, a few 
dispersed reelin positive cells (arrows in Fig. 4.4B’) were found, suggesting that a 
few Cajal-Retzius cells (Fig. 4.4B) may contribute to these clusters. However, it is 
also possible that these reelin positive cells are actually derived from the eminentia 
thalami, because reelin labels a population of eminentia thalami cells (Fig. 4.4A) 









Figure 4.4 Reelin and calbindin expression on E12.5 wild type (Gli3+/+) (A-D) and 
Gli3Xt/Xt mutant (A’-D’) coronal sections. B, B’, D, and D’ are high magnification 
images of boxed areas in A, A’, C and C’ respectively. Reelin expression is found in 
the Cajal-Retzius cells which are located in the outer layer of the neocortex (nctx) of 
wild type embryos (A and B). In the mutants, there are fewer Reelin positive cells in 
the neocortical area, and these are not located in the outer layer (arrowheads in B’). 
Reelin also labels cells in the eminentia thalami (EmT) of both wild type (A) and 
mutant (A’ and arrowheads in B’) embryos. Calbindin is expressed in the somata 
and fibers in the ventral telencephalon (GE) and fibers in eminentia thalami of both 
wild type (C and D) and mutant (arrowhead in C’) embryos. Small clusters of 
calbindin positive cells are present in the mutant neocortical area (C’ and D’). C, C’, 
D and D’ are counterstained with cresyl violet. Scale bars, A, A’, C and C’, 250 µm; 


















The expression of Lim2 and Pax2 were also examined in rostral telencephalic 
sections of the wild type and Gli3Xt/Xt mutant embryos. In the wild type embryos, 
Lim2 is continuously found in the diencephalon from the eminentia thalami to most 
rostral end of the diencephalon, lamina terminalis (Sheng et al., 1997) (Fig. 4.5A). 
This diencephalic expression is joined with its expression in the septum (Fig. 4.5A). 
In comparable Gli3Xt/Xt mutant sections, Lim2 expression is observed in both the 
lamina terminalis (arrow in Fig. 4.5A’) and the septum (arrowhead in Fig. 4.5A’), 
but these two structures have not joined yet. Note there are clusters of Lim2 positive 
cells in the neocortical area of the Gli3Xt/Xt mutant embryos at this level (Fig. 4.5A’). 
The lamina terminalis and the septum finally join in more rostral sections of the 
mutant embryos (Fig. 4.5B’), and Lim2 expression seems to be increased compared 
to that in wild types (Fig. 4.5A and B). Pax2 expression is highly observed in the 
septum, and in a few dispersed cells in the lamina terminalis of the wild type 
embryos (Fig. 4.5C) (V. Fotaki, unpublished data). In the Gli3Xt/Xt mutant embryos, 
Pax2 expression is observed in the septum, and its expression seems to be expanded 
(arrowhead in Fig. 4.5C’). Pax2 expression is also found ectopically in the lamina 
terminalis (arrow in Fig. 4.5C). These results suggest that the mutant diencephalon 
joins abnormally with the ventral telencephalon in more rostral areas, and the mutant 
septum seems to be enlarged.  
 
Altogether, these results clearly show that the neocortex of Gli3Xt/Xt embryos contains 
not only neocortical cells but also cells of eminentia thalami identity, and the rostral 
and ventral border between the telencephalon and diencephalon is compromised in 










Figure 4.5 Lim2 and Pax2 immunoreactivity in E12.5 wild type (Gli3+/+) (A-C) and 
Gli3Xt/Xt mutant (A’-C’) rostral telencephalic sections. Lim2 is expressed in wild type 
lamina terminalis at the rostral end of the diencephalon (Di), and the septum (SP) in 
the ventral telencephalon (A and B). In the Gli3Xt/Xt mutant embryos, expression of 
Lim2 in both lamina terminalis (arrow in A’ and B’) and septum (arrowhead in A’ and 
B’) is expanded. Pax2 expression in the Gli3Xt/Xt mutants is not only observed in the 
septum (arrowhead in C’) as in the wild types (C), but also ectopically in the lamina 
terminalis (arrow in C’). Note that Pax2 expression in the mutant septum also seems 




4.2.3 The size of dorsal telencephalon of the Gli3Xt/Xt mutant is severely 
decreased 
 
Having defined the telencephalic area of the Gli3Xt/Xt mutant, volumetric and areal 
measurements were carried out on E12.5 wild type and Gli3Xt/Xt mutant telencephalon 
to define the actual three and two dimensional sizes of the mutant dorsal and ventral 
telencephalon and to discover if there are any areal differences along the 
rostro-caudal axis (see Chapter 2.5 for details). Briefly, E12.5 embryos were cut in 
the coronal plane, and immunohistochemistry for different gene markers was carried 
out in serial sections. Foxg1 and Pax6 expression domains were used to identify the 
extent of the entire telencephalon and the dorsal telencephalic tissue, respectively, in 
wild type and Gli3Xt/Xt mutant embryos. The total volumes of Foxg1 and Pax6 
expression domains in the telencephalon were measured in wild type and mutant 
embryos. The area of expression of these markers at defined rostral, middle and 
caudal sections was also compared. Caudal and rostral telencephalic sections were 
defined as the sections located at a distance of about 30 µm from the most caudal and 
most rostral tips of the telencephalic lobes, respectively, in both wild type and 
Gli3Xt/Xt mutant embryos. The sections half way between the caudal and rostral ends 
were defined as middle telencephalic sections for these measurements. From now on, 
these terms will be used to refer to the different telencephalic levels. Examples of 
representative caudal, middle and rostral OPT sections of wild type and mutant 
embryos are shown in Figure 2.1. The expression pattern of Foxg1 in the Gli3Xt/Xt 
mutants (Fig. 4.1G’, H’ and I’) was largely unchanged, although the three 
dimensional shape was different compared to the wild type. The volume of Foxg1 
expression domain in the Gli3Xt/Xt telencephalon (0.77 ± 0.06 mm3) was significantly 
decreased (Student’s t test, p<0.001, n=4 per genotype) to about 53.5% compared to 
that of wild types (1.42 ± 0.08 mm3) (Fig. 4.6A). Pax6 expression in the 
telencephalon was used to measure the volume of the dorsal telencephalon. The 
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volume of Pax6 expression in the telencephalon of the Gli3Xt/Xt mutants (0.20 ± 0.02 
mm3) is significantly decreased (Student’s t test, p<0.001, n=4 per genotype) to 
about 27% of that of wild types (0.74 ± 0.04 mm3) at E12.5 (Fig. 4.6A), as expected 
from the fact that the Pax6 expression domain in the dorso-medial telencephalon is 
lost in the mutants (Fig. 4.1A’, B’ and C’). Areal measurements of Pax6 expression 
on defined caudal, middle and rostral sections showed that the reduction of the Pax6 
positive domain in the dorsal telencephalon was universal along the rostro-caudal 
axis in Gli3Xt/Xt mutants (Fig. 4.6B) (Table 4.1), and the difference is significant 
(Student’s t test, p<0.001, n=4 per genotype). The most severe reduction of Pax6 
expression is observed in the rostral sections of Gli3Xt/Xt mutant telencephalon (Fig. 
4.6B) (Table 4.1).  
 
Area (mm2) rTel mTel cTel 
Gli3+/+ 0.51±0.008 0.49±0.01 0.60±0.02 
Gli3Xt/Xt 0.32±0.01 0.22±0.008 0.28±0.007 
P value  ≤0.001 ≤0.001  ≤0.001  
Percentage of decrease in 
the mutants 37.3% 55.1% 53.3% 
 
Table 4.1 Areas of Pax6 expression in rostral (rTel), middle (mTel) and caudal (cTel) 















Figure 4.6 Volumetric (A) and areal (B, C and D) measurements of Foxg1, Pax6, 
Mash1 and Olig2 expression domain in the telencephalon of wild type (Gli3+/+) and 
Gli3Xt/Xt mutant embryos. (A) The volume of Foxg1 expressing telencephalon in the 
mutants is decreased to about 53.5% of the wild type. The volume of Pax6 positive 
dorsal telencephalon is decreased in the mutants to 27% of the wild type embryos, 
and the reduction of the Pax6 positive area in the mutants is continuous throughout 
the rostro-caudal axis (B). The volumes of the expression domain of two ventrally 
expressing markers, Mash1 and Olig2, in the telencephalon are also significantly 
decreased in the mutants to about 80% to those of wild types. The reduction of 
Mash1 (C) and Olig2 (D) expression is only observed in middle parts of the Gli3Xt/Xt 
mutants. Their expression in rostral parts of the mutant telencephalon shows a most 








4.2.4 E12.5 Gli3Xt/Xt ventral telencephalon is smaller than that of the wild type 
embryos 
 
Along with the measurements in the dorsal telencephalon, the overall volume of the 
E12.5 wild type and Gli3Xt/Xt ventral telencephalon was measured using the Mash1 
and Olig2 expression domains. The areas of expression of these markers were also 
measured in defined rostral, middle and caudal sections. At E12.5, Mash1 expression 
was confined to the ventral telencephalon on caudal (Fig. 4.1D’) and middle (Fig. 
4.1E’) Gli3Xt/Xt sections as in the wild types (Fig. 4.1D and E), as discussed before, 
whereas in very rostral sections of the Gli3Xt/Xt ventral telencephalon, Mash1 
expression was observed throughout the telencephalic vesicles (Fig. 4.1F’), in 
contrast to the ventrally restricted positive cells in the wild type embryos (Fig. 4.1F). 
The total volume of Mash1 expression domain in the Gli3Xt/Xt mutants (0.56 ± 0.04 
mm3) showed a significant 17.7% reduction (Student’s t test, p<0.05, n=4 per 
genotype) compared to that of wild types (0.68 ± 0.04 mm3) (Fig. 4.6A). 
Interestingly, this reduction is observed only in the mid-telencephalic sections, 
whereas in the caudal and rostral parts of the telencephalon, Mash1 expression is 
expanded (Fig. 4.6C) (Table 4.2). All these differences between wild types and 
mutants are significant (Student’s t test, p<0.05, n=4 per genotype). Olig2 expression 
was also measured in wild types and Gli3Xt/Xt mutant embryos. The expression of 
Olig2 is generally broader than that of Mash1 in wild type embryos (compare Fig. 
4.1G, H and I with Fig. 4.1J, K and L). In the mutants, the Olig2 positive area 
seemed to be also broader than the Mash1 positive domain (compare Fig. 4.1D’, E’ 
and F’ with Fig. 4.1J’, K’ and L’). The Olig2 expression domain in the Gli3Xt/Xt 
mutants (0.63 ± 0.06 mm3) showed a significant 19.2% reduction (Student’s t test, 
p<0.05, n=2 per genotype) compared to that of wild type embryos (0.78 ± 0.01 mm3) 
(Fig. 4.6A), and this reduction was only observed in the middle sections of the 
mutant telencephalon (Fig. 4.6D) (Table 4.3), similar to what was observed with the 
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Mash1 expression domains. Note that both Mash1 and Olig2 expression showed a 
most prominent expansion at rostral telencephalic sections of the mutants (Table 4.2 
and 4.3). These data suggest that the overall size of the Gli3Xt/Xt mutant ventral 
telencephalon is smaller than that of wild types at E12.5, but this reduction occurs 
only in the middle part of the ventral telencephalon.  
 
Area (mm2) rTel mTel cTel 
Gli3+/+ 0.29±0.01 0.91±0.02 0.37±0.02 
Gli3Xt/Xt 0.51±0.01 0.66±0.02 0.46±0.01 
P value ≤0.001 0.001 0.036 
Percentage of changes 
in the mutants 75.9% 27.5% 24.3% 
 
Table 4.2 Areas of Mash1 expression in rostral (rTel), middle (mTel) and caudal 
(cTel) telencephalon of the E12.5 wild type (Gli3+/+) and Gli3Xt/Xt mutant embryos. 
 
Area (mm2) rTel mTel cTel 
Gli3+/+ 0.26±0.02 1.31±0.03 0.31±0.02 
Gli3Xt/Xt 0.68±0.02 0.78±0.02 0.47±0.01 
P value ≤0.001  ≤0.001  0.02  
Percentage of changes 
in the mutants 161.5% 40.5% 51.6% 
 
Table 4.3 Areas of Olig2 expression in rostral (rTel), middle (mTel) and caudal (cTel) 
telencephalon of the E12.5 wild type (Gli3+/+) and Gli3Xt/Xt mutant embryos. 
 
4.2.5 The Gli3Xt/Xt mutant telencephalon becomes progressively disorganized 
after E12.5 
 
To study the development of Gli3Xt/Xt mutant telencephalon after E12.5, wild type 
and Gli3Xt/Xt mutant embryos were analysed from E13.5 to E16.5 using several 
telencephalic markers. The mutant telencephalon was found progressively 
disorganized after E12.5. Pax6 and Mash1 expression was examined by 
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immunohistochemistry on caudal to rostral sections at E13.5 and E14.5. In more 
caudal sections at both ages, Pax6 immunoreactivity was confined to the dorsal 
telencephalon, the epithalamus, the dorsal and ventral thalamus and the eminentia 
thalami (Fig. 4.7A, E, A’ and E’), and the expression of Mash1 was confined to the 
ventral telencephalon, the ventral thalamus and the hypothalamus (Fig. 4.7C, G, C’ 
and G’) in both wild type and Gli3Xt/Xt mutant embryos. Rostrally, Pax6 is expressed 
not only in the dorsal telencephalon of wild types, but also intensely in cells of the 
mantle layer of the GE (indicated by arrows in Fig. 4.7B and F). Pax6 expression in 
the dorsal telencephalon was still visible in the E13.5 Gli3Xt/Xt mutants (area between 
the lines in Fig. 4.7B’), but at a reduced level compared to wild types (Fig. 4.7B). 
There were also some strongly labelled Pax6 cells observed in the outer layer of the 
dorsal telencephalic lobes (arrows in Fig. 4.7B’), which are likely to be those 
detected in the wild type ventral telencephalon (compare cells indicated by arrows in 
Fig. 4.7B with B’). At E14.5, the normal expression of Pax6 in the Gli3Xt/Xt mutant 
dorsal telencephalon seemed to be lost completely. Instead, the strong Pax6 
expressing ventral cells were detected in the outer layer of the mutant telencephalic 
lobes (Fig. 4.7F’). In these rostral sections, Mash1 expression was confined to the 
ventral territory of the wild type embryos (Fig. 4.7D and H), but in the Gli3Xt/Xt 
mutants (Fig. 4.7D’ and H’), it was found throughout the telencephalic vesicles at 
both E13.5 and E14.5, similar to the results at E12.5. Note that Mash1 expression in 
the mutant septum is expanded at both ages (arrowheads in Fig. 4.7D’ and H’), and 
the diencephalon joins with the ventral telencephalon in very rostral sections, which 












Figure 4.7 Expression of Pax6 and Mash1 in E13.5 and E14.5 wild type (Gli3+/+) 
(A-H) and Gli3Xt/Xt mutant (A’-H’) coronal sections. In caudal sections at both E13.5 
and E14.5, Pax6 expression is found in the epithalamus (ET), dorsal (DT) and ventral 
(VT) thalamus, the eminentia thalami (EmT), the neocortex (nctx) and the 
dorso-medial telencephalon (dmT) of the wild types (A and E). In the mutants (A’ 
and E’), the expression pattern is similar except the dorso-medial telencephalon is 
not present. Mash1 expression at this level is confined to the ventral thalamus (VT), 
the hypothalamus (HT) and the ventral telencephalon (GE) of both wild type (C and 
G) and mutant (C’ and G’) embryos. Rostrally, Pax6 expression in the E13.5 mutant 
embryos (B’) is still visible in the dorsal telencephalon (dTel) but at a reduced level 
compared to that of wild types (B). The intensely stained Pax6 positive cells in the 
ventral telencephalon of the wild type (arrows in B) are observed in a more dorsal 
area in mutant embryos (arrows in B’). These mis-located cells are also observed at 
E14.5, and the normal Pax6 expression in the dorsal telencephalon (F) seems to 
have disappeared completely in the mutants (F’). In rostral sections, Mash1 
expression is found throughout the telencephalic vesicles of the mutants (D’ and H’) 
in great contrast to the wild type expression pattern (D and H) at both ages. Mash1 
expression in the mutant septum seems to be expanded at both ages (arrowheads in 

















At E13.5, Nkx2.1 expression was confined to the precursors of the MGE in 
mid-telencephalic sections, and was not observed in rostral sections of wild type and 
mutant embryos (Fig. 4.8A, A’, B and B’), similar to what was observed at E12.5 
(Fig. 4.2F, F’, G and G’). In E13.5 wild types and Gli3Xt/Xt mutants, Olig2 expression 
was still restricted to progenitor cells of the ventral thalamus and GE in caudal 
sections (Fig. 4.8C and C’). Rostrally, expression of Olig2 was found throughout the 
telencephalic lobes of mutants (Fig. 4.8D’), in contrast to the ventrally restricted 
expression in wild types (Fig. 4.8D). At both E13.5 and E14.5, Islet1 expression in 
middle sections was confined to the postmitotic neurons of the GE in both wild type 
(Fig. 4.8E and G) and Gli3Xt/Xt mutant embryos (Fig. 4.8E’ and G’). In rostral 
sections of the mutants at both ages, Islet1 expression was found in the outer layers 
of the whole telencephalic lobes (Fig. 4.8F’ and H’), and the expansion at these ages 
was more severe than that observed at E12.5 (Fig. 4.2B’). At both ages, Islet1 
expression in the postmitotic cells of the mutant septum seems to be also expanded 
(arrowheads in Fig. 4.8F’and H’). 
 
To study the development of the diencephalic clusters observed in the mutant 
neocortex, the eminentia thalami marker calretinin, and Lim2 expression, were 
examined at E14.5 wild type and Gli3Xt/Xt mutants. At this age, calretinin and Lim2 
were highly expressed in the ventral thalamus, the eminentia thalami, and in the 
marginal zone of the neocortex in wild types (Fig. 4.9A and B). In Gli3Xt/Xt mutants, 
this expression was found intensely in the ventral thalamus and eminentia thalami 
region, and also in the Foxg1 positive area (Fig. 4.9C’) in the form of clusters 
(arrows in Fig. 4.9A’ and B’). Note that at this age, Foxg1 expression in the mutants 
allowed the detection of rosette-like structures (Fig. 4.9C’), which were never 
observed in wild types (Fig. 4.9C) (see Chapter 4.2.6). These results suggest that at 
later developmental stages, diencephalic cells are still present in the Gli3Xt/Xt mutant 







Figure 4.8 Marker analyses in E13.5 and E14.5 wild type (Gli3+/+) (A-H) and Gli3Xt/Xt 
mutant (A’-H’) coronal sections. At E13.5, Nkx2.1 is restricted to the medial 
ganglionic eminence (MGE) of both wild types (A) and mutants (A’) in middle 
sections. No Nkx2.1 expression is observed at rostral levels (B and B’). Olig2 and 
Islet1 expression is observed in the ventral thalamus (VT) and the ganglionic 
eminences (GE) of E13.5 and/or E14.5 wild type (C, E and G) and mutants (C’, E’ 
and G’) in middle telencephalic sections. Rostrally, expression of these markers is 
observed throughout the telencephalic lobes of mutants (D’, F’ and H’), in contrast to 
that of wild types (D, F and H). Note that at both ages, Islet1 expression in the mutant 
septum (SP) is expanded (arrowheads in F’ and H’) compared to that of the wild 
types (F and H). EmT, eminentia thalami; LGE, lateral ganglionic eminence. Scale 


























Figure 4.9 Calretinin, Lim2 and Foxg1 expression in E14.5 wild type (Gli3+/+) (A-C) 
and Gli3Xt/Xt mutant (A’-C’) coronal sections. Calretinin is expressed in the 
postmitotic layer of the diencephalon (Di), the eminentia thalami (EmT), the 
Cajal-Retzius cells in the marginal zone of the wild types (indicated by arrowheads in 
A). Calretinin positive clusters (indicated by an arrow in A’) are observed in the 
Foxg1 positive area in the mutant neocortex (nctx, C’), but not in the dorsal (dmT + 
nctx) or ventral (GE) telencephalon of wild types (C). Lim2 is expressed in the ventral 
thalamus and the eminentia thalami in wild type (B) and mutant (B’) embryos. Lim2 
positive clusters are also observed in mutant neocortex (arrows in B’). Scale bars, 
250 µm.  
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4.2.6 Rosettes form in the residual Gli3Xt/Xt neocortex after E12.5 
 
From E13.5, Foxg1 positive and calretinin negative rosette-like structures were 
detected in the Gli3Xt/Xt neocortical region close to the ventricular zone (Fig. 4.10A, 
B, C, D, E, F and G). Although the number and size of these structures were variable, 
they all consistently contained a central lumen. There was no obvious correlation 
between the frequency of their appearance and position within the neocortex. These 
rosettes were positive for Pax6 (Fig. 4.7E’ and 4.10H) and negative for Mash1 (Fig. 
4.7G’), indicating that they comprised neocortical tissue and did not have a ventral 
telencephalic or diencephalic character. They were immunopositive for markers of 
neural progenitors, such as Pax6 (Fig. 4.10H), BrdU (Fig. 4.10I), and nestin (Fig. 
4.10J), and negative for the postmitotic neuronal marker β-III-tubulin (Tuj1) (Fig. 
4.10K). The expression of Tbr2, which is normally detected in the cortical 
intermediate zone and early postmitotic neurons (Englund et al., 2005) was found in 
the outermost cells of the rosettes (Fig. 4.10L). At later stages, rosettes became more 
numerous and were also found close to the pial surface (Fig. 4.10B, C and F). At 
E16.5, the lumen in the centre of the rosettes was not as clearly distinguishable as in 
previous stages (Fig. 4.10F’). These findings indicate that the rosettes contain well 










Figure 4.10 Marker analyses on Gli3Xt/Xt mutant coronal sections from E13.5 to 
E16.5. Foxg1 negative patches are observed at E13.5 (A), E14.5 (B) and E16.5 (C). 
These patches are positive for calretinin at E13.5 (D) and E14.5 (E), but not at E16.5. 
A, D and B, E are serial sections from the same specimens. Cresyl violet staining at 
E16.5, shows a greater number of rosettes with a lumen (F, F’). F’ is a high 
magnification image of the boxed area in F. These rosettes are positive for Foxg1 (G), 
Pax6 (H), BrdU (I), and nestin (J) and negative for β-III-tubulin (Tuj1) (K), showing 
their neocortical progenitor properties. Tbr2 is expressed in the outermost cells of the 
rosettes (L). Scale bars, A-F, 500 µm; G-L, 50 µm. 
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4.2.7 Cell proliferation and cell death properties are unchanged in E12.5 
Gli3Xt/Xt telencephalon 
 
The volumetric measurements showed that the Gli3Xt/Xt dorsal telencephalon was 
severely decreased in size compared to that of wild type embryos at E12.5. The 
dorsal telencephalon of the mutants became progressively disorganized later in 
development. To determine whether there were any gross abnormalities in the 
proliferative characteristics of the Gli3Xt/Xt neocortex, a short pulse of BrdU was 
administered to label the proliferating cells within the ventricular zone in both wild 
types and mutants at E12.5 and E13.5. Immunohistochemistry using an antibody 
against BrdU showed no obvious differences between mutants and control embryos 
at both E12.5 and E13.5 (Fig. 4.11A, A’, E and E’). Cell counts were done in 
sampling bins throughout the thickness of the neocortex of the wild type and mutant 
embryos. At both ages, the labelling indices (LI), which is the percentage of cells that 
are in S-phase during a 30-minute period, in the wild type and mutant dorsal 
telencephalon were very similar (Fig. 4.11H and I) (Table 4.4). The thickness of the 
postmitotic neuronal layer (PL) which is negative for BrdU was also similar between 
wild type and mutant embryos (Fig. 4.11B, B’, H and I) (Table 4.4), in agreement 
with the staining observed using an antibody against β-III-tubulin (Tuj1), which 
selectively marks the postmitotic neuronal layer (Fig. 4.11C, C’, D and D’).  
 
E12.5 BrdU Labelling Index (LI) Postmitotic Layer (PL) 
Gli3+/+ (n=6) 55.1%±3.1% 19.4%±4.5% 
Gli3Xt/Xt (n=6) 49.9%±3.9% 25.4%±3.2% 
P value 0.31 0.31 
E13.5 BrdU Labelling Index (LI) Postmitotic Layer (PL) 
Gli3+/+ (n=2) 43.0%±1.6% 33.5%±2.9% 
Gli3Xt/Xt (n=2) 35.4%±4.62% 31.2%±1.3% 
P value 0.17 0.50 
Table 4.4 BrdU labelling indices (LI) and postmitotic layer (PL) measurements at 







Figure 4.11 BrdU and β-III-tubulin (Tuj1) expression in E12.5 wild type (Gli3+/+) (A-D) 
and Gli3Xt/Xt mutant (A’–D’) coronal sections. B, B’, D and D’ are high magnification 
images of the boxed areas in A (box c), A’, C and C’ respectively. Box a, b and c in A 
corresponds to the sampling bins for BrdU counting. BrdU is expressed by cells that 
are in S-phase in both wild type (A and B) and Gli3Xt/Xt mutants (A’ and B’). The 
labelling index (LI) of the BrdU positive cells shows no differences between wild type 
and mutant dorsal telencephalon (H). Tuj1 expression is observed in the postmitotic 
layer (PL) of wild type (C and D) and mutant (C’ and D’) telencephalon. Note the 
thickness of this layer is similar between wild types and mutants (compare B with B’, 
D with D’, H). BrdU expression in E13.5 wild type (E) and mutant (E’) coronal 
sections show similar results (I) as in E12.5. Nestin and Tuj1 expression on E14.5 
coronal sections show complementary staining in both wild type (F and G) and 
mutant (F’ and G’) embryos. Scale bars, A, C, A’, C’, E-G and E’-G’, 250 µm; B, D, 

















Nestin and Tuj1 immunohistochemistry was studied in E14.5 wild type and Gli3Xt/Xt 
mutant embryos. Nestin is expressed in the proliferating cells and fibres (Dahlstrand 
et al., 1995), and Tuj1 is expressed by the postmitotic neurons. Their expression at 
E14.5 seems to be complementary to each other in both wild type and mutant 
embryos (Fig. 4.11F, F’, G and G’). These results demonstrate that no obvious 
change is detected in cell proliferation and differentiation in the Gli3Xt/Xt mutants 
between E12.5 and E14.5, suggesting that the size reduction of Gli3Xt/Xt 
telencephalon might be the result of a cell proliferation and/or differentiation defect 
occurring at earlier developmental stages. 
 
Cell death properties were studied in the E12.5 wild type and Gli3Xt/Xt mutant 
telencephalon, by using terminal deoxynucleotidyl transferase (TdT)-mediated 
dUTP-biotin nick end labelling (TUNEL) method on sections. In wild type embryos, 
many dying cells were detected in the dorso-midline area (Fig. 4.12A), which were 
never observed in the Gli3Xt/Xt mutants (Fig. 4.12A’), possibly due to the loss of 
cortical hem and the surrounding dorsal telencephalic tissue. Only a few TUNEL 
positive cells were observed in both the wild type and the Gli3Xt/Xt mutant dorsal (Fig. 
4.12B and B’) and ventral (Fig. 4.12C and C’) telencephalon. The number of 
TUNEL positive cells per 1000 cells calculated showed no difference between the 
wild type and mutant telencephalon (Fig. 4.12D). These suggest that size reduction 












Figure 4.12 TUNEL on E12.5 wild type (Gli3+/+) (A-C) and Gli3Xt/Xt mutants (A’-C’) 
coronal sections. Many TUNEL positive cells are present in the wild type 
dorso-midline area (A), but not in the Gli3Xt/Xt mutants (A’). Very few TUNEL positive 
cells are observed in the dorsal (neocortex, B and B’) and ventral (GE, C and C’) wild 
type (B and C) and mutant (B’ and C’) telencephalon. No significant differences in 
the number of TUNEL positive cells per 1000 cells within the telencephalon are 
detected between wild type and mutant embryos (D). Scale bars, A, 25 µm; B, C, B’ 






4.3.1 No ectopic expression of ventral telencephalic markers in middle sections 
of the Gli3Xt/Xt mutant dorsal telencephalon 
 
A reduction in the size of the dorsal telencephalon and lack of the dorso-midline 
invagination have been reported in Gli3Xt/Xt mutant embryos (Grove et al., 1998; 
Theil et al., 1999; Tole et al., 2000a). However, these studies neither delineated the 
telencephalon of the Gli3Xt/Xt mutants, nor measured its actual size. In this study, the 
Gli3Xt/Xt neocortex was precisely defined, using Foxg1 as a marker of the whole 
telencephalon (Tao and Lai, 1992; Hanashima et al., 2002). The dorsal telencephalon 
was defined using the expression domain of Pax6 (Walther and Gruss, 1991; 
Stoykova and Gruss, 1994; Mastick et al., 1997), and the ventral telencephalon using 
Mash1 (Lo et al., 1991; Guillemot and Joyner, 1993) and Olig2 (Lu et al., 2000; 
Zhou et al., 2000). The analysis presented in this chapter has shown that between 
E12.5 and E14.5 the Mash1, Olig2, Islet1, Dlx2 and Gsh2 positive areas, dorsally to 
the neocortex of the Gli3Xt/Xt mutant embryos, in middle sections along the 
rostro-caudal axis of the telencephalon, corresponds to the ventral thalamus and 
eminentia thalami, in contrast to previous publications that had interpreted this 
staining as ventral telencephalon (Tole et al., 2000a; Rallu et al., 2002b; Kuschel et 
al., 2003). This difference may be due to the fact that previous studies did not define 
the limits of the telencephalon and did not take into account the possibility that many 
ventral telencephalic markers are also expressed in the ventral thalamus. However, 
the Mash1, Olig2 and Islet1 expression in the very rostral telencephalon of the 
Gli3Xt/Xt mutants is expanded into the dorsal telencephalon, agreeing with previous 
results (Tole et al., 2000a; Kuschel et al., 2003). The areal measurements of ventral 
markers further support the conclusion that the rostral telencephalon of the mutants is 
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enlarged at E12.5. This expansion is also observed at E13.5 and E14.5.  
 
Another finding in very rostral sections of the Gli3Xt/Xt mutants is that at least some 
of the cells are expressed both dorsal telencephlic marker Pax6 and ventral 
telencephalic marker, such as Mash1 and Olig2. It will be interesting to know the 
fates of these cells and the reason they express both dorsal and ventral markers. 
 
4.3.2 Neocortical cells form rosettes surrounded by eminentia thalami cells in 
Gli3Xt/Xt mutants 
 
The Gli3Xt/Xt mutant telencephalon becomes highly disorganized at later 
developmental stages. Previous work has described the formation of some 
‘finger-like’ structures in the neocortical area of the Gli3Xt/Xt mutants (Theil et al., 
1999), but further studies of the properties of these cells were lacking. Rosette-like 
structures start to form at around E13 in the mutant neocortex, and comprise a central 
lumen surrounded by neural progenitor cells. The distribution of BrdU positive 
S-phase cells largely resembles that of the wild type ventricular zone. Tbr2 
expression in the outermost layers of the rosettes further suggests that the wall of the 
rosettes is very similar to the ventricular zone of the wild type neocortex. As 
development proceeds, these rosettes become more numerous, and are located in the 
area near the pial surface, and are well segregated from the surrounding tissue. In 
fact, these rosettes are surounded by diencephalic cells, suggesting that the formation 
of those rosettes might be the results that the telencephalic and diencephalic cells do 
not mix together. Studies of other mutations with brain heterotopias suggested that 
the formation of rosette-like structures might have been the result of changes in cell 
polarity or cell migration properties (Costa et al., 2001; Li et al., 2003; Klezovitch et 
al., 2004). A recent study showed apical-basal cell polarity defects in the Gli3Xt/Xt 
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neocortical area (Theil, 2005), which might be one cause for the formation of the 
rosettes. The fact that these rosettes are located near the ventricular zone at E13.5 but 
are found near the pial surface at E16.5, suggests that the migration properties of 
these cells might be changed.  
 
Patches of Foxg1 negative cells are present in the Gli3Xt/Xt dorsal telencephalon at 
E12.5, and these clusters are expressing markers of the neighbouring eminentia 
thalami such as calretinin, Lim2 and Tbr1 (Sheng et al., 1997; Abbott and 
Jacobowitz, 1999; Puelles et al., 2000). Additionally, Pax2, which was described 
here for the first time as a marker for an eminentia thalami population found close to 
the choroid plexus of the wild types, was also found in the Gli3Xt/Xt neocortical area. 
These results suggest that the boundary between the telencephalon and the 
diencephalon is compromised when Gli3 is lost. What might happen in the mutants is 
that loss of the cortical hem region and failure of the dorso-medial telencephalic wall 
to invaginate may result in an abnormal joining of the residual telencephalon with the 
diencephalon. The dorso-medial telencephalon in the wild types serves as a physical 
and (or) a possible signalling boundary to prevent the mixing of the cells from each 
territory (Grove et al., 1998; Grove and Tole, 1999). The loss of this restriction in the 
Gli3Xt/Xt mutants may result in the mixing of cell types in that region.  
 
There are other factors that might also contribute to the abnormalities described 
above. For example, the ZLI, the boundary between the dorsal and ventral thalamus 
(Figdor and Stern, 1993; Porteus et al., 1994; Kiecker and Lumsden, 2004), is 
characterized by Shh expression (Hashimoto-Torii et al., 2003; Kiecker and Lumsden, 
2004) and considered as an organizer of the diencephalon (Echevarria et al., 2003; 
Vieira et al., 2005). The expression of Shh seems to be confined to its normal place 
in the Gli3Xt/Xt mutants. However, the orientation is different from that of wild type 
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embryos. This change in orientation might affect Shh signalling diffusion or 
transduction in the mutant embryos, because the relative distance between the ZLI 
and the neocortex is altered, which might influence the formation of the 
telencephalic-diencephalic boundary, or even the patterning of the telencephalon, as 
studies have shown that in zebrafish Shh could act directly over a distance up to 200 
µm (Lewis et al., 2001).  
 
4.3.3 The volume of Gli3Xt/Xt telencephalon is severely reduced at E12.5 
 
The Foxg1 positive telencephalon of the Gli3Xt/Xt mutant is only about 53.5% the 
volume of wild types. The dorsal telencephalon of the Gli3Xt/Xt mutants is decreased 
severely to about 27% of the wild type dorsal telencephalon. In addition to this 
reduction, clusters of eminentia thalami cells are present in the neocortical area of the 
mutants. A 20% reduction of the ventral telencephalon of Gli3Xt/Xt mutant embryos 
has also been shown here. Interestingly, this reduction is only observed in middle 
telencephalic sections, whereas the rostro-ventral and caudo-ventral telencephalon is 
significantly enlarged in the mutants. The study of markers that are normally 
expressed in the septum of the ventral telencephalon, such as Islet1, Pax2 and Lim2 
(Sheng et al., 1997; Wang and Liu, 2001) in very rostral telencephalic sections, 
reveals that the mutant septum is enlarged and probably undergoes a shape change 
(Chapter 5.2.8). These results also indicate that the most rostral boundary between 
the telencephalon and diencephalon is formed abnormally in Gli3Xt/Xt mutants.  
 
The volumes of Gli3Xt/Xt mutant telencephalon are hard to measure in later 
developmental stages because the mutant telencephalon becomes highly disorganized 
and rosettes appear. The fact that no defects in cell proliferation, cell differentiation 
or cell death properties were detected suggests that the phenotypes observed at E12.5 
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must be a consequence of an earlier defect of the Gli3Xt/Xt mutants. Interestingly, 
analysis with a short pulse of BrdU at E12.5 revealed that the residual neocortex of 
the Gli3Xt/Xt embryos shares properties with the lateral neocortex of the wild type (Fig. 
4.11), indicating a more extensive area of the dorsal telencephalon in Gli3Xt/Xt 
mutants may be lost, rather than just the cortical hem region, as previously reported 




















Chapter 5: Analyses of Gli3Xt/Xt mutant forebrain at E10.5 
suggest that Gli3 is involved in forebrain regionalization 




Gli3 starts to be expressed as early as E7 during mouse development (Hui et al., 1994) 
in the derivatives of the ectoderm and the mesoderm, suggesting Gli3 might be 
involved in early forebrain patterning events. Forebrain analyses at E12.5 and at later 
stages of the Gli3Xt/Xt mutant embryos (Chapter 4) have shown that they have a 
smaller telencephalon compared to that of the wild types. Cell proliferation and cell 
death studies at E12.5 showed no differences between the mutant and control 
embryos. These results indicate that the defects of the Gli3Xt/Xt mutants must have 
happened in early developmental stages. Here in this Chapter, Gli3Xt/Xt mutants were 
analysed at E10.5, when neurogenesis starts.  
 
So far, marker analysis has been carried out in the Gli3Xt/Xt mutant telencephalon by 
several groups. However, there are some contradictions in their results. For example, 
the expression of the ventral marker Nkx2.1 was shown to be expanded to a more 
dorsal area of the Gli3Xt/Xt mutants by whole mount in situ hybridization at E11.5 
(Aoto et al., 2002). Interestingly, Nkx2.1 expression has been shown to be confined 
to the medial ganglionic eminences (MGE) of the Gli3Xt/Xt mutants at E10.5 and 
E12.5 by other groups (Tole et al., 2000a; Kuschel et al., 2003). This contradiction 
among different studies might be because most of these experiments were done by 
whole mount in situ hybridization, which does not allow visualizing with precision 
the expression domains of a given marker. In addition, these studies neither 
measured the relative sizes of the telencephalic structures, nor explored the 
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differences between ages. The study of the expression pattern by 
immunohistochemistry of several forebrain ventral markers, such as Nkx2.1, Olig2, 
Dlx2, Islet1 and Gsh2 is presented in this chapter and they all showed an expansion 
at E10.5 in Gli3Xt/Xt mutants.  
 
The cortical hem and the adjacent hippocampus and the choroid plexus were reported 
to be lost in the Gli3Xt/Xt mutant (Grove et al., 1998). The results obtained from the 
analyses of E12.5 Gli3Xt/Xt mutant embryos suggest that part of the dorsal 
telencephalon is also lost. To study the possibility of a more extensive loss of the 
mutant telencephalon, Wnt8b expression was examined by whole mount in situ 
hybridization, revealing the expression of Wnt8b in Gli3Xt/Xt mutant telencephalon 
was completely lost, while the expression in the diencephalon was preserved at E9.5 
and E10.5. These results suggest the dorso-medial telencephalon might never have 
been specified in the mutants. 
 
Shh has been shown to induce ventral fate along the antero-posterior axis along the 
neural tube (Ericson et al., 1995a; Marti et al., 1995b; Roelink et al., 1995; Chiang et 
al., 1996; Dale et al., 1997; Shimamura et al., 1997; Kohtz et al., 1998; Kohtz et al., 
2001). In the anterior limb and the dorsal spinal cord, Gli3 is shown to repress Shh 
expression (Buscher et al., 1997; Masuya et al., 1997; Ruiz i Altaba, 1998). It is 
possible that an ectopic Shh expression results in the malformations of Gli3Xt/Xt 
mutant telencephalon. This possibility has been tested by several groups by whole 
mount in situ hybridization from E8.5 to E11.5 (Theil et al., 1999; Tole et al., 2000a; 
Aoto et al., 2002), showing no obvious difference in the expression pattern of Shh 
between Gli3Xt/Xt mutants and control embryos. The expression of Shh downstream 
targets, including Ptch1 and Gli1, has also been examined by whole mount in situ 
hybridization (Theil et al., 1999; Tole et al., 2000a; Aoto et al., 2002). Their 
expression in the Gli3Xt/Xt mutants has been reported to be identical with those of the 
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wild types.  In this chapter, Shh mRNA expression was studied by whole mount in 
situ hybridization at E10.5, and those embryos were sectioned afterwards to further 
explore any differences between wild type and mutant embryos. The Shh protein 
expression pattern in Gli3Xt/Xt mutants was also studied here at E9.5 and E10.5. 
However, no significant difference was detected between the wild type and mutants 
in Shh mRNA and protein expression pattern. Expression of Shh early transcriptional 
target cyclin D1 (Kenney and Rowitch, 2000; Ishibashi and McMahon, 2002) was 
analysed in this chapter, showing no obvious difference in the mutants compared to 
wild types. These results indicate that Shh signalling might not be responsible for the 
expansion of ventral markers in Gli3Xt/Xt mutant ventral telencephalon. 
 
Aoto and colleagues (2002) have proposed that the Gli3Xt/Xt mutant dorsal 
telencephalon is reduced in size, while the ventral thalamus is significantly expanded, 
basing this on the expression pattern of Pax6 and Engrailed2 (En2) by whole mount 
in situ hybridization. However, no measurements were done in the ventral 
telencephalon. In this chapter, detailed measurements of the volume of the whole 
telencephalon, and of the dorsal and ventral telencephalon were carried out at E10.5. 
The overall size of the Gli3Xt/Xt mutant telencephalon was found to be reduced. 
Compared to the wild type embryos, the volume of Gli3Xt/Xt mutant dorsal 
telencephalon displayed a 62.2% reduction, and the volume of the mutant ventral 
telencephalon showed a 65% increase.  
 
Cell proliferation was previously studied in E10.5 Gli3Xt/Xt mutant telencephalon with 
a short pulse of BrdU incorporation. The distribution of BrdU in the mutants was 
comparable with that of their wild type littermates (Theil et al., 1999). In this study, 
cell cycle kinetic parameters were analysed by the IddU/BrdU method, a more 
precise and sophisticated experimental approach, which allows the measuring of not 
only the labelling index but also the duration of the cell cycle and S-phase (Shibui et 
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al., 1989; Martynoga et al., 2005). At E10.5, no significant differences were found in 
the length of the cell cycle and S-phase between the Gli3Xt/Xt mutants and control 
embryos. However, a significant increase of the labelling index was observed in the 
mutant dorsal telencephalon.  
 
Cell death has been reported to be reduced from the Gli3Xt/Xt dorsal telencephalon 
(Aoto et al., 2002), and no study has evaluated the cell death properties in the mutant 
ventral telencephalon. Cell death was examined by both on-section and whole-mount 
TUNEL, presenting a loss of TUNEL positive cells in the dorsal midline, as 
described before (Aoto et al., 2002), but an increase in the ventral midline area of the 
Gli3Xt/Xt mutants. This increase is universal along the rostro-caudal axis. In addition, 
in the ventral midline of the mutants, more β-III-tubulin positive cells were observed 
in all sections examined along the rostro-caudal axis, suggesting more cells exiting 
the cell cycle in the ventral area of the Gli3Xt/Xt mutants. 
 
The results obtained from the cell cycle, cell death and differentiation analyses can 
not explain the size reduction of the Gli3Xt/Xt mutant dorsal telencephalon at E10.5 
compared to wild types, suggesting that Gli3 might regulate an early specification 
event. The increase of cell death and differentiation in the Gli3Xt/Xt mutant ventral 
telencephalon at E10.5 might be responsible for the overall size reduction of the 
mutant ventral telencephalon at E12.5. However, because the changes in cell death 
and differentiation were observed along the rostro-caudal axis of the mutant ventral 
telencephalon, they can not explain why only the middle part of the E12.5 ventral 
telencephalon is reduced, whereas the rostral and caudal parts are expanded. These 
results leading to hypothesize that in addition to the size changes, the shape of the 
Gli3Xt/Xt mutant forebrain has also changed. In testing this hypothesis, embryos were 
scanned with an optical projection tomography (OPT) microscopy to get serial 
images of the entire forebrain. These revealed that the diencephalon and ventral 
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telencephalon (septum) of the Gli3Xt/Xt mutants are joined in a more rostral area than 
in the wild types. This was confirmed by the expression of diencephalic and (or) 
septal markers. These results suggest that the shape of the Gli3Xt/Xt mutant forebrain 
is changed between E10.5 and E12.5, and this might account for the differences in 
the size of the Gli3Xt/Xt ventral telencephalon along the rostro-caudal axis.  
 
The Wnt8b whole mount in situ hybridization experiment described in this chapter 




5.2.1 Volumetric measurements at E10.5 show a reduction of Gli3Xt/Xt dorsal 
telencephalon 
 
E10.5 embryos were analysed in a frontal plane: wild type (A-D) and Gli3Xt/Xt mutant 
(A’-D’) examples are shown in Figure 5.1. These embryos were scanned and 
reconstructed by OPT. In rostral sections (Fig. 5.1D and D’), there is the dorsal and 
ventral telencephalon; in sections half way between the rostro-caudal tips of the 
telencephalon (defined as middle sections along the rostro-caudal axis) (Fig. 5.1C 
and C’), diencephalic tissue can be seen dorsal to the telencephalon in the mutants, 
but not in wild types; caudally (Fig. 5.1B and B’), the diencephalon becomes very 
obvious dorsally, and the dorsal and ventral telencephalon are still visible in both 
wild types and Gli3Xt/Xt mutants. Note that the diencephalon of the mutant embryos is 
more obvious than that of the wild types (compare Fig. 5.1B with B’, C with C’), 
suggesting the diencephalon of the mutants might be enlarged, and this could lead to 
a shape change of the Gli3Xt/Xt mutant forebrain. 
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Foxg1 expression was examined throughout the rostro-caudal axis of the E10.5 wild 
type and Gli3Xt/Xt mutant telencephalon. As shown in Figure 5.2A, A’, B, B’, C and 
C’, Foxg1 expression delineates the telencephalon in each level of sections of wild 
type (Fig. 5.2A, B and C) and Gli3Xt/Xt embryos (Fig. 5.2A’, B’ and C’). The Foxg1 
negative diencephalic region in the Gli3Xt/Xt mutant forebrain sections seems to be 
more prominent than that of the wild type embryos (compare Fig. 5.2A with A’, B 
with B’). Volumetric measurements of the whole telencephalon were carried out in 
wild types and mutants by measuring the Foxg1 expression domain (see Materials 
and Methods (Chapter 2.5) for detail). A significant 38.6% reduction (Student’s t test, 
p<0.001, n=4 per genotype) of the volume of the Gli3Xt/Xt telencephalon (Fig. 5.2G) 
was recorded at E10.5 (Table 5.1).  
 
Volume (mm3) Gli3+/+ Gli3Xt/Xt P value 
Tel (Foxg1) 0.048±0.0005 0.029±0.001 <0.001 
dTel (Pax6) 0.038±0.002 0.014±0.001 <0.001 
vTel (Olig2) 0.014±0.001 0.023±0.0008 <0.001 
 
Table 5.1 Volume of wild type (Gli3+/+) and Gli3Xt/Xt mutant telencephalon (Tel), 
dorsal (dTel) and ventral (vTel) telencephalon, calculated using specific gene marker 
expression domains. 
 
The size of the dorsal telencephalon was measured using Pax6 expression domain in 
the telencephalon (green) of wild type (Fig. 5.2D-F) and Gli3Xt/Xt (Fig. 5.2D’-F’) 
embryos. Pax6 is expressed in the dorsal telencephalon and diencephalon (Walther 
and Gruss, 1991; Stoykova and Gruss, 1994; Mastick et al., 1997). The Pax6 
immunopositive area in caudal and middle sections in the Gli3Xt/Xt telencephalon (Fig. 
5.2D’ and E’) seems to be reduced compared to the wild types (Fig. 5.2D and E). 
Rostrally, Pax6 is expressed throughout the telencephalic lobes in wild types (Fig. 
5.2F), while in the Gli3Xt/Xt mutants (Fig. 5.2F’), Pax6 expression is maintained, 
although the positive area seems to be reduced dorsally. The measurements showed 
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that the volume of the Pax6 expressing tissue was significantly reduced (Student’s t 
test, p<0.001, n=4 per genotype) in the Gli3Xt/Xt mutants to about 37.8% of that of 
wild type embryos (Fig. 5.2G) (Table 5.1), and this reduction was the same no matter 
which level of section was examined (Fig. 5.2H) (Table 5.2). These results show that 
at E10.5, the telencephalon and the dorsal telencephalon of Gli3Xt/Xt mutants is 
already smaller than that of wild type littermates.  
 
Area (mm2) rTel mTel cTel 
Gli3+/+ 0.104±0.005 0.068±0.001 0.053±0.004 
Gli3Xt/Xt 0.038±0.002 0.030±0.001 0.025±0.002 
P value <0.001 <0.001 0.014 
Percentage of changes 
in the mutants 63.50% 55.90% 52.80% 
 
Table 5.2 Areas of Pax6 expression in rostral (rTel), middle (mTel) and caudal (cTel) 











Figure 5.1 OPT images of wild type (Gli3+/+) (A) and Gli3Xt/Xt mutant (A’) embryos at 
E10.5. E10.5 embryos are analysed on frontal sections along the rostro-caudal axis. 
The diencephalon (Di) is observed dorsally to the telencephalon in caudal (B and B’) 
sections of both wild type and mutant embryos, and in middle sections of the mutants 
(C’), but not in wild types (C). Dorsal (dTel) and ventral telencephalon (vTel) are 
observed on all sections of both genotypes (B-D and B’-D’). The tail of the Gli3Xt/Xt 















Figure 5.2 Marker analyses on frontal sections of wild type (A-F) and Gli3Xt/Xt mutant 
(A’-F’) forebrain from caudal to rostral. Foxg1 is expressed in the telencephalon (Tel) 
of the wild type (A-C) and mutant (A’-C’) embryos with a highventral to lowdorsal 
gradient, and not in the diencephalon (Di). Pax6 (green) and Olig2 (red) double 
immunofluorescence labelled the dorsal (dTel) and ventral (vTel) telencephalon 
respectively in both wild type (D, E and F) and mutant (D’, E’ and F’) sections. Notice 
that on very rostral sections of the wild types, only Pax6 expression is observed. In 
the comparable section of mutant embryos, Olig2 expression can still be seen clearly 
(F’). Scale bars, 100 µm. (G) Volume measurements of Foxg1, Pax6 and Olig2 
expression in wild type and mutant telencephalon. (H) Pax6 expression 
measurements in Gli3Xt/Xt mutant telencephalon show significant reduction (Student’s 
t test, p<0.001, n=4 per genotype) in rostral, middle and caudal parts compared to 






























5.2.2 Cell cycle parameters are not changed in Gli3Xt/Xt telencephalon at E10.5 
 
To examine whether misregulation of cell cycle progression of telencephalic 
progenitors contributes to the reduced telencephalon of Gli3Xt/Xt mutant embryos, cell 
cycle kinetic parameters were analysed by the IddU/BrdU double labelling method at 
E10.5 in vivo (Shibui et al., 1989; Martynoga et al., 2005). IddU and BrdU are 
thymidine analogues, and they become incorporated into the DNA synthesized 
during the S-phase of the cell cycle (Gratzner, 1982). This method allows a 
calculation of the percentage of cells that are in S-phase during a certain time period 
(LI), the length of S-phase (TS) and the length of the cell cycle (TC) (Chapter 2.6) 
(Martynoga et al., 2005). The distribution of IddU and BrdU was very similar 
between wild type and mutant sections (Fig. 5.3A and A’). Cell counts were done in 
sampling bins throughout the dorsal (Fig. 5.3B and B’) and ventral (Fig. 5.3C and C’) 
telencephalon. There was no significant difference (Student’s t test, n=5 per genotype) 
in either TC or TS between the wild type and Gli3Xt/Xt mutant dorsal or ventral 
telencephalon (Fig. 5.3D) (Table 5.3). Interestingly, although the average TS of the 
wild type and mutant dorsal telencephalon were quite similar (Fig. 5.3D) (Table 5.3), 
the labelling index (LI), which is the percentage of all the proliferating cells that are 
in S-phase, was significantly increased (Student’s t test, p<0.005, n=5 per genotype) 
in the Gli3Xt/Xt dorsal telencephalon compared to wild types (Fig. 5.3E) (Table 5.3), 
suggesting a larger progenitor pool in the Gli3Xt/Xt dorsal telencephalon. In the ventral 
telencephalon, no significant difference was detected in LI between the two groups 
(Fig. 5.3E) (Table 5.3). These results suggest that the proliferation rate of the Gli3Xt/Xt 
mutant is unlikely to contribute to the reduced size of the telencephalon, and the cell 
















Figure 5.3 IddU and BrdU double immunofluorescence on wild type (A-C) and 
Gli3Xt/Xt mutant (A’-C’) frontal sections. Cells labelled with only IddU are green, and 
cells immunoreacted with BrdU are yellow (both red and green). To-Pro-3 is used to 
stain the nuclei (blue). The expression of IddU and BrdU is similar between wild 
types (A-C) and Gli3Xt/Xt mutants (A’-C’). B, C and B’, C’ are higher magnification 
images of the boxed area in A and A’ respectively, showing dorsal (B and B’) and 
ventral (C and C’) expression of IddU and BrdU. Scale bars, A and A’, 100 µm; B, B’, 
C and C’, 25 µm. Cell cycle kinetic parameters including length of S-phase (TS) and 
cell cycle (TC) were calculated in wild type and Gli3Xt/Xt mutant dorsal (dTel) and 
ventral (vTel) telencephalon respectively. No significant differences were detected 
between any of them (n=5). The labelling index (LI) of IddU and BrdU during 2 hours 
period was measured in wild type and mutant dorsal and ventral telencephalon (E). A 
significant (Student’s t test, p<0.001, n=5 per genotype) increase of IddU and BrdU 





















dTel TS (hours) TC (hours) LI 
Gli3+/+  4.01±0.60 6.67±0.71 82.7±1% 
Gli3Xt/Xt 4.47±0.63 6.95±0.83 88.8±0.9% 
P value 0.62 0.81 0.0019 
    
vTel TS (hours) TC (hours) LI 
Gli3+/+  5.31±0.98 8.17±1.62 84.5±2.8% 
Gli3Xt/Xt 4.44±0.47 6.70±0.61 89.6±3% 
P value 0.45 0.43 0.26 
 
Table 5.3 Measurements of cell cycle parameters in dorsal (dTel) and ventral (vTel) 
telencephalon of wild type (Gli3+/+) and Gli3Xt/Xt mutant embryos at E10.5, including 
length of S-phase (TS), cell cycle (TC) and labelling indices (LI).  
 
5.2.3 More Tuj1 positive cells are found in E10.5 Gli3Xt/Xt ventral telencephalon 
 
In addition to cell proliferation rate, the rate of cells exiting from the cell cycle to 
differentiate also needs to be tightly controlled to get the correct numbers of neurons 
produced. The expression of β-III-tubulin (Tuj1), an early marker of differentiating 
neurons (Lee et al., 1990; Menezes and Luskin, 1994), was examined in sets of 
caudal to rostral sections of wild type (Fig. 5.4A-F) and Gli3Xt/Xt mutant (Fig. 
5.4A’-F’) telencephalon at E10.5. Tuj1 expression was observed in both wild type 
and mutant ventral telencephalon but not in the dorsal telencephalon (Fig. 5.4A-C 
and A’-C’), suggesting early cell differentiation does not contribute to the small 
dorsal telencephalon of the Gli3Xt/Xt mutant embryos. In the mutant ventral 
telencephalon, there are significantly more Tuj1 labelled cells in all levels of sections 
examined compared to wild types (compare Fig. 5.4D with D’, E with E’ and F with 
F’). Counts were made in 15 µm wide bins throughout the ventricular zone. Both the 
percentage of Tuj1 positive cells to total numbers of cells (counterstained with cresyl 
violet) (Fig. 5.4G) and the density (Fig. 5.4H) of Tuj1 positive cells per mm2 were 
increased significantly (Student’s t test, p<0.005, n=4 per genotype) in the mutant 
ventral telencephalon compared to those of the wild types. This result indicates that 
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there may be more cells leaving the cell cycle to differentiate in the Gli3Xt/Xt ventral 
telencephalon at E10.5.  
 
Tuj1+ Percentage Density (no. cells/mm2) 
Gli3+/+  9.25±1.2% 2271±426 
Gli3Xt/Xt 20.4±1.9% 4043±301 
P value 0.00014 0.003 
 
Table 5.4 Measurements of percentage and density of Tuj1 positive cells in ventral 





























Figure 5.4 β-III-tubulin (Tuj1) immunohistochemistry on wild type (A-F) and Gli3Xt/Xt 
mutant (A’-F’) frontal sections in caudal to rostral order. Sections were 
counterstained with cresyl violet. D, D’, E, E’, F and F’ are higher magnification 
images of boxed areas in A, A’, B, B’, C and C’, respectively. Almost no Tuj1 
positive cells are found in the wild type (A, B and C) and Gli3Xt/Xt mutant (A’, B’ and 
C’) dorsal telencephalon. More Tuj1 positive cells are found in the Gli3Xt/Xt mutant 
ventral telencephalon at all levels (D’, E’ and F’) compared to those of the wild types 
(D, E and F). Scale bars, A, A’, B, B’, C, and C’, 250 µm; D, D’, E, E’, F and F’, 100 
µm. Both the percentage (G) and the density (H) of Tuj1 positive cells are 
significantly increased in the mutant ventral telencephalon (Student’s t test, P<0.005, 
























5.2.4 Apoptotic cells are lost in Gli3Xt/Xt dorsal telencephalon while more 
apoptotic cells are located in Gli3Xt/Xt ventral telencephalon at E10.5 
 
Programmed cell death is an important mechanism that determines the size and shape 
of the vertebrate nervous system (Oppenheim, 1991). Much of the programmed cell 
death happens via apoptosis, a well characterized genetic program that exhibits 
specific morphological features such as membrane blebbling, nuclear segmentation, 
chromatin condensation, DNA fragmentation, and the appearance of apoptotic bodies 
(Kerr et al., 1972; Vaux and Korsmeyer, 1999). To study cell death in Gli3Xt/Xt 
mutant telencephalon, E10.5 wild type and Gli3Xt/Xt mutant embryos were embedded 
in plastic and sectioned at 4 µm. By histological stain, clusters of pyknotic cells were 
observed in the dorsal midline of wild type embryos (Fig. 5.5A), whereas no such 
were detected in the same area of the mutants (Fig. 5.5A’). By contrast, many 
clusters of pyknotic cells were observed in the ventral midline of Gli3Xt/Xt mutant 
embryos (indicated by arrows in Fig. 5.5B’). Pyknotic clusters were also detected in 
the ventral midline of the wild types (indicated by arrows in Fig. 5.5B), but in fewer 
numbers compared to those in the mutants. To detect the DNA fragmentation, both 
whole-mount (Fig. 5.5C, D, C’ and D’) and on-section (Fig. 5.5E, F, E’ and F’) 
terminal deoxynucleotidyl transferase (TDT)-mediated dUTP-biotin nick end 
labelling (TUNEL) were performed in the wild type and Gli3Xt/Xt mutant 
telencephalon. Some whole-mount TUNEL labelled embryos were visualized and 
reconstructed by optical projection tomography (OPT) (Sharpe et al., 2002), showing 
that apoptotic cells are located in the telencephalic neuroepithelium (green cells in 
sagittal sections in Fig. 5.5D and D’; and supplementary movies). At E10.5, TUNEL 
positive cells are mainly restricted to the dorsal midline area in wild types 
(arrowheads in Fig. 5.5C, D, E and F), from the diencephalic-telencephalic junction 
to the anterior dorsal telencephalic roof (Furuta et al., 1997; Aoto et al., 2002). In the 
Gli3Xt/Xt mutants, almost no TUNEL labelled cells were observed in the dorsal 
 148 
midline area (arrowheads in Fig. 5C’, D’, E’ and F’), in agreement with previous 
publications (Aoto et al., 2002). This reduction of dying cell in the dorsal midline 
area of the mutants can not explain the size reduction of the mutant dorsal 
telencephalon. In fact, this result suggests that the dorsal midline tissue in the 
Gli3Xt/Xt mutants may be completely lost. There is a small population of apoptotic 
cells located in the ventral midline area of wild type embryos (arrows in Fig. 5.5D, E 
and F). In the ventral midline of Gli3Xt/Xt mutant embryos, more apoptotic cells are 
observed (arrows in Fig. 5.5D’, E’ and F’ and supplementary movies) compared to 
wild types, indicating that more cells are dying in the ventral telencephalon. 
Furthermore, the increase in TUNEL positive cells is universal along the 
rostro-caudal axis of the mutant ventral telencephalon (compare Fig. 5E with E’, F 
with F’). This increase of apoptotic cells might be one of the causes leading to the 
decrease in the overall volume of the mutant ventral telencephalon at later 






Figure 5.5 Clusters of pyknotic cells are observed in the dorsal and ventral midline of 
wild types (arrows in A and B). In the Gli3Xt/Xt mutant embryos, few pyknotic cells are 
found in the dorsal midline (A’), and more are observed in the ventral midline (arrows 
in B’) by cresyl violet staining on plastic sections. DNA fragmentation revealed by 
whole mount (C, C’, D and D’) and on section (E, E’, F and F’) TUNEL in Gli3+/+ (C, D, 
E and F) and Gli3Xt/Xt mutant (C’, D’, E’ and F’) embryos. Some of the whole mount 
TUNEL labelled embryos (C and C’) were scanned with optical projection 
tomography (OPT) allowing for digital reconstruction, and examples of sagittal 
sections are shown in D and D’. The TUNEL positive cells that are normally observed 
in the dorsal midline of the wild type (arrowheads in C, D, E and F) are lost in the 
Gli3Xt/Xt mutants (arrowheads in C’, D’, E’ and F’). In the Gli3Xt/Xt mutants, more 
apoptotic cells are discovered in the ventral midline area (arrows in D’, E’ and F’) 
compared to the wild type embryos (arrows in D, E and F). Scale bars, A and A’, 50 

















5.2.5 Wnt8b expression is lost in the Gli3Xt/Xt telencephalon 
 
The volumetric measurements at E10.5 have shown that the dorsal telencephalon of 
Gli3Xt/Xt mutants is severely reduced at this age. However the rate of cell proliferation, 
cell cycle exit or cell death does not seem to contribute to the phenotype, suggesting 
an earlier defect in dorsal telencephalic patterning of this mutant. To examine 
whether the dorso-medial telencephalon is ever specified, Wnt8b expression was 
examined in E10.5 and E9.5 Gli3Xt/Xt mutant embryos. E10.5 embryos labelled with 
Wnt8b were scanned and reconstructed with OPT. In the forebrain, Wnt8b is 
expressed in the dorso-medial telencephalon, including the cortical hem, the 
hypothalamus, and the eminentia thalami (Lako et al., 1998; Richardson et al., 1999). 
Wnt8b expression was found in the telencephalon (arrows in Fig. 5.6A, B, C and D) 
and the diencephalon (arrowheads in Fig. 5.6A, B, C and D) of both E10.5 (Fig. 5.6A, 
B and C) and E9.5 (Fig. 5.6D) wild type embryos. Figure 5.6C and C’ are E10.5 wild 
type and mutant sagittal views of OPT reconstructed images. The bright green 
corresponds to Wnt8b expression. In the Gli3Xt/Xt mutants (Fig. 5.6A’, B’ and D’), the 
normal expression in the telencephalon (arrows in Fig. 5.6A, B and D; and bright 
green in dorso-medial telencephalon in Fig. 5.6C) is lost, but the diencephalic 
staining remains (arrowheads in Fig. 5.6A’, B’ and D’; bright green in EmT and 
hypothalamus indicated by arrowheads in Fig. 5.6C’) at both ages. Wnt8b expression 
(Lako et al., 1998; Richardson et al., 1999) is observed in a broader domain (the 
dorso-medial telencephalic wall, including the future hippocampus) than Wnt3a, 
which was described as a marker of the cortical hem area in wild type embryos 
(Grove et al., 1998). The loss of Wnt8b expression in the Gli3Xt/Xt mutant 
telencephalon suggests a more extensive loss than just the previously reported loss of 
the cortical hem area in the Gli3Xt/Xt mutants (Grove et al., 1998). Furthermore, this 
loss of Wnt8b telencephalic expression indicates that the dorso-medial telencephalon 
might never have been specified in the mutants. The above results show that Gli3 is 
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required for the specification the dorsal telencephalon at very early stages during 
development.  
 
5.2.6 Ventral markers are expanded in E10.5 Gli3Xt/Xt embryos 
 
Along with the analysis in the E10.5 dorsal telencephalon, Gli3Xt/Xt ventral 
telencephalon was also examined at E10.5, using several markers that are normally 
expressed in the ventral telencephalon, including Olig2, Islet1, Dlx, Gsh2 and 
Nkx2.1. Mash1 protein expression was also examined, but at this age, positive cells 
are seen not only in the ventral telencephalon, but also are found scattered in more 
dorsal regions of the wild type embryos, which is less informative (data not shown). 
 
Olig2 expression was examined in defined rostral, middle and caudal wild type and 
Gli3Xt/Xt mutant forebrain sections as shown in Figure 5.2D-F and D’-F’ (red). In 
caudal and middle sections, the expression pattern of Olig2 appears relatively normal 
in the Gli3Xt/Xt telencephalon (Fig. 5.2D’ and E’), except that the Olig2 expression 
seems to be expanded into more dorsal areas compared to wild types (Fig. 5.2D and 
E). Moving rostrally, Olig2 expression is no longer visible in the wild type (Fig. 
5.2F). In the Gli3Xt/Xt mutants (Fig. 5.2F’), Olig2 expression is clearly visible 
ventrally, and the diencephalic expression can be still seen dorsally. The 
measurements of the Olig2 expressing domain in the telencephalon of both wild 
types and Gli3Xt/Xt mutants at E10.5 showed that the volume of the Olig2 expression 
domain in the Gli3Xt/Xt telencephalon was increased remarkably (Student’s t test, 
p<0.001, n=4 per genotype) to about 165% of that of the wild types (Fig. 5.2G) 
(Table 5.1), and this significant increase (Student’s t test, p<0.05, n=4 per genotype) 
was universal along the rostro-caudal axis (Fig. 5.7G) (Table 5.5). Furthermore, the 
most prominent expansion is observed in the rostro-ventral Gli3Xt/Xt telencephalon, 





Figure 5.6 Whole mount in situ hybridization of Wnt8b expression in E10.5 (A-C and 
A’-C’) and E9.5 (D and D’) wild type (A-D) and Gli3Xt/Xt mutant (A’-D’) embryos. A, A’, 
D and D’ are frontal views and B and B’ are side views. After labelling with Wnt8b, 
some E10.5 embryos were scanned and reconstructed by OPT microscopy, C and 
C’ are mid-sagittal examples. Wnt8b is expressed in the dorso-medial telencephalon 
(arrow in A-D) and adjacent diencephalon (arrowheads in A-D) of the wild type 
embryos at both ages. The telencephalic expression is lost from the Gli3Xt/Xt mutant 
embryos, but the diencephalic expression (in eminentia thalami and hypothalamus) 










Area (mm2) rTel mTel cTel 
Gli3+/+ 0.01±0.002 0.033±0.001 0.018±0.002 
Gli3Xt/Xt 0.03±0.002 0.042±0.001 0.028±0.003 
P value <0.001 <0.001 0.021 
Percentage of changes 
in the mutants 200.00% 27.30% 55.60% 
 
Table 5.5 Areas of Olig2 expression in rostral (rTel), middle (mTel) and caudal (cTel) 













To test whether this expansion was Olig2 specific, expression of several other genes 
that usually mark different regions or specific cells type of the ventral telencephalon 
was examined. Nkx2.1 expression only starts to become obvious in more caudal 
sections of the wild type ventral telencephalon (Fig. 5.7A), that will become the 
future medial ganglionic eminence (MGE) (Shimamura et al., 1995; Sussel et al., 
1999). Very little Nkx2.1 expression can be found rostrally in wild type sections (Fig. 
5.7B). In the Gli3Xt/Xt mutant embryos, Nkx2.1 expression can be found not only in 
more caudal sections (Fig. 5.7A’), but also in very rostral sections (Fig. 5.7B’), and 
the expression seems to be expanded dorsally compared to that in wild types 
(compare Fig. 5.7A with A’, B with B’). Gsh2 is expressed in the ventricular zone of 
the wild type ventral telencephalon, and the highest expression is found in the future 
lateral ganglionic eminence (LGE) (the area below the line in Fig. 5.7C), as 
described before (Corbin et al., 2000; Toresson et al., 2000). In the Gli3Xt/Xt mutants, 
Gsh2 expression seems to be expanded to a more dorsal domain (the area below the 
line in Fig. 5.7C’). Islet1 is expressed in the postmitotic neurons of the ventral 
telencephalon in wild types (Wang and Liu, 2001), and the expression can only be 
found in more caudal sections at E10.5 (Fig. 5.7D and E). In the Gli3Xt/Xt mutants, 
Islet1 expression can be clearly seen on more rostral sections compared to wild types, 
and, in addition, it seems to be expanded (Fig. 5.7D’ and E’). Dlx2 is primarily 
expressed in wild type postmitotic ventral forebrain cells (Fig. 5.7F) (Eisenstat et al., 
1999; Puelles et al., 2000). In the Gli3Xt/Xt mutants, Dlx2 positive cells seem to be 
more numerous and the expression domain seems to be broader compared to wild 







Figure 5.7 Marker analyses in wild type (A-F) and Gli3Xt/Xt mutant (A’-F’) ventral 
telencephalon. Nkx2.1 and Islet1 expression is observed in caudal sections of wild 
type embryos (A, B, D and E), but is also obvious in rostral Gli3Xt/Xt sections 
(compare B with B’, E with E’). On all sections examined, Nkx2.1 (arrows in A, A’, B, 
B’), Gsh2 (line in C and C’), Islet1 (arrowheads in D, D’, E and E’) and Dlx2 (arrow in 
F and F’) expression in the mutant embryos is expanded dorsally. Scale bars, A-C, 
A’-C’, F and F’, 100 µm, D, D’, E and E’, 50 µm. Measurements of Olig2 expression 
in Gli3Xt/Xt mutant rostral, middle and caudal sections (G) show significant (Student’s t 
test, p<0.05, n=4 per genotype) expansion compared to those of wild types. The 
























5.2.7 Shh is not ectopically expressed in the Gli3Xt/Xt telencephalon 
 
Sonic hedgehog (Shh) has been shown to be vital for ventral telencephalic 
development. Especially during the period between E9 and E12, it is crucial for the 
induction of ventral cell fate (Ericson et al., 1995a; Machold et al., 2003; Fuccillo et 
al., 2004). Studies have shown that Gli3 acts as a major mediator of the Shh 
signalling pathway in limbs and spinal cord (Buscher et al., 1997; Ruiz i Altaba, 
1998). These lead to the hypothesis that the Gli3Xt/Xt mutant phenotype might be 
caused by ectopic Shh expression in the dorsal telencephalon. Previous studies using 
whole mount in situ hybridization have shown that Shh transcript expression is 
confined to the Gli3Xt/Xt ventral telencephalon from E8.5 to E11.5 (Theil et al., 1999; 
Tole et al., 2000a; Aoto et al., 2002). This result was confirmed and expanded here: 
the expression of Shh in the mutant embryos is confined to the ventral telencephalon 
and caudal diencephalon, which corresponds to the ZLI, as in wild types at E10.5. 
After whole mount in situ hybridization, embryos were cut in a frontal plane to study 
the expression of Shh in detail. The expression pattern in the ventral telencephalon 
(Fig. 5.8A and A’) and ZLI (Fig. 5.8B and B’) is quite similar between the wild type 
and mutant embryos. In addition, Shh protein expression was studied by 
immunofluorescence on wild type and Gli3Xt/Xt mutant sagittal sections at E9.5 (Fig. 
5.8C and C’) and E10.5 (Fig. 5.8D and D’). Instead of being ectopically expressed in 
more dorsal areas as one might have expected, Shh expression seemed to be slightly 
reduced in the Gli3Xt/Xt mutant telencephalon at both ages (Fig. 5.8C, C’, D and D’). 
In the E10.5 Gli3Xt/Xt mutant embryos, Shh expression seemed to occupy a smaller 
area than in wild types (compare area marked with white arrowheads in Fig. 5.8D 
with D’). At E9.5, Shh expression seems not only to be more restricted, but also to be 
more reduced in the mutant telencephalon (compare the brightness of fluorescence at 
the area indicated by arrowhead in Fig. 5.8C and C’). The expression pattern of Shh 
in the adjacent diencephalon also seemed to have changed in the mutants (Fig. 5.8C’ 
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and D’). The diencephalic expression in E9.5 mutant embryos seemed to be a lot 
brighter than in wild types (compare Fig. 5.8C with C’). This might indicate that 
there is more Shh expressed in the mutant diencephalon compared to the wild type. 
However, immunofluorescence is not a quantitive method, and the brightness of 
signal might not actually reflect absolute amounts of protein.  
 
The expression of several down stream targets of the Shh pathway has been studied 
previously, including Nkx2.1, Gli1 and Ptc1, and their expression pattern have not 
changed in the Gli3Xt/Xt mutants (Theil et al., 1999; Tole et al., 2000a; Aoto et al., 
2002). Expression of another Shh target, cyclin D1, was studied in this chapter at 
E10.5. Cyclin D1 was shown to be one of the early transcriptional targets of Shh 
signalling in the diencephalon and the mesencephalon (Ishibashi and McMahon, 
2002) and the cerebellum (Kenney and Rowitch, 2000). The expression pattern of 
cyclin D1 was similar between wild type and Gli3Xt/Xt mutant embryos (Fig. 5.8E and 
E’). These data suggest that the Shh signalling pathway does not seem to account for 
the expansion of Gli3Xt/Xt ventral telencephalon at E10.5. However, because both 
Gli3 and Shh start to be expressed very early in development (at around E7), it is 
possible that Shh within or outside the telencephalon influences the patterning of 













Figure 5.8 Expression of Shh mRNA (A, B, A’ and B’) and protein (C, D, C’ and D’) 
on wild type (A-D) and Gli3Xt/Xt mutant (A’-D’) embryos. After whole mount in situ 
hybridization at E10.5, embryos were sectioned on a frontal plane. Shh expression is 
observed in the ventral telencephalon (A and A’) and the diencephalon (ZLI) (B and 
B’) of wild type and mutant embryos. Fluorescent Shh expression was carried out on 
E9.5 (C and C’) and E10.5 (D and D’) wild type and mutant embryos. Shh expression 
in the mutant ventral telencephalon is slightly lower than that of the wild type (area 
indicated by arrowheads in C, C’, D and D’) at both ages. Cyclin D1 expression in the 
wild type (E) and mutant (E’) frontal sections is similar. Scale bars, A, A’, B, B’, E 
and E’, 100 µm; C, C’, D and D’, 250 µm. 
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5.2.8 The shape of the forebrain has changed in the Gli3Xt/Xt mutant embryos 
 
The overall volume of the Gli3Xt/Xt E10.5 ventral telencephalon is bigger, but it 
becomes smaller at E12.5, compared to that of wild types. The increase in the 
numbers of dying cells and early differentiated cells in the Gli3Xt/Xt ventral 
telencephalon at E10.5 might result in an overall volume reduction of the Gli3Xt/Xt 
ventral telencephalon at E12.5. However, the increase in cell death and early 
differentiation do not exhibit any differences along the rostro-caudal axis, and can 
not explain the regional size differences of the mutant ventral telencephalon at E12.5. 
This lead to the hypothesis that a shape change might occur in the Gli3Xt/Xt mutant 
telencephalon, in parallel with the size change described above. 
 
Pax2 and Lim2 expression in rostral telencephalic sections at E12.5 showed that the 
diencephalon and the septum of the mutants are joined in a more rostral area than in 
the wild types, and their expression in the mutant septum seems to be expanded 
(Chapter 4.2.2). At E10.5, Pax2 expression analysis on sagittal sections of Gli3Xt/Xt 
mutant embryos has shown that dispersed diencephalic cells are present in the dorsal 
telencephalic area, indicating the boundary between the telencephalon and the 
diencephalon is compromised (Fotaki et al., 2006). Pax2 expression was also 
examined in frontal sections at E10.5. In wild type frontal sections, Pax2 expression 
can only be found in the most rostral area of the telencephalon (Fig. 5.9A, B and C), 
and most of the Pax2 positive cells were found in the ventral area (arrowhead in Fig. 
5.9C). In Gli3Xt/Xt mutant embryos, Pax2 expression was observed in all forebrain 
sections examined (Fig. 5.9A’, B’ and C’). In caudal sections, Pax2 was ectopically 
expressed in the dorsal area (arrows in Fig. 5.9A’ and B’), which might correspond 
to the expression in the diencephalon, as described before (Fotaki et al., 2006). The 
Pax2 expression in the ventral telencephalon of the mutants starts to be obvious on 
more caudal sections compared to wild types, and its expression seems to be 
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expanded (Fig. 5.9B’ and C’). Note that in very rostral sections, the expression of 
Pax2 occupies the whole telencephalic lobe of the Gli3Xt/Xt mutant embryos (Fig. 
5.9C’).  
 
To further examine the possibility that the three dimensional shape of the Gli3Xt/Xt 
mutant forebrain is different from that of the wild type, E10.5 and E12.5 embryos 
were scanned and reconstructed by OPT microscopy (Fig. 5.1 and 5.10). In E10.5 
sagittal sections, the cortical hem and the adjacent tissue, including the future 
hippocampus and choroid plexus, are lost in the Gli3Xt/Xt mutants (Grove et al., 1998; 
Tole et al., 2000a). The boundary between the telencephalon and the diencephalon 
(between red lines in Fig. 5.9A) is compromised in the mutants (Fotaki et al., 2006). 
These result in an abnormal joining of the diencephalon with the caudal part of the 
telencephalon (Fig. 5.10A’) (Fotaki et al., 2006). The diencephalon is extended to a 
more rostral region in the mutants (approximately up to the red line in Fig. 5.10A’), 
in agreement with the results obtained from the OPT frontal images (Fig. 5.1B-D and 
B’-D’). The ventral telencephalon of the Gli3Xt/Xt mutants is expanded (up to the blue 
lines in Fig. 5.10A and A’), in agreement with the results of the volume 












Figure 5.9 Pax2 immunoreactivity in caudal to rostral sets of frontal sections of wild 
type (A-C) and Gli3Xt/Xt mutant (A’-C’) embryos. Sections were counterstained with 
cresyl violet. Pax2 expression is observed in the optic stalk (A and A’) on both wild 
type and mutant caudal sections, and also in the dorsal most region of the mutant 
embryos (arrows in A’). In middle sections, only very few Pax2 positive cells are 
observed in wild type sections (B), but a lot more are found in both the dorsal and 
ventral midline of the mutant embryos (arrows and arrowheads respectively in B’). 
Dorsal and ventral midline expression of Pax2 is observed in rostral wild type 
sections (arrows and arrowheads respectively in C), whereas in the mutants, Pax2 is 
expressed throughout the vesicle (C’). Scale bars, 100 µm.  
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As development proceeds, both the wild type and Gli3Xt/Xt mutant telencephalon 
grow extensively. Sets of lateral-to-medial sagittal sections of E12.5 wild type and 
Gli3Xt/Xt mutant forebrains are shown in Figure 5.10B-D and B’-D’. Based on the 
gene marker analysis presented in Chapter 4 and 5, forebrain structures are marked 
by coloured lines in wild type and Gli3Xt/Xt mutant embryos. Dorsal telencephalon is 
the area between the red and blue lines, and ventral telencephalon corresponds to the 
area between the blue and green lines. At E12.5, the volume of the mutant dorsal 
telencephalon is significantly reduced compared to that of wild types (compare areas 
between red and blue lines in Fig. 5.10B with B’, C with C’, D with D’). In 
mid-sagittal sections of wild types, the dorsal telencephalon is no longer visible, and 
the ventral telencephalon is joined with the diencephalon via a structure known as 
lamina terminalis (arrow in Fig. 5.10D). In the Gli3Xt/Xt mutants, because the 
dorso-medial wall does not invaginate, the telencephalic lobe is still clearly seen (Fig. 
5.10D’). The septum of the mutant (arrowhead in Fig. 5.10D’) seems to be elongated, 
and joined with the diencephalon in a more anterior position compared to the wild 
type (compared Fig. 5.10D and D’). In more lateral sections of the wild type, the 
diencephalon is located posterior to the area between the red and green lines, which 
corresponds to the dorso-medial telencephalon and the eminentia thalami (Fig. 5.10B 
and C). In comparable mutant sections, the area between the red and green line is the 
diencephalon (Fig. 5.10B’ and C’). In addition, clusters of diencephalic cells are 
present in the mutant dorsal telencephalon. The ventral telencephalon of mutant 
embryos is smaller compared to that of wild types (compare area between the blue 
and green lines in Fig. 5.10B with B’, C with C’) in these lateral sections. Note that 
in all the sections along the medial to lateral axis, the mutant diencephalon seems to 
be extended to a more rostral level (up to the red line from the left in Fig. 5.10B’ and 
C’ and blue line in D’) compared to the wild type (Fig. 5.10B, C and D).  
 
Coronal sections at rostral levels of E12.5 wild types reveals that the rostral end of 
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the diencephalon (the lamina terminalis) is joined with the septum (red arrow in Fig. 
5.10E), and this joining is no longer visible on more rostral sections of the wild type 
telencephalon (Fig. 5.10F, G, H and I). This joining is observed in more rostral 
sections in the Gli3Xt/Xt mutants (red arrow in Fig. 5.10H’ and I’) than in the wild 
types, which indicates that the diencephalon (red arrows in Fig. 5.10E’, F’ and G’) 
and the septum (red arrowheads in Fig. 5.10F’ and G’) of the mutants are enlarged as 
these structures can be seen in more sections of the mutants. These results agree with 
the Pax2 and Lim2 expression pattern at E12.5 (Chapter 4.2.2). These OPT imaging 
results and marker analysis have shown that the Gli3Xt/Xt mutant septum is enlarged, 
and the diencephalon is shifted in more rostral sections than the wild type embryos, 
supporting the hypothesis that the shape of the Gli3Xt/Xt mutant forebrain is changed 
and that this may account for the size difference of the Gli3Xt/Xt ventral telencephalon 


























Figure 5.10 Reconstructed OPT images of E10.5 and E12.5 wild type (A-I) and 
Gli3Xt/Xt mutant (A’-I’) embryos by OPT. A and A’ is E10.5 wild type and mutant 
mid-sagittal sections, B-D and B’-D’ are E12.5 sagittal sections from lateral to medial 
of wild type and Gli3Xt/Xt mutant embryos, and rostral is to the right side. The normal 
invagination of the dorso-medial telencephalon (dmT) (the area marked by red lines 
in A, and green and red line in B and C) is not observed in the mutant. The area 
between the red and green line in mutants is the diencephalon (Di) (A’, B’ and C’). 
The blue line in A, A’, B, B’, C and C’ indicates the relative boundary between the 
dorsal and ventral telencephalon (vTel), and marks the boundary between 
diencephalon and ventral telencephalon in D and D’. Sets of caudal to rostral coronal 
sections of wild type and Gli3Xt/Xt mutants are shown in E-I and E’-I’, respectively. 
The joining of the rostral end of the diencephalon and the septum is observed in E 
(arrow), but not in more rostral sections (F-I) of the wild type embryos. In the mutant, 
the joining of the rostral diencephalon (red arrow in E’, F’ and G’) and the septum 
(red arrowhead in E’, F’ and G’) is observed in most rostral sections (indicated by 


















5.3.1 The loss of Gli3 results in a smaller dorsal telencephalon at E10.5 
 
The volumetric measurements of E12.5 Gli3Xt/Xt mutant embryos have shown a 
smaller dorsal telencephalon compared to that of wild types. The fact that no cell 
proliferation or cell death changes could explain this reduction suggested an early 
cause for the dorsal telencephalic defect (see chapter 4). In this chapter, the volume 
of the dorsal telencephalon was measured at E10.5, when neurogenesis starts 
(Caviness, 1982; Caviness et al., 1995; Takahashi et al., 1995b). The Gli3Xt/Xt mutant 
dorsal telencephalon already showed a 61.2% reduction compared to that of wild 
types, even though the measurements at E10.5 also include the dispersed 
diencephalic cells found in the dorsal telencephalon (Fotaki et al., 2006). In the 
mutant telencephalon at E10.5, several dorsally expressed genes were shown to be 
lost specifically from the Gli3Xt/Xt mutant embryos, such as the dorsal telencephalic 
markers Emx1 and Emx2 (Theil et al., 1999; Tole et al., 2000a; Kuschel et al., 2003). 
The cortical hem and the expression of several Wnt and Bmp genes, including Wnt2b, 
3a, 5a, Bmp2, 4, 6 and 7, are reported to be lost in the Gli3Xt/Xt mutant (Grove et al., 
1998; Tole et al., 2000a). In this chapter, the expression of Wnt8b was shown to be 
lost specifically from the telencephalon. Wnt8b is expressed in the dorso-medial 
telencephalon (Lako et al., 1998; Richardson et al., 1999), in a broader area than 
Wnt3a expression (Grove et al., 1998). The loss of Wnt8b expression in the Gli3Xt/Xt 
mutant telencephalon suggests a more extensive dorsal telencephalic loss than just 
the cortical hem area.  
 
Cell cycle kinetic parameters, including the duration of S-phase (TS) and cell cycle 
(TC), have been measured at this age by IddU/BrdU double labelling methods (Shibui 
et al., 1989; Martynoga et al., 2005) to test the possibility that a reduced proliferation 
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rate might contribute to the small telencephalon of mutant embryos. This method is 
more powerful than a short pulse of BrdU labelling, which gives only the numbers of 
cells which are in S-phase during a certain time period (the labelling index) (Shibui 
et al., 1989; Martynoga et al., 2005). These experiments revealed no differences in 
the length of S-phase or cell cycle between the wild type and mutant dorsal or ventral 
telencephalon, suggesting that the defects observed in the Gli3Xt/Xt mutant 
telencephalon at later developmental stages are not the result of changes in cell cycle 
parameters at E10.5.  
 
Programmed cell death occurs during normal development of the central nervous 
system (Oppenheim, 1991). An increased cell death would result in decreased size of 
the Gli3Xt/Xt mutant dorsal telencephalon. Apoptotic cells were revealed by TUNEL 
staining in the wild type dorsal midline. However, in the Gli3Xt/Xt mutants instead of 
increased, TUNEL positive cells were found to be lost, specifically from the 
dorso-medial telencephalon, as previously reported (Aoto et al., 2002). This loss of 
dying cells from the mutant embryos can not explain the size reduction of the dorsal 
telencephalon. Rather, this result indicates that the cells which are normally 
undergoing apoptosis in the dorso-medial telencephalon are lost from the Gli3Xt/Xt 
mutant embryos.  
 
Another possible reason for a small dorsal telencephalon is more dorsal progenitors 
of the Gli3Xt/Xt mutants leaving the cell cycle. β-III-tubulin (Tuj1) labels newly 
differentiated neurons outside the ventricular zone (Lee et al., 1990; Menezes and 
Luskin, 1994). At E10.5, no Tuj1 positive cells were observed in the dorsal 
telencephalon of both wild type and Gli3Xt/Xt mutant embryos.  
 
These analyses suggest that the size reduction of Gli3Xt/Xt mutant dorsal 
telencephalon might not be the result of defects in cell proliferation, cell 
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differentiation or cell death at E10.5, and lead to the hypothesis that Gli3 is involved 
in early forebrain specification. In fact, the loss of Wnt8b expression in the Gli3Xt/Xt 
mutant telencephalon indicates that the dorso-medial telencephalon might have never 
been specified in the mutants. However, there is also the possibility that one or any 
combination of the following factors happened in the Gli3Xt/Xt mutant embryos earlier 
than E10.5: 
 
Decreased cell proliferation 
Increased cell death 
More cells exiting the cell cycle (less cells re-entering the cell cycle) 
More cells migrating out of the dorsal telencephalon 
 
One thing revealed by the IddU/BrdU double labelling experiments at E10.5 was a 
significant increase of IddU and BrdU labelling indices in the Gli3Xt/Xt mutant dorsal 
telencephalon during the two hours pulse compared to those of wild types. This 
result shows that more cells were in S-phase during that two-hour period, and 
probably means that the mutant dorsal telencephalon has a larger population of 
progenitor cells during that time period. This enlargement of the precursor pool 
would be expected to result in an increased size of the dorsal telencephalon at later 
developmental stages. However, the dorsal telencephalon of E12.5 Gli3Xt/Xt mutant is 
still significantly reduced in size compared to the wild type and the BrdU labelling 
index of E12.5 mutant dorsal telencephalon is relatively normal. It is possible that 
one or any combination of the factors above, happening between the E10.5 to E12.5 
period, might account for the dorsal telencephalic reduction. In addition, IddU and 
BrdU also label a second proliferative population (Takahashi et al., 1995a; Sheth and 
Bhide, 1997). The increased labelling index observed in the Gli3Xt/Xt mutant dorsal 
telencephalon might reflect an increase in this population.  
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5.3.2 The loss of Gli3 results in an enlarged ventral telencephalon at E10.5 
 
The ventral telencephalon of the Gli3Xt/Xt mutant embryos is significantly enlarged to 
about 165% of that of wild types. This expansion is observed along the rostro-caudal 
axis, and the rostral part shows the most remarkable increase. This enlargement of 
ventral tissue in the Gli3Xt/Xt mutants does not seem to be due to an ectopic 
expression of Shh or the upregulation of Shh signalling in the telencephalon at E10.5. 
Shh transcript and protein seem to be confined to their normal expression domains 
within the forebrain (Theil et al., 1999; Tole et al., 2000a). The expression of several 
down stream targets of the Shh pathway has been studied previously, including Gli1 
and Ptc1, which are also confined to their normal expression domain (Theil et al., 
1999; Tole et al., 2000a). However, there is still the possibility that Shh sources, 
within or outside the telencephalon, induce ventral cell fate in the Gli3Xt/Xt mutants at 
early developmental stages, since both Shh and Gli3 start to be expressed in the 
forebrain at around E7.5 (Echelard et al., 1993). Furthermore, Shh expression in the 
adjacent diencephalon might also influence telencephalic development at early stages. 
At E9.5, stronger Shh expression was observed in the mutant diencephalon compared 
to that of wild types. The loss of the dorso-medial telencephalon in the Gli3Xt/Xt 
mutants brings the diencephalon nearer to the telencephalon. This increases the 
possibility that the Shh source in diencephalon may induce ventral cell fates in 
Gli3Xt/Xt mutant embryos. In addition, Shh sources outside the telencephalon, such as 
the notochord, prechordal plate and floor plate, might be also involved in forebrain 
patterning during early embryogenesis, since evidence has shown that Shh can 
function in a distance up to 200 µm (Lewis et al., 2001).  
 
5.3.3 Gli3 loss changes the shape of forebrain during early embryogenesis 
 
One interesting result from the volumetric measurements reveals that the E10.5 
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mutant ventral telencephalon is significantly bigger compared to that of wild types, 
but at E12.5, although both the wild type and mutant ventral telencephalon grows 
extensively, the ventral telencephalon of the Gli3Xt/Xt mutants becomes smaller than 
that of wild types. This does not seem to be the result of changes in cell cycle 
parameters, but it is more likely explained by more cells leaving the cell cycle and by 
an increase in cell death observed in the ventral area of the Gli3Xt/Xt mutants. 
Furthermore, only the middle part of the ventral telencephalon is reduced at E12.5, 
suggesting that a shape change might have occurred in the Gli3Xt/Xt ventral 
telencephalon.  
 
Both morphological and marker analyses of the Gli3Xt/Xt mutants have shown that at 
E10.5, the three dimensional shape of the mutant forebrain is different from that of 
wild types. The diencephalon is normally located caudally to the telencephalon but 
can be observed in more rostral telencephalic sections in the Gli3Xt/Xt mutant, as 
shown by the OPT images. Furthermore, the expression of Olig2 and Pax2 is found 
dorsally to the dorsal telencephalon in rostral telencephalic sections. The ventral 
telencephalon of Gli3Xt/Xt mutants also seems to have changed its shape. The 
expansion of ventral markers like Olig2, Nkx2.1 and Islet1 are more prominent 
rostrally. This leads to the possibility that the most rostro-ventral structure of the 
telencephalon, the septum, might be enlarged. The E12.5 OPT images revealed that 
in the mutants, the rostral end of the diencephalon, the lamina terminalis, joins with 
the septum in more rostral areas than in the wild types, suggesting that the 
diencephalon of the Gli3Xt/Xt mutants might be shifted rostrally and probably enlarged, 
as suggested by Aoto et al (2002). In the Gli3Xt/Xt mutant forebrain, the dorso-medial 
telencephalon fails to be specified, the diencephalon expands rostrally and the ventral 
telencephalon expands dorsally, towards the dorsal telencephalon. As a result, the 
relative positions of the Gli3Xt/Xt mutant forebrain structures are different from those 
observed in wild types.  
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Many previous marker analyses on the Gli3Xt/Xt mutants might not have taken this 
shape change into account. Most of them were carried out by whole mount in situ 
hybridization, and interpretation of their results was sometimes contradictory. For 
example, the expression of Nkx2.1 was reported to be confined to ventral 
telencephalon at E10.5 by Theil et al. (1999) and at E12.5 by Tole et al. (2000a), but 
was shown to be expanded by Aoto et al. (2002) in E11.5 Gli3Xt/Xt mutant embryos. 
In this thesis, Nkx2.1 expression was examined systematically on sets of rostral to 
caudal sections throughout the wild type and mutant telencephalon. At E10.5, the 
expression of Nkx2.1 was indeed found expanded into more dorsal areas compared 
to the wild type, while at E12.5 Nkx2.1 was restricted to the MGE in middle sections 
as in wild types. 
 
In total, the results shown in this chapter suggest that Gli3 regulates the specification 
of the dorso-medial telencephalon, and the regionalization along not only the 














Chapter 6: Fibroblast growth factor 8 (Fgf8) is a potential 
candidate for inducing ectopic ventral telencephalic fate 




As mentioned before, signalling centres that are located within and outside the 
telencephalon are important for forebrain patterning. The anterior source of fibroblast 
growth factors (Fgfs) impart positions along the antero-posterior (rostro-caudal) axis 
(Fukuchi-Shimogori and Grove, 2001, 2003; Garel et al., 2003). One of the family 
members, Fgf8, is expressed in the anterior neural ridge (ANR) (Crossley and Martin, 
1995; Shimamura and Rubenstein, 1997) and has been demonstrated to regulate 
telencephalic patterning, cell proliferation and survival (Lee et al., 1997; Martinez et 
al., 1999; Storm et al., 2003; Storm et al., 2006). Fgf8 null mutants die during 
gastrulation, whereas Fgf8 hypomorphic and telencephalic conditional Fgf8 
knock-out mutants survive until birth. These mutants show an increase in dorsal 
telencephalic gene markers, such as Pax6, Emx2 and Tbr1, and loss of ventral gene 
markers, such as Nkx2.1, Dlx2 and Dlx5 (Meyers et al., 1998; Sun et al., 1999; Garel 
et al., 2003; Storm et al., 2003; Storm et al., 2006). A recent study on mutants of Fgf 
receptors has shown that Fgfs act downstream of Shh and Gli3 to generate ventral 
cell fate (Gutin et al., 2006). In addition, ectopic application of Fgf8 can induce the 
expression of ventral markers and repress that of dorsal markers in dorsal 
telencephalic explants (Crossley et al., 2001; Kuschel et al., 2003). 
 
Results from Chapters 4 and 5 suggest a rostral expansion of ventral telencephalic 
markers in the Gli3Xt/Xt telencephalon, and this expansion correlates to an expanded 
expression of Fgf8 and its downstream gene Sprouty2 in the ANR, as shown by 
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previously published results (Theil et al., 1999; Aoto et al., 2002; Kuschel et al., 
2003). The possibility that ectopic Fgf8 expression results in the expansion of ventral 
cell fate in the Gli3Xt/Xt mutant embryos was tested in this thesis with an explant 
culture system.  
 
In vitro cultures with an antibody that blocks Fgf8b bioactivity (anti-Fgf8b antibody, 
R&D system) were carried out on wild type and Gli3Xt/Xt mutant forebrain explants at 
E9.5, one day before the expanded expression of ventral markers is observed in the 
Gli3Xt/Xt mutant rostral telencephalon. This antibody has been shown to block 100% 
of mouse Fgf8b activity on NR6R-3T3 fibroblasts after 1 hour incubation at 37 ℃ 
(according to manufacturer’s information). Alternative splicing of the Fgf8 gene 
gives rise to eight different protein isoforms (a-h) in mice and they differ in their 
N-terminus (Crossley and Martin, 1995; MacArthur et al., 1995a). The biological 
function of these isoforms is still unknown, but Fgf8b has been shown to have the 
strongest affinity for the three receptors, Fgfr1, Fgfr2 and Fgfr3 (MacArthur et al., 
1995a; MacArthur et al., 1995b; Blunt et al., 1997). Deletion of Fgfr1 and Fgfr2 or 
Fgfr1 and Fgfr3 results in telencephalic abnormalities, including loss of ventral 
characters from early stages, and in cells along the dorso-ventral axis adopting a 
dorsal fate (Gutin et al., 2006). This suggests Fgf8b might be one potential isoform 
that is involved in forebrain patterning. E9.5 wild type and mutant forebrains were 
cut into halves, sagittally. One half was cultured in defined medium with the 
presence of the anti-Fgf8b antibody, and the other half was used as control. After 16 
hours incubation, explants were fixed and immunoreacted with markers that were 
found expanded in the Gli3Xt/Xt ventral telencephalon at E10.5. The prediction of this 
experiment was that in the anti-Fgf8b treated wild type explants the expression of 
ventral markers would be reduced, but only slightly, compared to the non-treated half. 
If Fgf8 is directly responsible for the expansion of ventral telencephalic markers in 
the Gli3Xt/Xt mutant rostral telencephalon, we might have expected that in the 
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anti-Fgf8b treated explants of the Gli3Xt/Xt mutant embryos, the expression of ventral 
markers would be reduced more than in wild type explants. So far, only changes in 
Olig2 expression have been examined. Whether Fgf8 is responsible for the rostral 
expansion of ventral telencephalic markers in the Gli3Xt/Xt mutants has not been 




Olig2 immunofluorescence was performed on cultured E9.5 Gli3Xt/Xt mutant and 
control telencephalon. At this stage, Olig2 is expressed in the ventral telencephalon 
and diencephalon (Lu et al., 2000). Preliminary results showed that Olig2 expression 
in the wild type ventral telencephalon of the anti-Fgf8b treated half seemed to be 
reduced slightly compared to the control half (compare the area pointed to by 
arrowheads in Fig. 6.1A and B). In the mutant explants, the difference between the 
anti-Fgf8b treated half (Fig. 6.1B’) and the control (Fig. 6.1A’) is still obscure. Olig2 
expression is so robust in both the mutant control and anti-Fgf8b treated explants that 
any difference between them is hard to see. A detailed morphometric measurement 
might help detect any existing differences. For example, tracing the domain of Olig2 
expression on each confocal stack image and averaging the Olig2 positive area 
would give a more precise result. This result does not exclude the possibility that 
Fgf8 may induce ventral cell fate in the Gli3Xt/Xt mutants, since only Olig2 expression 
has been tested with this explant culture experiment and further analysis, including 















Figure 6.1 Olig2 immunoreactivity on wild type (A and B) and Gli3Xt/Xt mutant (A’ and 
B’) explant cultures. A and A’ were incubated with culture medium, and B and B’ 
were incubated with anti-Fgf8b antibody added to the culture medium for 16 hours 
before being immunoreacted with Olig2. Olig2 expression in the ventral 
telencephalon seems to be reduced in the wild type explant with anti-Fgf8b (compare 
arrowheads pointed area in A with B). There seems to be no difference in Olig2 










Fgf8 has been proposed to induce ventral cell fate in the telencephalon along the 
anterior-posterior axis. Fgf8-soaked beads can induce ventral cell fate and repress 
dorsal fate in dorsal telencephalic explant cultures, even if Shh signalling is inhibited 
with cyclopamine (Kuschel et al., 2003). A recent study has shown that Fgf8 
signalling can generate telencephalic ventral fate independently of Shh (Gutin et al., 
2006). Furthermore, the expression of Fgf8 and its down stream target Sprouty2 is 
remarkably expanded in the rostral telencephalon of the Gli3Xt/Xt mutants (Theil et al., 
1999; Aoto et al., 2002; Kuschel et al., 2003). These results raise the possibility that 
Fgf8 is responsible for the expansion of ventral gene expression in the Gli3Xt/Xt 
mutant embryos. This hypothesis was tested in this chapter by an explant culture 
system. The structure of the Fgf8 gene is more complicated than that of other 
members of the Fgf family. It has been shown that there are eight protein isoforms in 
mice (a-h), and they differ in NH2 terminus (Crossley and Martin, 1995; MacArthur 
et al., 1995a). Among them, Fgf8a and Fgf8b are expressed in the isthmus and play 
distinct roles in early patterning of the midbrain and anterior hindbrain of many 
species (Liu and Joyner, 2001; Sato and Nakamura, 2004; Olsen et al., 2006). 
Ectopic expression of Fgf8a in mice results in an extended midbrain (Lee et al., 
1997), whereas ectopic expression of Fgf8b transforms midbrain to cerebellum (Liu 
et al., 1999), and Fgf8b has stronger transforming activity than Fgf8a (MacArthur et 
al., 1995b). Morphological changes induced by low levels of Fgf8b ectopic 
expression are similar to those induced by high levels of Fgf8a expression (Sato et al., 
2001). These findings lead to the possibility that the differences in Fgf8a and Fgf8b 
bioactivity are due to the differences in the intensity of the signal generated by these 
isoforms (Sato et al., 2001; Sato and Nakamura, 2004). Furthermore, Fgf8b has the 
highest affinity with the three receptors (MacArthur et al., 1995a; MacArthur et al., 
1995b; Blunt et al., 1997), and is likely the main molecule for activation of the 
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Ras-ERK (Ras-extracellular signal-regulated kinase) pathway, which is involved in 
Fgf8 signal transduction in the isthmus (Sato and Nakamura, 2004). In this study, an 
anti-Fgf8b antibody was used and the preliminary results have shown that anti-Fgf8b 
reduces Olig2 expression in the wild type telencephalon, which suggests that Fgf8b, 
at least partially, induces Olig2 expression in wild type embryos. Whether this is the 
case in the mutants is still unknown. This explant culture experiment in this thesis 
was not optimal for various reasons. First, only Olig2 expression was tested so far. 
Second, since Fgf8 starts to be expressed in the embryonic ectoderm as early as E6 
(Crossley and Martin, 1995) and is observed in rostral telencephalon at around E8 
(Crossley and Martin, 1995; Aoto et al., 2002), blocking Fgf8 activity in the brain 
from E9.5 might be already too late for repressing ventral telencephalic fate. Third, 
Fgf8 is also highly expressed in the isthmus (Aoto et al., 2002), and this source might 
also influence the development of telencephalon. Last, the anti-Fgf8b antibody used 
in this study has been shown to neutralize the bioactivity of Fgf8b and Fgf8c on 
NR6R-3T3 fibroblasts but not that of Fgf8a. Although a previous study has shown 
that Fgf8b, but not Fgf8a, induces Pax2 expression in the isthmus (Sato et al., 2001), 
it is possible that Fgf8a is also involved in forebrain patterning. In that case, the 
anti-Fgf8b is not sufficient to block completely Fgf8 activity in the telencephalon. In 
fact, other members of the Fgf family, like Fgf17 and Fgf18, are also expressed in 
the anterior pole of the cortical primordium (Bachler and Neubuser, 2001), 
suggesting they might work together to impart antero-posterior patterning.  
 
It is also possible that the expansion of Gli3Xt/Xt mutant ventral telencephalon is the 
result of losing Wnts and Bmps expression from the dorso-medial telencephalon. 
There is evidence that Fgf8 and Wnts and Bmps are antagonists in patterning the 
forebrain (Shimogori et al., 2004). These possibilities will be discussed in the 
Discussion (Chapter 8).  
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6.4 FUTURE STUDIES 
 
The conditions used in this culture experiment were not very well established and 
several changes should be made in future studies in order to improve the 
experimental protocol.  
 
1) The concentration of anti-Fgf8b antibody used in this thesis was the one 
suggested by the manufacturer. The neutralizing ability of this antibody was 
commercially tested using this concentration in cell lines only (R&D system). 
The ability of this antibody to neutralize Fgf8b activity in tissue cultures has 
not been tested yet. In this aspect, a titer experiment with different doses of 
anti-Fgf8b antibody might be crucial to final the optimal antibody 
concentration for complete blockage of Fgf8b activity, using wild type ventral 
telencephalic tissue. 
 
2) The effect of anti-Fgf8b antibody was only tested in a 16-hour culture in this 
thesis. A pilot experiment with different culture duration could be done to 
determine the optimal growth conditions. There is evidence that as culture time 
period increases, embryos show gradual morphological changes after Fgf8b 
bead implantation (Crossley et al., 2001). 
 
3) In these experiments, E9.5 embryos were cultured flat on 6-well dishes, which 
might result in a poor penetration of the antibody. A more sophisticated 
rotating system would be helpful in this aspect (Moore-Scott et al., 2003).   
 
4) In vitro culture normally used media with a high concentration of serum 
(Cockroft, 1991; Van Maele-Fabry et al., 1991). The medium used in this 
study contains 10% fetal bovine serum. This might influence the growth of the 
 181 
explant, and the blockage of Fgf8, since Fgf8 is a member of the fibroblast 
growth factors. A recently developed serum-free culture technique for 
midgestation mouse embryos might be better for allowing growth factor 
studies to be performed without the potentially confounding effects of 

























Chapter 7: Protein expression studies of Gli3 and the 
molecules that might interact with Gli3 in forebrain 




Sonic hedgehog (Shh) has been suggested to be important for dorso-ventral (DV) 
patterning in the CNS. The telencephalon of the Shh-/- mutants is severely 
hypoplastic and ventral structures are absent from very early stages along the neural 
tube (Chiang et al., 1996; Ishibashi and McMahon, 2002; Ishibashi et al., 2005). The 
expression of ventral telencephalic markers, such as Nkx2.1, Gsh1, Olig2 and Lhx6, 
is absent due to the loss of the most of the ventral telencephalon (Corbin et al., 2000; 
Lu et al., 2000; Corbin et al., 2003). On the contrary, dorsal telencephalic markers, 
including Emx1 and Pax6, are expressed throughout most of the remaining 
telencephalic tissue in the Shh-/- mutants (Chiang et al., 1996; Ohkubo et al., 2002). 
These results suggest that the telencephalon of the Shh-/- mutants is ‘dorsalized’. 
Foxg1-/- mutant embryos exhibit similar phenotypes as the Shh-/- mutants: the ventral 
structures are not detectable even at very early developmental stages (Xuan et al., 
1995; Martynoga et al., 2005). Shh expression is reported to be absent from the 
Foxg1-/- telencephalon at E10.5 by Huh et al. (1999), and they suggested that Shh 
might be responsible for the defects in ventral telencephalic development in Foxg1-/- 
embryos (Huh et al., 1999). Shh is shown to inhibit Gli3 being cleaved and the 
balance between full-length and cleaved isoforms of Gli3 is important for neural tube 
patterning (Persson et al., 2002; Meyer and Roelink, 2003; Lei et al., 2004; 
Stamataki et al., 2005). In the ventral spinal cord, increasing the level of full length 
Gli3 results in increased expression of ventral marker genes at the expense of dorsal 
genes (Lei et al., 2004; Stamataki et al., 2005), while overexpression of the cleaved 
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isoform of Gli3 represses ventral identities and induces dorsal marker genes’ 
expression (Persson et al., 2002; Meyer and Roelink, 2003). Similarly in the 
telencephalon, it is possible that an increased level of cleaved Gli3 protein causes the 
dorsalization of the Shh-/- and Foxg1-/- mutant telencephalon.  
 
Fuccillo et al. (2006) have shown that several defects observed in the Shh-/- mutants 
are rescued by removing Pax6. For example, in the Shh-/- single mutants, Dlx2 
expression is lost, and the pallial-subpallial boundary (PSB) is compromised (Chiang 
et al., 1996; Rallu et al., 2002b). By removing Pax6 from the Shh-/- mutants, 
expression of Dlx2 in the dorso-lateral ganglionic eminence (dLGE) is rescued and 
the PSB is partially restored (Fuccillo et al., 2006). Based on the fact that more 
pronounced rescue of the ventral telencephalon was observed in the Shh-/-;Gli3-/- 
compound mutants than that in Shh-/-;Pax6-/- double mutants (Rallu et al., 2002b; 
Fuccillo et al., 2006) and Gli3 expression was shown to be unaffected in either 
Pax6-/-, or Shh-/-;Pax6-/- compound mutants by in situ hybridization, Fuccillo and 
colleagues suggested that Pax6 might be required for Gli3 repressor function in DV 
patterning (Fuccillo et al., 2006). In addition, Pax6 is suggested to be important for 
many aspects of cortical development, such as proliferation, differentiation, cell-cell 
adhesion (Caric et al., 1997; Warren et al., 1999), and crucial for DV patterning 
(Stoykova et al., 2000; Toresson et al., 2000; Yun et al., 2001). Pax6 is expressed in 
the dorsal telencephalon, and the strongest expression is observed in the lateral 
neocortex. Interestingly, the results from analysing the forebrain of Gli3Xt/Xt mutants 
in Chapter 4 and 5 suggest that although the dorsal telencephalon is severely affected 
by the loss of Gli3, part of the dorsal telencephalon is still present in the Gli3Xt/Xt 
mutants, which most likely corresponds to the lateral cortex of wild types. Since the 
DV patterning and cell adhesion properties are affected in the Gli3Xt/Xt mutants, it is 
possible that this might be the result of changes in the amount of Pax6 protein in the 
Gli3Xt/Xt mutant telencephalon. Conversely, it is also possible that some of the defects 
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of the Pax6Sey/Sey mutants that are also observed in the Gli3Xt/Xt mutants, such as D/V 
patterning and cell adhesion defects, might be caused by changes in Gli3 protein 
levels.  
 
In this chapter, western blot studies were used to analyze Gli3 expression in Shh-/- 
and Foxg1-/- mutants to test whether any changes in the amounts of the two isoforms 
were present in the telencephalon of these mutants. The results show that more 
cleaved Gli3 protein is produced when Shh is lost in the telencephalon (in both Shh-/- 
and Foxg1-/- mutants). Gli3 expression in Pax6Sey/Sey mutant telencephalon revealed 
that less cleaved Gli3 isoform is generated when Pax6 is lost. Pax6 protein 
expression was analyzed in the Gli3Xt/Xt mutant telencephalon showing no significant 
differences in the amounts of Pax6 protein between Gli3Xt/Xt mutants and wild types. 
Shh protein expression was also studied in the Gli3Xt/Xt mutant telencephalon, but the 
results are not yet conclusive. These results shed lights on the possible functions of 
Gli3 in DV patterning and the interactions between Gli3 and these molecules (Shh, 




7.2.1 More cleaved Gli3 is generated in Shh-/- and Foxg1-/- mutant telencephalon 
 
As suggested in Chapter 3, Gli3 might act as a repressor of the Shh signalling 
pathway in the dorsal telencephalon. To test whether Gli3 expression is affected by 
the loss of Shh, Gli3 expression was examined in Shh-/- mutant telencephalon by 
western blot analysis. Both the full length (Gli3-F) and the cleaved (Gli3-C) isoforms 
of Gli3 were present in Shh-/- mutant telencephalic tissue (Fig. 7.1A). β-actin 
expression in these tissues was used to control the loadings and allow normalization 
of protein amounts. The relative ratio between the two isoforms (Gli3-C/Gli3-F) was 
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found increased in the Shh-/- mutants (8.66 ± 1.27) to about 5.97 times of that of the 
wild type telencephalon (1.45 ± 0.196) (Fig. 7.1C). The difference between the wild 
types and Shh-/- mutants is statistically significant (Student’s t test, p<0.05, n=4 per 
genotype). In addition, the total amount of Gli3 (Gli3-C+Gli3-F) in the Shh-/- mutants 
(mean optical density (O.D): 4.00 ± 0.50) is significantly increased (Student’s t test, 
p<0.01, n=4 per genotype) to about 2.23 times more than that in the wild type 
littermates (mean O.D: 1.79 ± 0.26) (Fig. 7.1B), suggesting there is more Gli3 
produced in the telencephalon when Shh is lost. The increase of total amount of Gli3 
(Gli3-C+Gli3-F) together with the ratio (Gli3-C/Gli3-F) change in Shh-/- mutants 
suggest that the increase of Gli3 observed in the Shh-/- mutant telencephalon is 
mainly due to an increase of the cleaved isoform (Gli3-C). These results demonstrate 
that more cleaved Gli3 protein is generated when Shh is absent, mimicking Gli3 
expression in the wild type dorsal telencephalon, where Shh is not expressed 
(Chapter 3) (Echelard et al., 1993). And these results also suggest that the 
dorsalization of the Shh-/- telencephalon might be due to increased levels of Gli3 
cleaved isoform.  
 
Ventral telencephalic fate is not specified and Shh expression is completely lost in 
the telencephalon of Foxg1-/- mutant embryos (Xuan et al., 1995; Huh et al., 1999; 
Martynoga et al., 2005). This phenotype is highly reminiscent of that of Shh-/- 
mutants. Both isoforms of Gli3 are expressed in the Foxg1-/- mutant telencephalic 
tissue (Fig. 7.1D), and the ratio between them (11.40 ± 2.39) is increased 
significantly (Student’s t test, p<0.05, n=4) to about 7.86 times that of the wild types 
(Fig. 7.1E). Note the ratio between the Gli3 isoforms is comparable between the 
Shh-/- and Foxg1-/- mutant telencephalon. It is possible that the change in ratio of Gli3 
protein is due to the loss of Shh in the ventral telencephalon. However, this does not 
exclude the possibility that Foxg1 is required to maintain the balance between two 







Figure 7.1 Western blot analysis shows expression of Gli3 in wild type (wt) and Shh-/- 
mutant (Shh KO) embryos (A). Both full length (Gli3-F) and short (Gli3-C) Gli3 
protein are expressed in wild type and Shh-/- tissue. β-actin is used as loading control. 
The total amount (Gli3-C+Gli3-F) (B) and the ratio (Gli3-C/Gli3-F) (C) of Gli3 proteins 
are significantly increased in the Shh-/- mutant telencephalic samples. The 
expression of Gli3 in wild type and Foxg1-/- mutant (Foxg1 KO) embryos is shown in 
D. Both Gli3-C and Gli3-F are present and the ratio of them is significantly increased 





7.2.2 Less Gli3 is cleaved in the Pax6-/- mutant telencephalon 
 
To test the possibility that Pax6 might be required for the generation of Gli3 in the 
telencephalon, western blot with an antibody against Gli3 was performed on 
Pax6Sey/Sey mutants. Both full length and cleaved isoforms of Gli3 were present in 
Pax6Sey/Sey mutant telencephalic tissue, and the total amount of Gli3 (Gli3-C+Gli3-F) 
was comparable with that of wild type littermates (Fig. 7.2A and B). Interestingly, 
the ratio of cleaved Gli3 to full length isoform in Pax6Sey/Sey mutants (0.69 ± 0.11) 
was significantly decreased (Student’s t test, p<0.05, wild types=3 and Pax6Sey/Sey 
mutants=2) to about half that of wild types (1.45 ± 0.196) (Fig. 7.2C). This change in 
ratio is due to both an increase of full length Gli3 (26.7%) and a reduction of cleaved 
Gli3 (29.7%) in the mutant telencephalon and both changes are statistically 
significant (Student’s t test, p<0.05, wild types=3, Pax6Sey/Sey mutants=2) (Fig. 7.2B), 
suggesting that less cleaved Gli3 protein is generated when Pax6 is lost. This result 























Figure 7.2 Western blot analyses with an antibody against Gli3 on wild type (wt) and 
Pax6Sey/Sey mutant (Sey/Sey) telencephalic extracts (A). Both isoforms of Gli3 protein 
(Gli3-C and Gli3-F) are observed in wild type and Pax6Sey/Sey mutant extracts, and 
β-actin is used as a loading control. The total amount of Gli3 (Gli3-C+Gli3-F) is 
comparable between wild type and Pax6Sey/Sey mutants. However, in the Pax6Sey/Sey 
mutant telencephalon, the amount of Gli3-F is increased significantly and Gli3-C is 
significantly reduced (B). As a result, the ratio of Gli3-C/Gli-F is significantly 







7.2.3 Pax6 expression is unaltered in the Gli3Xt/Xt mutant telencephalon 
 
To test whether Pax6 protein expression levels are changed in the Gli3Xt/Xt mutants, 
western blots with an antibody against Pax6 were carried out in Gli3Xt/Xt mutant 
telencephalic tissues. The amount of Pax6 protein in wild type (mean O.D: 3.20 ± 
0.64) was similar to that found in Gli3Xt/Xt mutant telencephalon (mean O.D: 3.44 ± 
0.68). Pax6 expression was further analysed on dorsal and ventral telencephalic 
tissues of wild type and Gli3Xt/Xt mutant embryos. In both samples, Pax6 was 
expressed highly in the dorsal telencephalon (mean O.D is 2.58 ± 0.56 in wild types 
and 2.90 ± 0.47 in mutants), and lightly in the ventral telencephalon (mean O.D is 
0.62 ± 0.08 in wild types and 0.64 ± 0.21 in mutants) (Fig. 7.3B), corresponding to 
its expression pattern observed by immunohistochemistry (Fig. 4.1A-C and A’-C’). 
The differences of Pax6 expression between the dorsal and ventral telencephalon 
were significant (Student’s t test, p<0.05, n=3 per genotype) in both wild type and 
Gli3Xt/Xt mutant embryos (Fig. 7.3C). These results show that Pax6 expression is not 
changed in the Gli3Xt/Xt mutant embryos and Gli3 loss does not affect the expression 




















Figure 7.3 Western blots with anti-Pax6 antibody on wild type (Gli3+/+) and Gli3Xt/Xt 
mutant telencephalic (A) as well as dorsal (dTel) and ventral (vTel) telencephalic 
extracts (B). β-actin expression in these tissues is used as loading control. Pax6 
expression is unaltered in the Gli3Xt/Xt mutant embryos compared to wild types. The 
highdorsal-to-lowventral expression pattern of Pax6 is observed in both wild type and 








7.2.4 The amount of Shh protein is not likely to be increased in Gli3Xt/Xt mutant 
telencephalon 
 
As shown in Chapter 5, the Shh expression pattern is comparable in E10.5 and E9.5 
wild type and Gli3Xt/Xt mutant embryos (Fig. 5.8). To explore whether there is any 
change in the amount of Shh protein produced in the Gli3Xt/Xt mutant telencephalon, 
western blots were performed with a Shh antibody. Mouse Shh is a glycoprotein that 
is proteolytically cleaved into two smaller isoforms (Bumcrot et al., 1995), a 19 kDa 
N-terminal peptide that mediates all Shh signalling activities (Hammerschmidt et al., 
1997), and a 28 kDa C-terminal product that is responsible for the protein cleavage 
(Porter et al., 1995). The antibody used in this study is generated against the 
biologically active amino-terminal fragment of Shh (Ericson et al., 1996), and in 
theory, it should recognize both the full length and N-terminal Shh protein in wild 
type telencephalic and ventral telencephalic tissues, but not in wild type dorsal 
telencephalic extracts or Shh-/- mutant extracts. This antibody showed many bands, 
not only in wild type and Gli3Xt/Xt mutant embryos, but also in Shh-/- mutant 
telencephalic tissues, although at a lower level (lane a, b and c in Fig. 7.4, 
respectively). In wild type samples, four bands around 50 kDa were observed, which 
might correspond to the full length Shh protein (1, 2, 3 and 4 in lane a in Fig. 7.4). 
These bands disappeared in the Shh-/- mutant tissue (lane c in Fig. 7.4), but 1 and 2 
appeared in the wild type dorsal telencephalon (lane d in Fig. 7.4), suggesting they 
might be non-specific bands. The other two bands around 50 kDa (band 3 and 4 in 
Fig. 7.4) might correspond to the lipid modified and unmodified full length Shh 
protein. They disappeared in wild type dorsal telencephalic tissue (lane d in Fig. 7.4), 
but were present in wild type and Gli3Xt/Xt ventral telencephalic extracts (lane e and g 
in Fig. 7.4) as well as in the Gli3Xt/Xt dorsal telencephalic extract (lane f in Fig. 7.4). 
There are several bands detected around 20 kDa, in which two are the most 
prominent and might correspond to the lipid modified and unmodified N-terminal 
 192 
Shh protein (band 5 and 6 in Fig. 7.4). However, these bands also appeared in the 
wild type dorsal telencephalic tissue (lane d in Fig. 7.4). Nevertheless, these two 
bands seemed to be expressed at a lower level in the Gli3Xt/Xt mutant telencephalic 
extracts (lane b in Fig. 7.4), as well as in dorsal and ventral telencephalic extracts 
(lane f and g in Fig. 7.4, respectively) compared to those of wild types (lane a, d and 
e in Fig. 7.4). Whether there is any change in the amount of Shh protein in the 
Gli3Xt/Xt mutant telencephalon is still obscure, since this antibody does not seem to be 



























Figure 7.4 Western blot with anti-Shh antibody on wild type (lane a, d and e), Gli3Xt/Xt 
mutant (lane b, f and g), and Shh-/- mutant tissue (lane c). Lanes a, b and c are 
extracts from wild type, Gli3Xt/Xt mutant and Shh-/- mutant telencephalon (Tel), 
respectively. Lanes d and e are extracts from wild type dorsal (dTel) and ventral (vTel) 
telencephalon, respectively, and f and g are tissue from Gli3Xt/Xt mutant dorsal and 
ventral telencephalon, respectively. At least four bands (1, 2, 3 and 4) are observed 
at around 50 kDa in wild type tissue, which might correspond to the full length Shh 
protein. 5 and 6 are about 20 kDa, and they might correspond to the N-terminal Shh 








The Gli3 expression study in Chapter 3 reveals that in the wild type dorsal 
telencephalon where Shh is not expressed, more cleaved Gli3 protein is produced. 
This result suggests that Gli3 in the dorsal telencephalon may act as a repressor of 
the Shh signalling pathway. In this chapter, the ratios between the two isoforms of 
Gli3 protein were examined in Shh-/- and Foxg1-/- mutant embryos, which lack ventral 
telencephalon and Shh expression (Xuan et al., 1995; Chiang et al., 1996; Huh et al., 
1999; Ishibashi and McMahon, 2002; Ishibashi et al., 2005; Martynoga et al., 2005). 
The ratios of the Gli3 isoforms were found significantly increased in these mutants, 
agreeing with the notion that Shh prevents the cleavage of Gli3. In the absence of 
both Shh and Foxg1, Gli3 produces higher amounts of the cleaved isoform. This 
might be the primary cause of the dorsolization defects in both of these mutants. In 
addition, the total amount of Gli3 is significantly increased in the Shh-/- mutants, 
especially the cleaved isoform, indicating that Shh is required to repress Gli3 in the 
ventral telencephalon. 
 
The ratio of Gli3 proteins in the Pax6 mutants is changed, although the total amount 
of Gli3 remains the same as in wild types. These results show that the predominant 
isoform of Gli3 is the full length protein when Pax6 is lost, in agreement with the 
hypothesis that Pax6 might be responsible for the cleavage of Gli3 (Fuccillo et al., 
2006). However, this can not exclude the possibility that the change in the ratio of 
the Gli3 isoforms may simply be because the telencephalon of the Pax6Sey/Sey mutants 
is partially ventralized (Stoykova et al., 1996; Stoykova et al., 2000; Yun et al., 
2001), and the expanded expression of Shh (Stoykova et al., 2000) inhibits the 
generation of more short Gli3 isoforms.  
 
In the wild type, Pax6 is expressed in the dorsal telencephalon, and its highest 
 195 
expression is observed in the lateral neocortex dorsally to the pallial-subpallial 
boundary (PSB) (Walther and Gruss, 1991; Stoykova et al., 2000). This region is 
ventralized, and the PSB is compromised when Pax6 is lost (Stoykova et al., 2000; 
Yun et al., 2001). Interestingly, this region is present in the Gli3Xt/Xt mutant embryos, 
whereas a large part of the rest of the dorsal telencephalon is lost (Grove et al., 1998; 
Theil et al., 1999; Tole et al., 2000a). This raises the possibility that Pax6 is crucial 
for the formation of the lateral cortex in Gli3Xt/Xt mutant embryos. Pax6 expression in 
the Gli3Xt/Xt mutants does not seem to have changed, which is in agreement with the 
results obtained from the immunohistochemistry. 
 
The expression of Shh by western blots does not seem to show any changes in the 
Gli3Xt/Xt mutant telencephalon, in agreement with the results revealed from the 
immunohistochemistry and in situ hybridization experiments (Chapter 5.2.7). Quite a 
few bands are observed with the Shh antibody, not only in the wild type embryos, but 
also in the Shh-/- mutants. It is possible that this antibody recognizes the other 
members of the hedgehog family, namely, Indian hedgehog (Ihh) or Desert hedgehog 
(Dhh), although so far, there is no evidence for their expression in the developing 
telencephalon. These western blots also can not exclude the possibility that Shh is 
expressed at a low level in the Gli3Xt/Xt mutant dorsal telencephalon. This has never 
been observed by immunohistochemistry or in situ hybridization, and it might be 
possible since western blotting is a very sensitive approach. Shh expression was also 
studied using another anti-Shh antibody (Ab19897, Abcam), which also detected 
several bands in the Shh-/- mutant telencephalic tissue. A more specific anti-Shh 






Chapter 8: Discussion 
 
Potential signalling centres have been identified and studied in the mouse forebrain, 
and there is evidence that they regulate the patterning process of the telencephalon 
along both the AP and DV axes (Shimamura and Rubenstein, 1997; Ye et al., 1998; 
Rubenstein et al., 1999; Lee et al., 2000; Fukuchi-Shimogori and Grove, 2001; 
Ragsdale and Grove, 2001; Hebert et al., 2002; O'Leary and Nakagawa, 2002; 
Ohkubo et al., 2002; Fukuchi-Shimogori and Grove, 2003; Garel et al., 2003; Grove 
and Fukuchi-Shimogori, 2003; Ligon et al., 2003). The candidate signalling 
molecules secreted from these signalling centres include Fibroblast growth factors 
(Fgf) (Fukuchi-Shimogori and Grove, 2001, 2003; Garel et al., 2003), Wingless-Int 
(Wnt) (Galceran et al., 2000; Lee et al., 2000), Bone morphogenetic proteins (Bmp) 
(Hebert and McConnell, 2000; Panchision et al., 2001), Sonic hedgehog (Shh) 
(Ericson et al., 1995b; Dale et al., 1997; Kohtz et al., 1998; Rubenstein and Beachy, 
1998; Gunhaga et al., 2000; Machold et al., 2003; Fuccillo et al., 2006) and Retinoic 
acid (RA) (LaMantia, 1999; Toresson et al., 1999; Schneider et al., 2001; Smith et al., 
2001; Marklund et al., 2004). In the developing telencephalon, these signalling 
molecules impart position and regulate regional growth by interacting with 
transcription factors. Studies have also demonstrated that these signalling centres 
interact with each other in the developing telencephalon. In this thesis, several 
approaches have been undertaken to elucidate the function of the transcription factor 
Gli3 in forebrain development. Severe telencephalic defects are observed in mice 
lacking functional Gli3, indicating a role in patterning the telencephalon.  
 
8.1 Shh and Gli pathway in the developing forebrain  
 
The Shh and Gli pathway is important for many aspects of the development of the 
CNS (Dahmane et al., 2001; Ruiz i Altaba et al., 2002a; Ruiz i Altaba et al., 2002b; 
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Ruiz i Altaba et al., 2003). In this thesis, the interaction between Shh and Gli3 has 
been analyzed by several approaches. Loss of Gli3 results in an expansion of ventral 
markers’ expression in the telencephalon as early as E10.5 (Chapter 5.2.6). Shh is 
shown to be responsible for the generation of several of them, for example, Nkx2.1 
and Olig2 (Goodrich et al., 1997; Kohtz et al., 1998; Lu et al., 2000; Zhou et al., 
2000; Tekki-Kessaris et al., 2001; Rallu et al., 2002b; Gulacsi and Anderson, 2006). 
The expansion of the expression of ventral markers might be the result of ectopic 
activation of the Shh signalling pathway in the ventral telencephalon. This possibility 
has been tested here by in situ hybridization and immunohistochemistry (Chapter 
5.2.7), and western blot analysis (Chapter 7.2.4). These results show no evidence for 
Shh and its downstream targets being ectopically expressed in Gli3Xt/Xt mutant 
ventral telencephalon, in agreement with previous works (Theil et al., 1999; Tole et 
al., 2000a; Aoto et al., 2002). However, the loss of tissue from the mutant dorsal 
telencephalon results in an abnormal joining of the telencephalon with the 
diencephalon, and a shape change of these structures. These changes might lead to 
changes in the position of these signalling centres and probably their diffusion in the 
extracellular matrix. The position of the Shh source in the diencephalon, particularly 
in the ZLI, is changed in the Gli3Xt/Xt mutants. In addition, there is evidence that the 
mutant diencephalon is bigger compared to that of the wild types (Aoto et al., 2002) 
(this study). It is possible that Shh signalling from the diencephalon influences gene 
expression in the Gli3Xt/Xt mutant telencephalon. Other sources of Shh outside the 
forebrain might also be involved in telencephalic patterning during early 
embryogenesis, for example, Shh in the notochord, the floor plate and the prechordal 
plate (Echelard et al., 1993; Krauss et al., 1993; Roelink et al., 1994; Ericson et al., 
1995a; Marti et al., 1995b; Roelink et al., 1995; Ericson et al., 1996; Dale et al., 1997; 
Dale et al., 1999).  
 
Changes in expression of other members of the Gli family might also contribute to 
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the patterning of the telencephalon. Gli2 is expressed in the developing 
telencephalon, mainly ventrally, and has been shown to function as an activator of 
the Shh signalling pathway in the spinal cord and limb (Mo et al., 1997; Ruiz i 
Altaba, 1999; Sasaki et al., 1999; Jacob and Briscoe, 2003). Studies in chick and 
mouse provide evidence that the activator function of Gli2 and Gli3 partially overlap 
downstream of Shh signalling in patterning and cell fate specification in the spinal 
cord (Motoyama et al., 2003; Lei et al., 2004) and in skeletal formation (Mo et al., 
1997). In fact, results from the Gli3 protein analysis show that a high level of the 
cleaved isoform forms in the dorsal telencephalon, which is severely affected by the 
loss of Gli3. In the ventral telencephalon, where there is more full length Gli3, Gli2 
might function as an activator to compensate for the loss of Gli3 activity and that 
might account for the lack of severe phenotypic defects. 
 
8.2 Gli3 and Wnt and Bmp signalling in forebrain patterning 
 
One extreme requirement for Gli3 is in the dorsal midline area of the telencephalon. 
Studies have shown that the dorso-medial telencephalic wall fails to invaginate and 
midline structures, including the cortical hem, hippocampus and choroid plexus in 
the lateral ventricles, are lost in the Gli3Xt/Xt mutant embryos from very early stages 
(Grove et al., 1998; Theil et al., 1999). The expression of Wnt and Bmp genes is lost 
specifically from these regions (Grove et al., 1998; Theil et al., 1999). In this study, 
loss of Wnt8b expression from the Gli3Xt/Xt mutant telencephalon already at E9 
(Chapter 5.2.5), indicates a more extensive loss of the dorsal tissue, including the 
dorso-medial telencephalon and part of the dorsal telencephalon. It is still unknown 
whether the loss of dorsal tissue or the loss of Wnt/Bmp is the primary defect in 
Gli3Xt/Xt mutants. The fact that Wnt and Bmp expression is lost specifically from the 
telencephalon might indicate that the loss of dorsal tissue is the primary defect. 
However, it is possible that the interactions between Gli3 and Wnt/Bmp in the 
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telencephalon are different from other regions of the developing nervous system.  
 
Wnt and Bmp signalling might also be responsible for DV patterning in the Gli3Xt/Xt 
mutant telencephalon. Wnt and Bmp signalling have been shown to regulate Emx1 
and Emx2 expression in the dorsal telencephalon, and loss of Wnt and Bmp 
expression might correlate with the severe reduction and/or loss of Emx1 and Emx2 
in the dorsal telencephalon of Gli3Xt/Xt mutants (Tole et al., 2000a; Ohkubo et al., 
2002; Theil et al., 2002a). The loss of Wnt and Bmp genes from the dorso-medial 
telencephalon might also be involved in the expansion of Gli3Xt/Xt ventral 
telencephalon (Chapter 5.2.6). Wnt3a can induce dorsal cell fate, including Pax6 and 
Ngn2 expression, and repress ventral cell fate (Gunhaga et al., 2003). It is possible 
that the loss of Wnt and Bmp signalling in the Gli3Xt/Xt mutant embryos relieves that 
repression leading to the expansion of the ventral telencephalon.  
 
The Wnts and their inhibitor SFRP2 (secreted frizzled related protein-2) (Rattner et 
al., 1997; Dennis et al., 1999; Ladher et al., 2000) expressed in the pallial-subpallial 
boundary (PSB) and eminentia thalami, may also influence telencephalic patterning. 
Wnts and SFRP2 expression at these sites is negatively regulated by Pax6 (Kim et al., 
2001). In addition, starting at E10.5, eminentia thalami cells can be detected in the 
Gli3Xt/Xt mutant neocortex (Fotaki et al., 2006). It would not be surprising if Wnt 
signalling is increased in the diencephalon of Gli3Xt/Xt mutants, and Wnts and SFRP2 
from the eminentia thalami affect dorsal telencephalic patterning in the mutants. 
However, more experiments need to be carried out to test this.  
 
8.3 Gli3 and Fgf signalling in forebrain patterning 
 
Fgf8 has been shown to induce ventral cell fate and repress dorsal cell fate in dorsal 
telencephalic explants (Kuschel et al., 2003). It has been hypothesized that Fgf8 
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induces ventral markers’ expression in Gli3Xt/Xt mutants, because Fgf8 expression is 
expanded in the rostral telencephalon of Gli3Xt/Xt mutants (Theil et al., 1999; Aoto et 
al., 2002; Kuschel et al., 2003). In this thesis, detailed morphological studies of the 
Gli3Xt/Xt mutant telencephalon strongly suggest that the mutant septum is enlarged 
(Chapter 5.2.8). Fgf8 null mutants die during gastrulation, whereas the Fgf8 
hypomorphic and telencephalic conditional Fgf8 knock-out mutants survive until 
birth. These mutants show an increase in dorsal telencephalic gene expression, such 
as Pax6, Emx2 and Tbr1, and they do not have septal structures (Meyers et al., 1998; 
Sun et al., 1999; Garel et al., 2003; Storm et al., 2003; Storm et al., 2006). These 
results further indicate the interactions between Gli3 and Fgf8 in ventral 
telencephalic formation. Whether Fgf8 is directly responsible for the expansion of 
rostro-ventral fate in the Gli3Xt/Xt mutants has been tested in this thesis (Chapter 6), 
but the results have not been conclusive. 
 
Fgf8 has also been implicated in dorsal telencephalic development, specifically, by 
regulating Emx2 expression. Studies have shown that exogenous Fgf8 can repress 
Emx2 expression (Crossley et al., 2001; Storm et al., 2003), and Emx2 expression is 
increased in Fgf8 mutants (hypomorphic and telencephalic conditional knock-out 
embryos) (Garel et al., 2003; Storm et al., 2003; Storm et al., 2006). Emx2 expression 
is largely lost in the Gli3Xt/Xt mutants (Theil et al., 1999; Tole et al., 2000a; Theil et 
al., 2002a), which could also be the result of an increase in Fgf8 signalling.  
 
Other members of the Fgf family might also influence forebrain patterning, for 
example, Fgf17 and Fgf18. Fgf8, Fgf17 and Fgf18 are expressed in the anterior 
telencephalon (ANR) and the isthmus during early development (Maruoka et al., 
1998; Xu et al., 1999; Shinya et al., 2001), and they have similar receptor specificity 
and ability to induce proliferation (Xu et al., 1999; Xu et al., 2000). Furthermore, a 
study in cerebellum development has shown an overlap in function between Fgf8 and 
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Fgf17 (Xu et al., 2000). A more recent study has pointed out the importance of Fgf17 
in telencephalic patterning (Cholfin and Rubenstein, 2007). In new born mice, the 
loss of Fgf17 selectively reduces the size of dorso-rostral telencephalon, whereas the 
ventral part appears normal (Cholfin and Rubenstein, 2007). Whether Fgf17 
expression is expanded in the Gli3Xt/Xt mutant telencephalon, and whether it is 
responsible for the loss of dorsal cell fate in the Gli3Xt/Xt mutants, needs to be 
examined.  
 
8.4 Gli3 and Retinoic acid signalling 
 
Gli3 is highly expressed in the developing dorsal telencephalon (Chapter 3.2), and 
the loss of Gli3 results in partial loss of the dorsal telencephalon, lack of lamination 
and formation of rosette-like structures (Chapter 4.2.6 and 5.2.3-5). The fact that not 
all the dorsal telencephalon is lost in Gli3Xt/Xt mutants suggests that some other 
factors might contribute to promote dorsal telencephalic fate. Pax6, which is highly 
expressed in the dorsal telencephalon in a highlateral-to-lowmedial fashion, is largely 
unchanged in the Gli3Xt/Xt mutants, and the highest Pax6 expression site, the lateral 
cortex, is still observed in the Gli3Xt/Xt mutants. Pax6 expression in the dorsal 
telencephalon is partially regulated by Wnt signalling (Gunhaga et al., 2003). 
However, Wnt expression is lost from the Gli3Xt/Xt mutant dorsal telencephalon, 
suggesting there might be other signals responsible for the Pax6 expression in the 
lateral cortex of Gli3Xt/Xt mutants. RA signalling has been shown to be responsible 
for telencephalic intermediate fates, including Pax6 expression in the lateral cortex 
and dorsal LGE (Marklund et al., 2004). A study has shown that RA-dependent gene 
expression is absent in the Gli3Xt/Xt mutant forebrain (LaMantia, 1999). In addition, it 
has been proposed that RA signalling might contribute to the rescue of LGE fates in 
Shh-/-;Gli3-/- double mutants (Rallu et al., 2002b). However, how RA signalling 




8.5 Interactions between signalling centres in forebrain development 
 
Accumulating data from studies in telencephalic development have implied that the 
signalling centres interact to regulate one another. There is evidence that Fgf from 
the ANR antagonizes the Bmp/Wnt in the dorsal midline area (Fukuchi-Shimogori 
and Grove, 2001; Shimogori et al., 2004). In chick, Fgf8 expression is downregulated 
by Bmp4 in the anterior telencephalon (Ohkubo et al., 2002), and in mouse, noggin 
can induce ectopic Fgf8 expression in the cortical neuroepithelium (Shimogori et al., 
2004). In mice lacking chordin and having only one copy of noggin, Bmp activity is 
increased and Fgf8 expression is lost from the ANR (Anderson et al., 2002). These 
findings suggest that Bmp represses Fgf8 expression in the ANR.  
 
Wnt signalling is required to generate dorsal telencephalic cells in chick embryos, 
including Pax6, Ngn2 and Emx1 positive cells (Gunhaga et al., 2003). Wnts can 
induce dorsal cell fate in ventral telencephalic cells, and suppress ventral cell fate 
(Gunhaga et al., 2003). Fgf8 has been shown to be necessary for the generation of 
Emx1 and Emx2 positive cells in the dorsal telencephalon (Crossley et al., 2001; 
Gunhaga et al., 2003; Storm et al., 2003), but not Pax6 or Ngn2 positive cells 
(Gunhaga et al., 2003). Furthermore, the increase of Fgf8 in the ANR leads to a 
reduction of Wnt3a expression in the cortical hem (Shimogori et al., 2004). This 
evidence highlights the importance of the interactions between Wnt and Fgf 
signalling in dorsal telencephalic development.  
 
In the Gli3Xt/Xt telencephalon, Fgf8 expression is expanded rostrally, whereas Bmp 
and Wnt genes are lost specifically from the dorsal midline area (Grove et al., 1998; 
Theil et al., 1999; Tole et al., 2000a; Aoto et al., 2002). These results suggest that 
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Gli3 might function upstream of Wnt, Bmp and Fgf8 signalling in telencephalic 
development in three possible ways:  
 
1. Gli3 negatively regulates Fgf8 directly and loss of Gli3 increases Fgf8 expression 
in the ANR, which in turn suppresses Wnts and Bmps in the dorsal midline.  
 
2. Loss of Gli3 leads to loss of Wnts and Bmps expression in the dorsal midline, 
which in turn relieves the inhibition of Fgf8.  
 
3. Gli3 regulates these pathways in parallel.  
 
Both Shh and Fgf8 signalling are required to generate ventral telencephalic fate, but 
the interaction between them is still largely unknown. Studies from Shh-/-;Gli3-/- 
double mutants (Aoto et al., 2002; Rallu et al., 2002b) and mutants for Fgf receptors 
(Gutin et al., 2006) have suggested that Shh and Fgf signalling work in parallel to 
generate ventral precursors. In the rostral telencephalon, Shh is shown to be 
necessary to maintain Fgf8 expression (Ohkubo et al., 2002). In the Shh-/- mutants, 
Fgf8 expression is lost from the ANR (Ohkubo et al., 2002), which may be due to an 
activation of the repressor form of Gli3 (Chapter 6). By contrast, Fgf8 expression is 
expanded in the Gli3Xt/Xt mutants (Theil et al., 1999; Aoto et al., 2002; Kuschel et al., 
2003). In Shh-/-;Gli3-/- double mutants, where Gli3 no longer exists, Fgf8 expression 
is still expanded (Aoto et al., 2002). These results suggest that Shh regulates Fgf8 
expression indirectly, by repressing Gli3 activity.  
 
8.6 Gli3 and cell proliferation and cell differentiation 
 
Gli3 is mainly expressed in proliferating cells (Chapter 3.2), which suggests that Gli3 
might play a role in cell proliferation. However, the study of cell cycle parameters, 
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including the duration of S-phase and cell cycle in the Gli3Xt/Xt mutants, revealed no 
significant defects (Chapter 5.2.2). The only difference detected was in the labelling 
index in the E10.5 Gli3Xt/Xt mutant dorsal telencephalon, but not ventrally (Chapter 
5.2.2), nor at later ages (E12.5 and E13.5, Chapter 4.2.7) (Theil et al., 1999). An 
increase in labelling index would be expected to result in an overgrowth of tissue at 
later stages. However, at E12.5, the dorsal telencephalon of the Gli3Xt/Xt mutants is 
smaller compared to that of wild types (Chapter 4.2.3). These results are quite hard to 
interpret without further analysis and can not exclude the possibility that Gli3 may 
regulate other aspects of the cell cycle. Gli3 seems to regulate cell differentiation in a 
specific region at a specific time (Chapter 5.2.3). However, the exact role of Gli3 in 
cell differentiation needs to be further studied, for example, the fraction of daughter 
cells which leave the cell cycle (Q fraction).  
 
8.7 Gli3 and cell survival 
 
Several lines of evidence have indicated a role of Gli3 in regulating cell survival. 
Aoto et al. (2002) have reported that cell death is lost from the Gli3Xt/Xt mutant 
dorso-medial telencephalon. In vitro studies have shown that telencephalic cells of 
E14.5 and E15.5 Gli3Xt/Xt mutant embryos survive better than those of wild types, 
and are more resistant to cell death induced by exogenous factors (Zaki et al., 2005). 
In this thesis, increased apoptosis has been observed in the ventral midline, as well as 
a reduction in the dorsal midline of the Gli3Xt/Xt mutant telencephalon at E10.5 
(Chapter 5.2.4). The loss of apoptotic cells in the dorsal midline might actually 
reflect a tissue loss in the Gli3Xt/Xt mutant embryos. However, the results from the 
analysis of the ventral telencephalon show an increase of apoptotic cells in E10.5 
Gli3Xt/Xt mutants, suggesting that Gli3 might inhibit cell death at a specific place and 
time point during early embryogenesis.  
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In vitro studies have shown that exogenous Bmp2 and Bmp4 can induce cell death in 
telencephalic explant cultures (Furuta et al., 1997; Ohkubo et al., 2002), and the Bmp 
antagonist noggin has been shown to inhibit apoptosis in limb (Bastida et al., 2004), 
suggesting Bmp signalling is important for cell survival. Shh-/- mutants exhibit 
ectopic cell death in spinal cord and an increase in Bmp and Msx expression (Chiang 
et al., 1996; Litingtung and Chiang, 2000; Ohkubo et al., 2002). However, since Bmp 
expression is lost from the Gli3Xt/Xt mutant telencephalon, this is less likely to be the 
apoptotic inducer.  
 
In the telencephalon, loss or increase of Fgf8 expression can induce cell death, and a 
reduced level of Fgf8 expression promotes cell survival (Ohkubo et al., 2002; Storm 
et al., 2003). Perhaps, the increased level of Fgf8 is responsible for the increase in 




The present study re-examined the forebrain defects of the Gli3Xt/Xt mutants. These 
results shed light into the function of Gli3 in the developing mouse forebrain. Gli3 
seems to be involved in many aspects of forebrain development, such as, establishing 
the dorso-medial telencephalon, establishing the dorsal and ventral boundary 
between the telencephalon and the diencephalon, repressing ventral telencephalic 
fate, regulating the size and shape of the telencephalon and the diencephalon, and 
regulating cell death in the ventral telencephalon in both dorso-ventral and 
rostro-caudal axis. Accumulating data suggest that Gli3 regulates the expression of 
and the response to morphogenetic signals. It would be important to identify the 
direct and indirect downstream targets of Gli3 and investigate the exact interactions 
between Gli3 and these signalling molecules in order to explore further their 
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